
<html lang="en"     class="pb-page"  data-request-id="787fcfdc-e49a-4697-a1f8-8d68ceda09c7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b00177"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation" /></meta><meta name="dc.Creator" content="Berthold A.  Nock" /></meta><meta name="dc.Creator" content="David  Charalambidis" /></meta><meta name="dc.Creator" content="Werner  Sallegger" /></meta><meta name="dc.Creator" content="Beatrice  Waser" /></meta><meta name="dc.Creator" content="Rosalba  Mansi" /></meta><meta name="dc.Creator" content="Guillaume P.  Nicolas" /></meta><meta name="dc.Creator" content="Eleni  Ketani" /></meta><meta name="dc.Creator" content="Anastasia  Nikolopoulou" /></meta><meta name="dc.Creator" content="Melpomeni  Fani" /></meta><meta name="dc.Creator" content="Jean-Claude  Reubi" /></meta><meta name="dc.Creator" content="Theodosia  Maina" /></meta><meta name="dc.Description" content="We have previously reported on the gastrin releasing peptide receptor (GRPR) antagonist [99mTc]1, ([99mTc]demobesin 1, 99mTc-[N4′-diglycolate-dPhe6,Leu-NHEt13]BBN(6–13)). [99mTc]1 has shown superio..." /></meta><meta name="Description" content="We have previously reported on the gastrin releasing peptide receptor (GRPR) antagonist [99mTc]1, ([99mTc]demobesin 1, 99mTc-[N4′-diglycolate-dPhe6,Leu-NHEt13]BBN(6–13)). [99mTc]1 has shown superio..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 8, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00177" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00177" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00177" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00177" /></link>
        
    
    

<title>New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00177" /></meta><meta property="og:title" content="New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0011.jpeg" /></meta><meta property="og:description" content="We have previously reported on the gastrin releasing peptide receptor (GRPR) antagonist [99mTc]1, ([99mTc]demobesin 1, 99mTc-[N4′-diglycolate-dPhe6,Leu-NHEt13]BBN(6–13)). [99mTc]1 has shown superior biological profile compared to analogous agonist-based 99mTc-radioligands. We herein present a small library of [99mTc]1 mimics generated after structural modifications in (a) the linker ([99mTc]2, [99mTc]3, [99mTc]4), (b) the peptide chain ([99mTc]5, [99mTc]6), and (c) the C-terminus ([99mTc]7 or [99mTc]8). The effects of above modifications on the biological properties of analogs were studied in PC-3 cells and tumor-bearing SCID mice. All analogs showed subnanomolar affinity for the human GRPR, while most receptor-affine 4 and 8 behaved as potent GRPR antagonists in a functional internalization assay. In mice bearing PC-3 tumors, [99mTc]1–[99mTc]6 exhibited GRPR-specific tumor uptake, rapidly clearing from normal tissues. [99mTc]4 displayed the highest tumor uptake (28.8 ± 4.1%ID/g at 1 h pi), which remained high even after 24 h pi (16.3 ± 1.8%ID/g), well surpassing that of [99mTc]1 (5.4 ± 0.7%ID/g at 24 h pi)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00177"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00177">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00177&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00177&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00177&amp;href=/doi/10.1021/acs.jmedchem.8b00177" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3138-3150</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00156" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00208" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">New Gastrin Releasing Peptide Receptor-Directed [<sup>99m</sup>Tc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Berthold A. Nock</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Berthold A. Nock</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Radiopharmacy, INRASTES, National Center for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Berthold+A.++Nock">Berthold A. Nock</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Charalambidis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Charalambidis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Radiopharmacy, INRASTES, National Center for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Charalambidis">David Charalambidis</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Werner Sallegger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Werner Sallegger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">piCHEM, A-8045 Graz, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Werner++Sallegger">Werner Sallegger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Beatrice Waser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Beatrice Waser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, CH-3010 Berne, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Beatrice++Waser">Beatrice Waser</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rosalba Mansi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rosalba Mansi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Divisions of Radiopharmaceutical Chemistry, University Hospital Basel, CH-4031 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rosalba++Mansi">Rosalba Mansi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guillaume P. Nicolas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guillaume P. Nicolas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nuclear Medicine, University Hospital Basel, CH-4031 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guillaume+P.++Nicolas">Guillaume P. Nicolas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eleni Ketani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eleni Ketani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Radiopharmacy, INRASTES, National Center for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eleni++Ketani">Eleni Ketani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anastasia Nikolopoulou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anastasia Nikolopoulou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Radiopharmacy, INRASTES, National Center for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anastasia++Nikolopoulou">Anastasia Nikolopoulou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Melpomeni Fani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melpomeni Fani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Divisions of Radiopharmaceutical Chemistry, University Hospital Basel, CH-4031 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melpomeni++Fani">Melpomeni Fani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean-Claude Reubi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-Claude Reubi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, CH-3010 Berne, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Claude++Reubi">Jean-Claude Reubi</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Theodosia Maina</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Theodosia Maina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Radiopharmacy, INRASTES, National Center for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +30 210 650 3908. E-mail: <a href="/cdn-cgi/l/email-protection#1d707c74737c426975787c5d757269707c7471337e7270"><span class="__cf_email__" data-cfemail="92fff3fbfcf3cde6faf7f3d2fafde6fff3fbfebcf1fdff">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Theodosia++Maina">Theodosia Maina</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1123-2486" title="Orcid link">http://orcid.org/0000-0002-1123-2486</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00177&amp;href=/doi/10.1021%2Facs.jmedchem.8b00177" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3138–3150</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 8, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 February 2018</li><li><span class="item_label"><b>Published</b> online</span>8 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00177" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00177</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3138%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBerthold%2BA.%2BNock%252C%2BDavid%2BCharalambidis%252C%2BWerner%2BSallegger%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D7%26contentID%3Dacs.jmedchem.8b00177%26title%3DNew%2BGastrin%2BReleasing%2BPeptide%2BReceptor-Directed%2B%255B99mTc%255DDemobesin%2B1%2BMimics%253A%2BSynthesis%2Band%2BComparative%2BEvaluation%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3150%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00177"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">721</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00177" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Berthold&quot;,&quot;last_name&quot;:&quot;A. Nock&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Charalambidis&quot;},{&quot;first_name&quot;:&quot;Werner&quot;,&quot;last_name&quot;:&quot;Sallegger&quot;},{&quot;first_name&quot;:&quot;Beatrice&quot;,&quot;last_name&quot;:&quot;Waser&quot;},{&quot;first_name&quot;:&quot;Rosalba&quot;,&quot;last_name&quot;:&quot;Mansi&quot;},{&quot;first_name&quot;:&quot;Guillaume&quot;,&quot;last_name&quot;:&quot;P. Nicolas&quot;},{&quot;first_name&quot;:&quot;Eleni&quot;,&quot;last_name&quot;:&quot;Ketani&quot;},{&quot;first_name&quot;:&quot;Anastasia&quot;,&quot;last_name&quot;:&quot;Nikolopoulou&quot;},{&quot;first_name&quot;:&quot;Melpomeni&quot;,&quot;last_name&quot;:&quot;Fani&quot;},{&quot;first_name&quot;:&quot;Jean-Claude&quot;,&quot;last_name&quot;:&quot;Reubi&quot;},{&quot;first_name&quot;:&quot;Theodosia&quot;,&quot;last_name&quot;:&quot;Maina&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3138-3150&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00177&quot;},&quot;abstract&quot;:&quot;We have previously reported on the gastrin releasing peptide receptor (GRPR) antagonist [99mTc]1, ([99mTc]demobesin 1, 99mTc-[N4′-diglycolate-dPhe6,Leu-NHEt13]BBN(6–13)). [99mTc]1 has shown superior biological profile compared to analogous agonist-based 99mTc-radioligands. We herein present a small library of [99mTc]1 mimics generated after structural modifications in (a) the linker ([99mTc]2, [99mTc]3, [99mTc]4), (b) the peptide chain ([99mTc]5, [99mTc]6), and (c) the C-terminus ([99mTc]7 or [99mTc]8). The effects of above modifications on the biological properties of analogs were studied in PC-3 cells and tumor-bearing SCID mice. All analogs showed subnanomolar affinity for the human GRPR, while most receptor-affine 4 and 8 behaved as potent GRPR antagonists in a functional internalization assay. In mice bearing PC-3 tumors, [99mTc]1–[99mTc]6 exhibited GRPR-specific tumor uptake, rapidly clearing from normal tissues. [99mTc]4 displayed the highest tumor uptake (28.8 ± 4.1%ID/g at 1 h pi), which remained hig&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00177&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00177" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00177&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00177" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00177&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00177" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00177&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00177&amp;href=/doi/10.1021/acs.jmedchem.8b00177" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00177" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00177" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00177%26sid%3Dliteratum%253Aachs%26pmid%3D29517903%26genre%3Darticle%26aulast%3DNock%26date%3D2018%26atitle%3DNew%2BGastrin%2BReleasing%2BPeptide%2BReceptor-Directed%2B%255B99mTc%255DDemobesin%2B1%2BMimics%253A%2BSynthesis%2Band%2BComparative%2BEvaluation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D7%26spage%3D3138%26epage%3D3150%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/jmcmar.2018.61.issue-7/20180412/jmcmar.2018.61.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have previously reported on the gastrin releasing peptide receptor (GRPR) antagonist [<sup>99m</sup>Tc]<b>1</b>, ([<sup>99m</sup>Tc]demobesin 1, <sup>99m</sup>Tc-[N<sub>4</sub>′-diglycolate-<span class="smallcaps smallerCapital">d</span>Phe<sup>6</sup>,Leu-NHEt<sup>13</sup>]BBN(6–13)). [<sup>99m</sup>Tc]<b>1</b> has shown superior biological profile compared to analogous agonist-based <sup>99m</sup>Tc-radioligands. We herein present a small library of [<sup>99m</sup>Tc]<b>1</b> mimics generated after structural modifications in (a) the linker ([<sup>99m</sup>Tc]<b>2</b>, [<sup>99m</sup>Tc]<b>3</b>, [<sup>99m</sup>Tc]<b>4</b>), (b) the peptide chain ([<sup>99m</sup>Tc]<b>5</b>, [<sup>99m</sup>Tc]<b>6</b>), and (c) the C-terminus ([<sup>99m</sup>Tc]<b>7</b> or [<sup>99m</sup>Tc]<b>8</b>). The effects of above modifications on the biological properties of analogs were studied in PC-3 cells and tumor-bearing SCID mice. All analogs showed subnanomolar affinity for the human GRPR, while most receptor-affine <b>4</b> and <b>8</b> behaved as potent GRPR antagonists in a functional internalization assay. In mice bearing PC-3 tumors, [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> exhibited GRPR-specific tumor uptake, rapidly clearing from normal tissues. [<sup>99m</sup>Tc]<b>4</b> displayed the highest tumor uptake (28.8 ± 4.1%ID/g at 1 h pi), which remained high even after 24 h pi (16.3 ± 1.8%ID/g), well surpassing that of [<sup>99m</sup>Tc]<b>1</b> (5.4 ± 0.7%ID/g at 24 h pi).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The gastrin releasing peptide receptor (GRPR)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> has emerged as an attractive molecular target in nuclear oncology owing to its high-density expression in a wide spectrum of human cancers, including the frequently occurring prostate and breast cancers.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11">(2−11)</a> For this purpose, peptide radionuclide carriers have been developed based on analogs either of the frog tetradecapeptide bombesin (BBN) or of the native human GRP and neuromedin C (NMC, GRP(18–27)) sequences.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> These frog BBN- or human GRP/NMC-derived radiopeptides bind with high affinity to the human GRPR and internalize rapidly within target cells, displaying typical receptor-agonist profiles. Until recently, internalization of agonist radioligands was considered essential for a strong diagnostic signal or for optimum delivery of cytotoxic doses to cancer lesions. However, after intravenous injection in patients, GRPR agonists may elicit adverse effects following receptor binding and activation.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> Such undesirable effects are expected to intensify during radionuclide therapy whereby higher peptide doses are typically administered.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Our search toward GRPR-targeting radiopeptides has involved GRPR antagonist-based radioligands already in the early days of our work.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In a more recent study, we have directly compared the biological profile of the antagonist-based [<sup>99m</sup>Tc]<b>1</b> ([<sup>99m</sup>Tc]demobesin 1 or [<sup>99m</sup>Tc]DB1, <sup>99m</sup>Tc-[N<sub>4</sub>′-diglycolate-<span class="smallcaps smallerCapital">d</span>Phe<sup>6</sup>,Leu-NHEt<sup>13</sup>]BBN(6–13),<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> N<sub>4</sub>′ = 6-{<i>p</i>-[(carboxymethoxy)acetyl]-aminobenzyl}-1,4,8,11-tetraazaundecane), and the agonist-based [<sup>99m</sup>Tc]demobesin 4<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> ([<sup>99m</sup>Tc]DB4, <sup>99m</sup>Tc-[N<sub>4</sub>-Pro<sup>1</sup>,Tyr<sup>4</sup>,Nle<sup>14</sup>]BBN, N<sub>4</sub> = 6-(carboxy)-1,4,8,11-tetraazaundecane) in several cell and animal models.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> [<sup>99m</sup>Tc]<b>1</b> showed a superior pharmacokinetic profile in mice bearing human PC-3 xenografts. Specifically, radioactivity cleared more rapidly from the mouse GRPR-rich pancreas than from the implanted tumor as compared to [<sup>99m</sup>Tc]DB4. Subsequent studies have corroborated these findings in animal models and in patients leading to a shift of paradigm from GRP/BBN-based radioagonists to GRPR radioantagonists.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29 ref30">(25−30)</a> The molecular basis for this unexpected behavior is currently under investigation and may provide opportunities for safer and more efficacious diagnosis and therapy of GRPR-expressing tumors in man.</div><div class="NLM_p">Following this line of research, we now introduce a series of new [<sup>99m</sup>Tc]<b>1</b> mimics, generated after structural modifications in (a) the linker (N<sub>4</sub> coupled without a linker, [<sup>99m</sup>Tc]<b>2</b>; via the PEG<sub>2</sub> linker, [<sup>99m</sup>Tc]<b>3</b>; or via the AMA-DGA (aminomethylaniline diglycolate) linker, [<sup>99m</sup>Tc]<b>4</b>), (b) the peptide chain (N<sub>4</sub>-AMA-DGA to mono-<span class="smallcaps smallerCapital">d</span>Ala<sup>11</sup>- ([<sup>99m</sup>Tc]<b>5</b>) or bis-<span class="smallcaps smallerCapital">d</span>Gln<sup>7</sup>,<span class="smallcaps smallerCapital">d</span>Ala<sup>11</sup>-substituted peptide ([<sup>99m</sup>Tc]<b>6</b>)) aiming at higher metabolic stability, and (c) the C-terminus ((N<sub>4</sub>′-DGA, [<sup>99m</sup>Tc]<b>7</b>; or N<sub>4</sub>-AMA-DGA, [<sup>99m</sup>Tc]<b>8</b>; both C-terminal hydrazides<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>) (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). The biological profile of new analogs was directly compared in several in vitro and in vivo GRPR-positive models using [<sup>99m</sup>Tc]<b>1</b> as reference. A major goal of this search was to obtain GRPR-directed <sup>99m</sup>Tc radiotracers with longer tumor retention compared to our “gold standard” [<sup>99m</sup>Tc]<b>1</b>, which undesirably washed out of the tumor lesions at time points beyond 4 h pi.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Yet for successful clinical translation in patients with GRPR-positive tumors, longer retention in pathological lesions is highly desirable, not only because it would provide flexibility of time for acquiring scans in a routine clinical setting. Moreover, prolonged tumor retention, in combination with the faster background clearance typical for receptor antagonists, would offer the opportunity of advantageous later-time imaging, anticipated to result in higher-contrast images and enhanced diagnostic accuracy. It should be added that prolonged tumor retention may pave the way for radionuclide therapy with the analogous [<sup>186</sup>Re/<sup>188</sup>Re]<b>1</b> mimics owing to the similarities of Tc and Re chemistries.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical structures of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>8</b>, Including the Bifunctional Chelator N<sub>4</sub>′ (Blue) or N<sub>4</sub> (Green) Binding <sup>99m</sup>Tc, the Linker (Magenta), and the Peptide Chain with Modifications at Positions 7, 11, and the C-Terminal Highlighted (Red)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>No spacer is used in [<sup>99m</sup>Tc]<b>2</b>. *In the case of the two hydrazide analogs, labeling with <sup>99m</sup>Tc led to a mixture of unidentified species.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Ligands and Radioligands</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Synthesis of <b>1</b>–<b>8</b></h4><div class="NLM_p">The ethylamide analogs <b>1</b>–<b>6</b> were assembled on the solid support following typical Fmoc-protection methodology, and either the Boc-protected bifunctional chelator N<sub>4</sub>′ (<b>1</b>) or the Boc-protected bifunctional chelator N<sub>4</sub> (<b>2</b>–<b>6</b>) was attached to their N-terminus directly (<b>2</b>) or via a linker (<b>1</b>, <b>3</b>–<b>6</b>). In the cases of <b>1</b>–<b>6</b> an ethylindole AM resin, typically used for the preparation of NH-ethylamide peptides, led to poor yields. Therefore, synthesis of analogs <b>1</b>–<b>6</b> was performed using another strategy involving several consecutive steps. In the first step, the analog sequences comprising the chelator precursors were assembled on a trityl resin. Cleavage with 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) delivered the protected analog fractions, which could be coupled with H-Leu-NHEt to generate the protected C-ethylamide derivatives. In a final step, all protecting groups were removed by treatment with TFA.</div><div class="NLM_p">Synthesis of C-terminal hydrazides <b>7</b> and <b>8</b> was performed with assembling peptide sequences on a 4-hydroxymethylbenzoic acid AM resin (HMBA), following the same methodology as in the case of C-terminal ethylamides <b>1</b> and <b>4</b>, respectively. Release from the resin was accomplished with hydrazine hydrate solution. Lateral protecting groups could be subsequently removed by treatment with TFA. Purification by preparative HPLC and lyophilization afforded analogs <b>1</b>–<b>8</b> as white solids in good yield and high purity (≥95%), as verified by analytical HPLC in two different systems; MALDI-TOF spectra of the products were consistent with the expected formulas (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Analytical Data for <b>1</b>–<b>8</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">HPLC <i>t</i><sub>R</sub> (min), UV trace</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">% purity<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MW<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> calcd</th><th class="colsep0 rowsep0" align="center">MW<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> found, <i>m</i>/<i>z</i></th><th class="colsep0 rowsep0" align="center" char=".">system 1<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">system 2<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">1347.7</td><td class="colsep0 rowsep0" align="left">1348.2 [M + H]<sup>+</sup></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">98.5</td><td class="colsep0 rowsep0" align="char" char=".">1169.7</td><td class="colsep0 rowsep0" align="left">1171.1 [M + H]<sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">13.0</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">98.5</td><td class="colsep0 rowsep0" align="char" char=".">1316.1</td><td class="colsep0 rowsep0" align="left">1316.4 [M + H]<sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">99.6</td><td class="colsep0 rowsep0" align="char" char=".">1390.7</td><td class="colsep0 rowsep0" align="left">1391.2 [M + H]<sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">15.4</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">97.4</td><td class="colsep0 rowsep0" align="char" char=".">1404.7</td><td class="colsep0 rowsep0" align="left">1406.5 [M + H]<sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">18.0</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">97.1</td><td class="colsep0 rowsep0" align="char" char=".">1404.7</td><td class="colsep0 rowsep0" align="left">1406.7 [M + H]<sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">18.4</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">97.9</td><td class="colsep0 rowsep0" align="char" char=".">1334.6</td><td class="colsep0 rowsep0" align="left">1336.0 [M + H]<sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">18.4</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">97.6</td><td class="colsep0 rowsep0" align="char" char=".">1377.6</td><td class="colsep0 rowsep0" align="left">1378.3 [M + H]<sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">18.9</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Purity was determined by HPLC systems 1 and 2.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Average mass.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">System 1: RP-HPLC with UV detection at 220 nm. An Xterra RP18 column (5 μm, 4.6 mm × 150 mm) was eluted at a flow rate of 1 mL/min with linear gradient 15% B to 30% B in 30 min, with A = 0.1% TFA in H<sub>2</sub>O (v/v) and B = MeCN.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">System 2: A Nucleosil-100 C18 column (5 μm, 150 mm × 4 mm) was eluted at a flow rate of 1 mL/min with a linear gradient 0.1% TFA in MeCN (from 10% to 90% in 15 min) and 0.1% aqueous TFA as complementary phase. Runs were monitored by UV detection at 215 nm.</p></div></div></div></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Radiolabeling and Quality Control of [<sup>99m</sup>Tc]<b>1</b> Mimics</h4><div class="NLM_p last">After labeling with <sup>99m</sup>Tc, [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> formed in >95% yield and >98% radiochemical purity, as verified by RP-HPLC. However, the presence of the hydrazide function at the C-terminus of <b>7</b> and <b>8</b> interfered with <sup>99m</sup>Tc-labeling, and as a result a mixture of unidentified species formed.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In all other cases, <sup>99m</sup>Tc-radiotracers were obtained as single radioactive species at typical specific activities of 18–37 MBq/nmol peptide in ≥98% radiochemical purity, as verified by RP-HPLC and TLC; therefore, the resulting [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> were used without purification in all subsequent experiments.</div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vitro Studies</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Binding Affinity of <b>1</b>–<b>8</b> for the Human GRPR</h4><div class="NLM_p">All eight <b>1</b>–<b>8</b> analogs displaced [<sup>125</sup>I-Tyr<sup>4</sup>]BBN from GRPR binding sites in PC-3 cell membranes in a monophasic and dose-dependent manner exhibiting subnanomolar affinities for the human GRPR (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), revealing a positive influence of the pendent cationic N<sub>4</sub>-framework at the N-terminus of <b>1</b>–<b>8</b> on receptor affinity.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The two hydrazides and especially <b>8</b> (IC<sub>50</sub> = 0.17 ± 0.01 nM) as well as <b>4</b> (IC<sub>50</sub> = 0.26 ± 0.03 nM) showed the highest affinity for the GRPR,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> while <b>3</b> containing the PEG<sub>2</sub> linker displayed the lowest affinity for the GRPR (IC<sub>50</sub> = 0.93 ± 0.01 nM) in this series of analogs. It should be noted that the affinity of [Tyr<sup>4</sup>]BBN for the GRPR under the applied experimental conditions was slightly lower (IC<sub>50</sub> = 1.22 ± 0.18 nM) compared to <b>1</b>–<b>8</b>.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Displacement of [<sup>125</sup>I-Tyr<sup>4</sup>]BBN from GRPR binding sites in PC-3 cell membranes by increasing concentrations of <b>1</b> (∗, IC<sub>50</sub> = 0.70 ± 0.08 nM), <b>2</b> (▼  in magenta, IC<sub>50</sub> = 0.72 ± 0.06 nM), <b>3</b> (●  in blue, IC<sub>50</sub> = 0.93 ± 0.01 nM), and <b>4</b> (◆  in red, IC<sub>50</sub> = 0.26 ± 0.03 nM) and (B) of <b>5</b> (∗  in green, IC<sub>50</sub> = 0.56 ± 0.09 nM), <b>6</b> (▼ in violet, IC<sub>50</sub> = 0.71 ± 0.08 nM), <b>7</b> (●  in wine-red, IC<sub>50</sub> = 0.30 ± 0.03 nM), and <b>8</b> (◆ in greenish-blue, IC<sub>50</sub> = 0.17 ± 0.01 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Antagonistic Properties of <b>4</b> and <b>8</b></h4><div class="NLM_p">The antagonistic properties of the two most GRPR-affine analogs <b>4</b> and <b>8</b> were confirmed by immunofluorescence-based internalization assays with HEK293-GRPR cells. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, 10 nM BBN could trigger a massive GRPR internalization in HEK293-GRPR cells compared with the condition without peptide. Conversely, <b>4</b> or <b>8</b> alone could not trigger the internalization of the GRPR at 1 μM. Furthermore, when given at a concentration of 1 μM together with 10 nM BBN, <b>4</b> or <b>8</b> was able to completely prevent the BBN-induced GRPR internalization.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The GRPR resides on the cell membrane of in HEK293-GRPR cells (A) in the absence of peptide in the medium, but (B) massive receptor-internalization is observed in the presence of 10 nM BBN. Analogs <b>4</b> (C) and <b>8</b> (E) were unable to trigger the internalization of GRPR in HEK293-GRPR cells at 1 μM but were effective (D and F, respectively) in preventing the stimulation of GRPR internalization by 10 nM BBN, as consistent with a receptor-antagonist profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Cell-Association/Internalization of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> in PC-3 Cells</h4><div class="NLM_p">The internalization properties of radioligands [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> were studied in PC-3 cells by 1 h incubation at 37 °C in the absence or presence of excess [Tyr<sup>4</sup>]BBN to define nonspecific involvement. As shown in the comparative data in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, the major portion of cell-associated radioactivity remained bound on the cell membrane of PC-3 cells with only a minor fraction of radioactivity detected inside the cells, as expected for receptor radioantagonists.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In all cases, cell-associated activity was significantly reduced in the presence of 1 μM [Tyr<sup>4</sup>]BBN, suggesting a GRPR-mediated process. Interestingly, differences could be observed in the amount of cell-associated activity across this series of [<sup>99m</sup>Tc]<b>1</b> mimics, depending both upon the linker and on modifications in the peptide chain. Thus, [<sup>99m</sup>Tc]<b>1</b> and [<sup>99m</sup>Tc]<b>4</b>, combining an aromatic ring-containing bifunctional anchor or linker, respectively, with the unmodified peptide chain, displayed the highest overall cell association (12.9 ± 1.1% and 36.1 ± 0.4%, respectively). Conversely, the absence of linker ([<sup>99m</sup>Tc]<b>2</b>, 2.2 ± 0.1%) or the introduction of a shorter and hydrophilic PEG<sub>2</sub> linker ([<sup>99m</sup>Tc]<b>3</b>, 3.8 ± 0.4%) resulted in the poorest cell association in the series. Mono amino acid substitution in [<sup>99m</sup>Tc]<b>5</b> only slightly deteriorated cell-association levels (10.6 ± 0.4%) vs the [<sup>99m</sup>Tc]<b>1</b> reference, whereas double amino acid substitution in [<sup>99m</sup>Tc]<b>6</b> further reduced the uptake in PC-3 cells (6.0 ± 0.5%). In short, [<sup>99m</sup>Tc]<b>4</b> showed the highest binding to PC-3 cells, well surpassing that of the lead compound [<sup>99m</sup>Tc]<b>1</b>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (Α) Specific binding of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> to PC-3 cells after 1 h incubation at 37 °C: percentage of specific cell-bound activity of total added = percentage of specific membrane bound fraction (solid colored bars) + percentage of specific internalized fraction (checkered color bars): gray, [<sup>99m</sup>Tc]<b>1</b> (12.87 ± 1.05); magenta, [<sup>99m</sup>Tc]<b>2</b> (2.19 ± 0.05); blue, [<sup>99m</sup>Tc]<b>3</b> (3.84 ± 0.39); red, [<sup>99m</sup>Tc]<b>4</b> (36.05 ± 0.43); green, [<sup>99m</sup>Tc]<b>5</b> (2.2 ± 0.1%); violet, [<sup>99m</sup>Tc]<b>6</b> (3.8 ± 0.4). (Β) Specific saturation binding curve of [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b> in PC-3 cell membranes (<i>K</i><sub>d</sub> = 0.24 ± 0.03 nM; <i>B</i><sub>max</sub> = 380 ± 25 fmol/mio cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Saturation Binding of [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b></h4><div class="NLM_p last">Binding data for the highest cell-binding metalated analog, [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b>, was additionally acquired from saturation binding assays in PC-3 cell membranes. Due to the high specific activity of <sup>99m</sup>Tc (19.24 TBq/μmol) and radiation safety limitations, the required concentration series (0.01–10 nM) for a single radioligand chemical entity could be achieved using the pseudo-stable β emitter <sup>99g</sup>Tc. As depicted in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b> demonstrated a strong and dose-dependent interaction to a single class of high affinity binding sites in the PC-3 cell membranes. The <i>K</i><sub>d</sub> value of 0.24 ± 0.03 nM illustrates the high affinity of [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b> to the human GRPR. This finding showed that incorporation of the radiometal by the N<sub>4</sub>-framework and the presence of the positively charged [Tc(O)<sub>2</sub>(N<sub>4</sub>)]<sup>+</sup> chelate at the peptide N-terminus were well-tolerated by the receptor, as previously reported.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Metabolic Studies in Mice</h3><div class="NLM_p">Analysis of mouse blood collected 5 min after administration of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> in the animals by HPLC revealed a different extent of radiotracer degradation in mouse peripheral blood, as well as a diverse pattern of radiometabolites (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Apparently, not only the type of linker but also key amino acid replacements in the peptide chain affected the in vivo stability of these analogs. Specifically, the mono-<span class="smallcaps smallerCapital">d</span>Ala<sup>11</sup>-substituted [<sup>99m</sup>Tc]<b>5</b> and the PEG<sub>2</sub>-containing [<sup>99m</sup>Tc]<b>3</b> analogs represented the most in vivo robust members in the series (75% and 70% intact at 5 min postinjection, pi). Interestingly, doubly <span class="smallcaps smallerCapital">d</span>Gln<sup>7</sup>,<span class="smallcaps smallerCapital">d</span>Ala<sup>11</sup>-substituted [<sup>99m</sup>Tc]<b>6</b> was less stable in vivo displaying comparable stability with the reference [<sup>99m</sup>Tc]<b>1</b> and its mimic [<sup>99m</sup>Tc]<b>4</b> (60% intact at 5 min pi). The least in vivo stable radiotracer turned out to be [<sup>99m</sup>Tc]<b>2</b> (45% intact at 5 min pi), altogether lacking a linker.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Radiochromatograms (HPLC system 4) of mouse blood samples 5 min after injection of (A) [<sup>99m</sup>Tc]<b>1</b> (gray line, 60% intact radioligand), (B) [<sup>99m</sup>Tc]<b>2</b> (magenta line, 45% intact radioligand), (C) [<sup>99m</sup>Tc]<b>3</b> (blue line, 70% intact radioligand), (D) [<sup>99m</sup>Tc]<b>4</b> (red line, 60% intact radioligand), (E) [<sup>99m</sup>Tc]<b>5</b> (green line, 75% intact radioligand), and (F) [<sup>99m</sup>Tc]<b>6</b> (violet line, 60% intact radioligand). The <i>t</i><sub>R</sub> of the parent radioligand is indicated by the arrows.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Biodistribution of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> in PC-3 Xenograft-Bearing SCID Mice</h3><div class="NLM_p">Biodistribution results of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> in SCID mice bearing GRPR-positive PC-3 xenografts for 1, 4, and 24 h pi are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Results are presented as percent injected dose per gram (%ID/g) tissue and correspond to mean values ± sd, <i>n</i> = 4. In addition, tumor-to-physiological tissue ratios can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf" class="ext-link">Figure S3 (Supporting Information)</a>. All radiotracers cleared rapidly from blood and the background mainly via the kidneys and the urinary system. The analogs [<sup>99m</sup>Tc]<b>1</b>, [<sup>99m</sup>Tc]<b>4</b>, [<sup>99m</sup>Tc]<b>5</b>, and [<sup>99m</sup>Tc]<b>6</b>, containing an aromatic residue between the linear tetraamine framework and the peptide chain, exhibited some transient bowel activity. In the case of [<sup>99m</sup>Tc]<b>4</b> intestinal accumulation could be partially blocked by co-injection of excess [Tyr<sup>4</sup>]BBN, implying specific interaction with bombesin binding sites in the intestinal tract.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> It is interesting to also observe the lower liver uptake for [<sup>99m</sup>Tc]<b>4</b> (3.19 ± 0.20%ID/g at 1 h pi) compared to [<sup>99m</sup>Tc]<b>1</b> (9.62 ± 0.97%ID/g at 1 h pi).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biodistribution of [<sup>99m</sup>Tc]<b>1</b> and [<sup>99m</sup>Tc]<b>2</b> in PC-3 Xenograft-Bearing SCID Mice<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">%ID/g tissue ± SD, <i>n</i> = 4</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">[<sup>99m</sup>Tc]<b>1</b></th><th class="rowsep1 colsep0" colspan="3" align="center">[<sup>99m</sup>Tc]<b>2</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organ</th><th class="colsep0 rowsep0" align="center">1 h</th><th class="colsep0 rowsep0" align="center">4 h</th><th class="colsep0 rowsep0" align="center">24 h</th><th class="colsep0 rowsep0" align="center">1 h</th><th class="colsep0 rowsep0" align="center">4 h</th><th class="colsep0 rowsep0" align="center">24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="left">1.36 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.24 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.07 ± 0.01</td><td class="colsep0 rowsep0" align="left">1.19 ± 0.16</td><td class="colsep0 rowsep0" align="left">0.07 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.05 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.14 ± 0.01</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.29 ± 0.21</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">9.62 ± 0.97</td><td class="colsep0 rowsep0" align="left">6.62 ± 0.66</td><td class="colsep0 rowsep0" align="left">2.61 ± 0.16</td><td class="colsep0 rowsep0" align="left">2.61 ± 0.11</td><td class="colsep0 rowsep0" align="left">1.72 ± 0.48</td><td class="colsep0 rowsep0" align="left">0.39 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>14.48 ± 0.96</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>3.12 ± 0.31</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">0.76 ± 0.08</td><td class="colsep0 rowsep0" align="left">0.19 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.14 ± 0.03</td><td class="colsep0 rowsep0" align="left">1.13 ± 0.58</td><td class="colsep0 rowsep0" align="left">0.33 ± 0.47</td><td class="colsep0 rowsep0" align="left">0.06 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.25 ± 0.03</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.01 ± 0.00</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidneys</td><td class="colsep0 rowsep0" align="left">8.08 ± 0.65</td><td class="colsep0 rowsep0" align="left">4.33 ± 0.44</td><td class="colsep0 rowsep0" align="left">1.02 ± 0.18</td><td class="colsep0 rowsep0" align="left">13.64 ± 4.15</td><td class="colsep0 rowsep0" align="left">4.10 ± 0.87</td><td class="colsep0 rowsep0" align="left">0.87 ± 0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>9.01 ± 0.30</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.70 ± 0.11</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach</td><td class="colsep0 rowsep0" align="left">2.10 ± 0.30</td><td class="colsep0 rowsep0" align="left">2.12 ± 0.48</td><td class="colsep0 rowsep0" align="left">1.37 ± 0.98</td><td class="colsep0 rowsep0" align="left">0.61 ± 0.15</td><td class="colsep0 rowsep0" align="left">0.33 ± 0.14</td><td class="colsep0 rowsep0" align="left">0.43 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.57 ± 0.04</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.11 ± 0.01</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intestines</td><td class="colsep0 rowsep0" align="left">10.27 ± 0.55</td><td class="colsep0 rowsep0" align="left">10.36 ± 0.46</td><td class="colsep0 rowsep0" align="left">1.35 ± 0.51</td><td class="colsep0 rowsep0" align="left">2.40 ± 0.45</td><td class="colsep0 rowsep0" align="left">2.30 ± 0.70</td><td class="colsep0 rowsep0" align="left">0.59 ± 0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>10.72 ± 0.85</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>5.81 ± 0.40</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="left">1.66 ± 0.25</td><td class="colsep0 rowsep0" align="left">1.68 ± 0.94</td><td class="colsep0 rowsep0" align="left">0.90 ± 0.17</td><td class="colsep0 rowsep0" align="left">1.16 ± 0.77</td><td class="colsep0 rowsep0" align="left">0.50 ± 0.29</td><td class="colsep0 rowsep0" align="left">0.42 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.78 ± 0.27</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.03 ± 0.01</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">0.24 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.06 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.04 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.22</td><td class="colsep0 rowsep0" align="left">0.03 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.04 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.07 ± 0.01</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.42 ± 0.05</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">1.37 ± 0.12</td><td class="colsep0 rowsep0" align="left">0.38 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.15 ± 0.02</td><td class="colsep0 rowsep0" align="left">1.99 ± 1.00</td><td class="colsep0 rowsep0" align="left">0.23 ± 0.18</td><td class="colsep0 rowsep0" align="left">0.10 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>1.35 ± 0.49</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.04 ± 0.01</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pancreas</td><td class="colsep0 rowsep0" align="left"><b>104.39 ± 3.59</b></td><td class="colsep0 rowsep0" align="left"><b>49.82 ± 6.69</b></td><td class="colsep0 rowsep0" align="left"><b>1.29 ± 0.46</b></td><td class="colsep0 rowsep0" align="left"><b>2.97 ± 1.52</b></td><td class="colsep0 rowsep0" align="left"><b>0.35 ± 0.08</b></td><td class="colsep0 rowsep0" align="left"><b>0.12 ± 0.02</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b><i>6.48 ± 0.20</i></b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i><b>0.02 ± 0.01</b></i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tumor</td><td class="colsep0 rowsep0" align="left"><b>24.61 ± 1.98</b></td><td class="colsep0 rowsep0" align="left"><b>22.66 ± 2.20</b></td><td class="colsep0 rowsep0" align="left"><b>5.38 ± 0.72</b></td><td class="colsep0 rowsep0" align="left"><b>9.88 ± 3.25</b></td><td class="colsep0 rowsep0" align="left"><b>4.71 ± 1.00</b></td><td class="colsep0 rowsep0" align="left"><b>1.33 ± 0.20</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i><b>5.19 ± 1.35</b></i><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i><b>0.84 ± 0.15</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></i></td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values in italics at 4 h pi represent animals co-injected with 20 nmol of [Tyr<sup>4</sup>]BBN for in vivo GRPR blockade.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Highly significant (<i>P</i> < 0.005) difference between blocked and unblocked animals (unpaired two-tailed Student’s <i>t</i> test).</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biodistribution of [<sup>99m</sup>Tc]<b>3</b> and [<sup>99m</sup>Tc]<b>4</b> in PC-3 Xenograft-Bearing SCID Mice<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">%ID/g tissue ± SD, <i>n</i> = 4</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">[<sup>99m</sup>Tc]<b>3</b></th><th class="rowsep1 colsep0" colspan="3" align="center">[<sup>99m</sup>Tc]<b>4</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organ</th><th class="colsep0 rowsep0" align="center">1 h</th><th class="colsep0 rowsep0" align="center">4 h</th><th class="colsep0 rowsep0" align="center">24 h</th><th class="colsep0 rowsep0" align="center">1 h</th><th class="colsep0 rowsep0" align="center">4 h</th><th class="colsep0 rowsep0" align="center">24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="left">1.15 ± 0.37</td><td class="colsep0 rowsep0" align="left">0.30 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.02 ± 0.01</td><td class="colsep0 rowsep0" align="left">1.36 ± 0.47</td><td class="colsep0 rowsep0" align="left">0.50 ± 0.40</td><td class="colsep0 rowsep0" align="left">0.13 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.08 ± 0.03</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.43 ± 0.31</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">1.67 ± 0.34</td><td class="colsep0 rowsep0" align="left">0.89 ± 0.14</td><td class="colsep0 rowsep0" align="left">0.36 ± 0.05</td><td class="colsep0 rowsep0" align="left">3.19 ± 0.20</td><td class="colsep0 rowsep0" align="left">2.78 ± 1.67</td><td class="colsep0 rowsep0" align="left">1.05 ± 0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>2.11 ± 0.43</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>4.26 ± 0.79</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">0.45 ± 0.14</td><td class="colsep0 rowsep0" align="left">0.04 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.06 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.99 ± 0.25</td><td class="colsep0 rowsep0" align="left">0.33 ± 0.28</td><td class="colsep0 rowsep0" align="left">0.11 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.09 ± 0.03</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.27 ± 0.10</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidneys</td><td class="colsep0 rowsep0" align="left">5.71 ± 1.23</td><td class="colsep0 rowsep0" align="left">1.48 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.58 ± 0.23</td><td class="colsep0 rowsep0" align="left">11.75 ± 0.42</td><td class="colsep0 rowsep0" align="left">4.87 ± 2.46</td><td class="colsep0 rowsep0" align="left">1.99 ± 0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>2.38 ± 0.56</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>6.22 ± 2.92</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach</td><td class="colsep0 rowsep0" align="left">0.58 ± 0.12</td><td class="colsep0 rowsep0" align="left">0.32 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.59 ± 0.35</td><td class="colsep0 rowsep0" align="left">3.23 ± 0.62</td><td class="colsep0 rowsep0" align="left">3.81 ± 1.26</td><td class="colsep0 rowsep0" align="left">2.20 ± 0.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.45 ± 0.34</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.95 ± 0.62</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intestines</td><td class="colsep0 rowsep0" align="left">1.42 ± 0.27</td><td class="colsep0 rowsep0" align="left">1.27 ± 0.27</td><td class="colsep0 rowsep0" align="left">0.28 ± 0.23</td><td class="colsep0 rowsep0" align="left">12.01 ± 0.32</td><td class="colsep0 rowsep0" align="left">11.40 ± 2.33</td><td class="colsep0 rowsep0" align="left">3.85 ± 1.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>2.85 ± 0.39</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>5.04 ± 0.82</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.10</td><td class="colsep0 rowsep0" align="left">0.27 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.29 ± 0.08</td><td class="colsep0 rowsep0" align="left">3.20 ± 1.61</td><td class="colsep0 rowsep0" align="left">2.76 ± 1.64</td><td class="colsep0 rowsep0" align="left">0.81 ± 0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>1.33 ± 0.37</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>2.98 ± 1.88</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">0.22 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.15 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.04 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.32 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.15 ± 0.15</td><td class="colsep0 rowsep0" align="left">0.05 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.02 ± 0.01</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.10 ± 0.06</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">1.02 ± 0.32</td><td class="colsep0 rowsep0" align="left">0.14 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.08 ± 0.02</td><td class="colsep0 rowsep0" align="left">3.19 ± 2.53</td><td class="colsep0 rowsep0" align="left">1.95 ± 0.40</td><td class="colsep0 rowsep0" align="left">0.86 ± 0.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.55 ± 0.26</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.93 ± 0.12</i></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pancreas</td><td class="colsep0 rowsep0" align="left"><i><b>5.71 ± 0.41</b></i></td><td class="colsep0 rowsep0" align="left"><b>0.68 ± 0.06</b></td><td class="colsep0 rowsep0" align="left"><b>0.19 ± 0.02</b></td><td class="colsep0 rowsep0" align="left"><b>161.00 ± 10.37</b></td><td class="colsep0 rowsep0" align="left"><b>119.04 ± 44.87</b></td><td class="colsep0 rowsep0" align="left"><b>30.26 ± 14.65</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i><b>0.37 ± 0.09</b></i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b><i>9.88 ± 1.08</i></b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tumor</td><td class="colsep0 rowsep0" align="left"><i><b>15.48 ± 2.59</b></i></td><td class="colsep0 rowsep0" align="left"><b>4.78 ± 1.47</b></td><td class="colsep0 rowsep0" align="left"><b>1.02 ± 0.25</b></td><td class="colsep0 rowsep0" align="left"><b>28.80 ± 4.13</b></td><td class="colsep0 rowsep0" align="left"><b>21.49 ± 3.18</b></td><td class="colsep0 rowsep0" align="left"><b>16.32 ± 1.82</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i><b>0.53 ± 0.20</b></i><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i><b>5.66 ± 1.92</b></i><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values in italics at 4 h pi represent animals co-injected with 20 nmol [Tyr<sup>4</sup>]BBN for in vivo GRPR blockade.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Highly significant (<i>P</i> < 0.005) difference between blocked and unblocked animals (unpaired two-tailed Student’s <i>t</i> test).</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biodistribution of [<sup>99m</sup>Tc]<b>5</b> and [<sup>99m</sup>Tc]<b>6</b> in PC-3 Xenograft-Bearing SCID Mice<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">%ID/g tissue ± SD, <i>n</i> = 4</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">[<sup>99m</sup>Tc]<b>5</b></th><th class="rowsep1 colsep0" colspan="2" align="center">[<sup>99m</sup>Tc]<b>6</b><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organ</th><th class="colsep0 rowsep0" align="center">1 h</th><th class="colsep0 rowsep0" align="center">4 h</th><th class="colsep0 rowsep0" align="center">24 h</th><th class="colsep0 rowsep0" align="center">1 h</th><th class="colsep0 rowsep0" align="center">4 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="left">1.98 ± 0.37</td><td class="colsep0 rowsep0" align="left">0.62 ± 0.11</td><td class="colsep0 rowsep0" align="left">0.07 ± 0.01</td><td class="colsep0 rowsep0" align="left">1.69 ± 0.35</td><td class="colsep0 rowsep0" align="left">0.17 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.32 ± 0.01</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.16 ± 0.04</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">3.14 ± 0.46</td><td class="colsep0 rowsep0" align="left">2.59 ± 0.80</td><td class="colsep0 rowsep0" align="left">0.61 ± 0.17</td><td class="colsep0 rowsep0" align="left">4.16 ± 0.19</td><td class="colsep0 rowsep0" align="left">2.83 ± 0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>4.13 ± 0.62</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>4.73 ± 0.11</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">0.88 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.32 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.14 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.98 ± 0.15</td><td class="colsep0 rowsep0" align="left">0.16 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.29 ± 0.03</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.20 ± 0.01</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidneys</td><td class="colsep0 rowsep0" align="left">11.29 ± 1.53</td><td class="colsep0 rowsep0" align="left">6.49 ± 1.97</td><td class="colsep0 rowsep0" align="left">1.10 ± 0.38</td><td class="colsep0 rowsep0" align="left">12.59 ± 1.03</td><td class="colsep0 rowsep0" align="left">4.96 ± 0.88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>5.57 ± 1.15</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>7.68 ± 1.65</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach</td><td class="colsep0 rowsep0" align="left">3.15 ± 0.37</td><td class="colsep0 rowsep0" align="left">3.06 ± 1.05</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.32</td><td class="colsep0 rowsep0" align="left">1.75 ± 0.51</td><td class="colsep0 rowsep0" align="left">1.75 ± 0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.57 ± 0.34</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.91 ± 0.93</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intestines</td><td class="colsep0 rowsep0" align="left">10.77 ± 0.52</td><td class="colsep0 rowsep0" align="left">7.58 ± 1.26</td><td class="colsep0 rowsep0" align="left">1.22 ± 0.06</td><td class="colsep0 rowsep0" align="left">6.14 ± 0.96</td><td class="colsep0 rowsep0" align="left">3.11 ± 0.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>6.14 ± 3.32</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>2.67 ± 0.06</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="left">2.77 ± 2.56</td><td class="colsep0 rowsep0" align="left">1.16 ± 0.34</td><td class="colsep0 rowsep0" align="left">0.48 ± 0.06</td><td class="colsep0 rowsep0" align="left">1.33 ± 0.15</td><td class="colsep0 rowsep0" align="left">0.58 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>1.15 ± 0.37</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>1.17 ± 0.19</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">0.25 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.10 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.05 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.31 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.05 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.07 ± 0.01</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.05 ± 0.01</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">1.76 ± 0.18</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.15</td><td class="colsep0 rowsep0" align="left">0.17 ± 0.02</td><td class="colsep0 rowsep0" align="left">2.69 ± 1.24</td><td class="colsep0 rowsep0" align="left">0.28 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.76 ± 0.28</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>0.60 ± 0.16</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pancreas</td><td class="colsep0 rowsep0" align="left"><b>181.05 ± 15.78</b></td><td class="colsep0 rowsep0" align="left"><b>88.39 ± 6.23</b></td><td class="colsep0 rowsep0" align="left"><b>4.43 ± 1.92</b></td><td class="colsep0 rowsep0" align="left"><b>60.98 ± 11.67</b></td><td class="colsep0 rowsep0" align="left"><b>6.83 ± 2.55</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b><i>19.43 ± 6.01</i></b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i><b>0.92 ± 0.11</b></i><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tumor</td><td class="colsep0 rowsep0" align="left"><b>24.39 ± 2.45</b></td><td class="colsep0 rowsep0" align="left"><b>18.91 ± 4.98</b></td><td class="colsep0 rowsep0" align="left"><b>4.54 ± 1.30</b></td><td class="colsep0 rowsep0" align="left"><b>12.08 ± 3.35</b></td><td class="colsep0 rowsep0" align="left"><b>3.53 ± 1.49</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i><b>4.82 ± 1.55</b></i><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b><i>0.74 ± 0.07</i></b><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Values in italics at 4 h pi represent animals co-injected with 20 nmol [Tyr<sup>4</sup>]BBN for in vivo GRPR blockade.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">For [<sup>99m</sup>Tc]<b>6</b> the 24 h pi results have not been included due to the very low and declining tumor uptake already in the earlier time points.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Highly significant (<i>P</i> < 0.005) difference between blocked and unblocked animals (unpaired two tailed Student’s <i>t</i> test).</p></div></div></div><div class="NLM_p last">All radiotracers specifically localized in the human PC-3 xenografts as well as in mouse pancreata, via a GRPR-mediated process, as demonstrated by the significantly lower values in these tissues during in vivo GRPR blockade with excess [Tyr<sup>4</sup>]BBN. Tumor uptake for all analogs was initially high at 1 h pi, resulting in the following radiotracer rank: [<sup>99m</sup>Tc]<b>4</b> (28.80 ± 4.13%ID/g) > [<sup>99m</sup>Tc]<b>1</b> (24.61 ± 1.98%ID/g) ≈ [<sup>99m</sup>Tc]<b>5</b> (24.39 ± 2.45%ID/g) > [<sup>99m</sup>Tc]<b>3</b> (15.48 ± 2.59%ID/g) > [<sup>99m</sup>Tc]<b>6</b> (12.08 ± 3.35%ID/g) > [<sup>99m</sup>Tc]<b>2</b> (9.88 ± 3.25%ID/g). Surprisingly, [<sup>99m</sup>Tc]<b>4</b> surpassed the tumor uptake of our “gold standard” [<sup>99m</sup>Tc]<b>1</b>, despite the high structural similarity of the chain connecting the tetraamine backbone to the N-terminus of the peptide moiety, in both cases including an aromatic residue. Pancreatic values at 1 h pi were also initially high for most radiotracers, with the exception of [<sup>99m</sup>Tc]<b>2</b> and [<sup>99m</sup>Tc]<b>3</b>, but rapidly declined for all analogs at later time points. Washout of radioactivity from the implanted tumors was observed as well but proceeded in an exceptionally slower pace for [<sup>99m</sup>Tc]<b>4</b>. The latter showed significant retention in the tumor even at 24 h pi (16.32 ± 1.82%ID/g), notably surpassing the retention of reference [<sup>99m</sup>Tc]<b>1</b> (5.38 ± 0.72%ID/g) and of all other [<sup>99m</sup>Tc]<b>1</b> mimics.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> SPECT/CT Imaging of [<sup>99m</sup>Tc]<b>1</b> and [<sup>99m</sup>Tc]<b>4</b> in PC-3 Xenograft-Bearing Mice</h3><div class="NLM_p">Static SPECT/CT images of PC-3 tumor-bearing mice injected with [<sup>99m</sup>Tc]<b>1</b> or [<sup>99m</sup>Tc]<b>4</b> are shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. Both radiotracers clearly delineated the GRPR-expressing tumor revealing comparable abdominal radioactivity levels. Despite the fact that the overall radioactivity distribution patterns were not strikingly different for the two tracers in the 15 h pi images (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B), still higher tumor uptake is evident for [<sup>99m</sup>Tc]<b>4</b> compared to [<sup>99m</sup>Tc]<b>1</b>. The observed difference in the tumor uptake is expected to become more pronounced at later time points, according to the quantitative biodistribution data retrieved at 24 h pi (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>; <a href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf" class="ext-link">Figure S3</a>). However, SPECT/CT images could not be acquired at this later time point due to technical limitations, such as the rather short half-life of <sup>99m</sup>Tc, the amount of peptide that can be injected at a practically accessible specific activity, and the sensitivity threshold of the preclinical camera. The GRPR specificity of uptake in the PC-3 tumor could be well-visualized at 1 h pi by comparing the transaxial tumor images of [<sup>99m</sup>Tc]<b>4</b> injected alone (20 pmol/2.4 MBq) or with co-injection of excess [Tyr<sup>4</sup>]BBN (20 nmol) for in vivo GRPR blockade (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D, respectively).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Maximum intensity projection (MIP) SPECT/CT static images of mice bearing subcutaneous PC-3 xenografts on their right shoulders euthanized 15 h after injection of (A) [<sup>99m</sup>Tc]<b>1</b> or (B) [<sup>99m</sup>Tc]<b>4</b>; in both cases animals received 20 MBq radiotracer corresponding to 200 pmol of peptide conjugate. The GRPR specificity of tumor uptake could be demonstrated for [<sup>99m</sup>Tc]<b>4</b> by comparing the transaxial images of PC-3 tumors in mice euthanized 1 h after receiving 20 pmol/2.4 MBq [<sup>99m</sup>Tc]<b>4</b> (C) alone or (D) after coinjection of 20 nmol of [Tyr<sup>4</sup>]BBN.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Molecular imaging with the aid of systemically administered radiopeptide probes, such as radiolabeled BBN-like peptides, which are directed at specific tumor biomarkers, like GRPR expressed in human cancer, is a rapidly expanding field in oncology.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35−37)</a> Besides allowing for noninvasive evaluation of key disease parameters, such as localization and spread, it is gradually being established as a reliable tool for patient stratification for subsequent targeted therapies, monitoring of therapeutic responses, and overall disease follow-up. Radiolabeled BBN-like agonists at the GRPR were originally preferred on the basis of their ability to internalize in cancer cells for enhancing diagnostic sensitivity.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, GRPR agonists inadvertently activate the receptor eliciting acute pharmacological effects after intravenous injection in human,<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> as those observed during the clinical evaluation of <sup>177</sup>Lu-AMBA<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> for systemic therapy of prostate cancer.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Conversely, GRPR antagonists are not expected to trigger acute adverse responses after systemic administration and are consequently characterized by higher inherent biosafety. In the preceding decades, a great number of GRPR antagonists have been developed for the study of the bombesin receptor system.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> They have also been evaluated as antiproliferative agents in several cell lines and, most importantly, in animal models bearing GRPR-positive xenografts.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42">(39−42)</a> The above efforts have generated a broad collection of GRPR antagonists potentially serving as motifs for the development of the respective radiolabeled GRPR antagonists for diagnostic imaging of human cancer. Despite their inability to internalize, several GRPR radioantagonists were able to successfully visualize GRPR-expressing xenografts in mice clearing faster from physiological tissues than from tumor sites, resulting in attractive in vivo profiles.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Yet sufficient retention at the tumor site(s) for longer periods of time remains a significant challenge for a wider use of GRPR radioantagonists in tumor diagnosis in a clinical setting and particularly in radionuclide therapy.</div><div class="NLM_p">In our search for anti-GRPR radiotracers of clinical interest, we have previously presented [<sup>99m</sup>Tc]<b>1</b>,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> based on the potent GRPR antagonist [<span class="smallcaps smallerCapital">d</span>Phe<sup>6</sup>,Leu<sup>13</sup>-NHEt]BBN(6–13)<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> and exhibiting excellent GRPR-specific accumulation in human PC-3 xenografts in nude mice and much faster washout from physiological tissues, including the GRPR-rich mouse pancreas. However, at 24 h pi the tumor uptake declined to less than 25% of its value at 4 h pi, leaving space for improvements.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> On the other hand, longer tumor-residing times of the radiotracer, especially when combined with the faster background clearance of a receptor-antagonist, may lead to favorably enhanced-contrast imaging and hence to improved diagnostic accuracy. Such prolonged tumor retention of a diagnostic <sup>99m</sup>Tc-radiotracer may provide opportunities for radionuclide therapy with the analogous <sup>186</sup>Re/<sup>188</sup>Re-therapeutic agent, based on the similarities of Tc and Re chemistries.</div><div class="NLM_p">Aiming toward prolonged tumor retention, we hereby introduce a series of [<sup>99m</sup>Tc]<b>1</b> mimics generated by diverse structural modifications on the [<sup>99m</sup>Tc]<b>1</b> motif (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>; <a class="ref internalNav" href="#sec1" aria-label="Introduction">Introduction</a>). The impact of these changes on the GRPR affinity of <b>1</b>–<b>8</b> was minor, with receptor affinities of all analogs remaining in the subnanomolar range (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). This finding is in agreement with previous reports on the favorable influence of the pendant cationic N-terminal tetraamine framework on the binding affinity of BBN-like analogs to the GRPR.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> It is interesting to note that by replacing the tetraamine chelator by negatively charged DOTA in SB3, the GRPR affinity was found >19-fold lower (IC<sub>50</sub> = 5.0 ± 0.04 nM)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> compared to <b>4</b> (IC<sub>50</sub> = 0.26 ± 0.03 nM), in support of this observation. It should be noted that an analogous switch in GRPR affinity (from 3.7 ± 1.3 nM to 35 ± 0.5 nM) was observed when substituting the N<sub>4</sub>-to-DOTA in another set of GRPR antagonists, coupled to the Gly-4-aminobenzoyl-<span class="smallcaps smallerCapital">d</span>Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH<sub>2</sub> sequence.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> As exemplified by the binding affinity of [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b> for the GRPR (<i>K</i><sub>d</sub> = 0.24 ± 0.03 nM), incorporation of the radiometal by the tetraamine framework under formation of a monocationic metal chelate did not negatively affect interaction with the receptor, in agreement with previous observations on [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>1</b> and other tetraamine-derivatized peptide receptor-ligands.<a onclick="showRef(event, 'ref19 ref33'); return false;" href="javascript:void(0);" class="ref ref19 ref33">(19,33)</a> The antagonistic properties at the GRPR were preserved after N-terminal coupling of the chelator as verified by an immunofluorescence microscopy-based receptor internalization assay for the two representative analogs with the highest GRPR affinity, <b>4</b> and <b>8</b>, as previously reported also for reference <b>1</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Access to the corresponding [<sup>99m</sup>Tc]<b>1</b> mimics was straightforward, as reported for several other acyclic tetraamine-functionalized peptides, with the exception of the two hydrazides, <b>7</b> and <b>8</b>. In the latter case a mixture of unidentified radiochemical species formed, most probably due to interaction of the hydrazide function with the metal center.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The rest of the radioligands [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> showed a consistent GRPR radioantagonist behavior during a cell internalization assay, with the bulk of radioactivity localizing on the cell membrane. The highest cell-binding member in the series was [<sup>99m</sup>Tc]<b>4</b>, which well-surpassed the cell-binding of [<sup>99m</sup>Tc]<b>1</b>. This finding showed that minor linker “architecture” differences were sufficient to provoke such pronounced response differences in PC-3 cells. The exceptionally high PC-3 cell association of [<sup>99m</sup>Tc]<b>4</b> may be indicative of higher uptake and longer retention in PC-3 tumor lesions in mice (vide infra).</div><div class="NLM_p">A significant prerequisite for effective in vivo tumor targeting of radiopeptides is bioavailability. Radiopeptides due to their small size exhibit very rapid in vivo kinetics and localize very fast in tumor sites.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Therefore, metabolic integrity in the first critical minutes when they need to reach their target is decisive for optimum supply and uptake to tumor sites. Several recent studies have shown that in vitro serum stability results may not be representative of the real situation encountered by the circulating radiotracer in the body. Metabolism often occurs much faster in vivo simply because of the bigger pool of proteases present in vivo, leading to a higher number of potential degradation pathways. Accordingly, the action of highly abundant cell-surface proteases (often not or only in traces present in serum) anchored on blood cells, endothelial cells of blood vasculature, and major organs is totally disregarded during in vitro serum incubation assays.<a onclick="showRef(event, 'ref44 ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46 ref47">(44−47)</a> Furthermore, in vitro stability studies using incubates of tissue homogenates are also problematic, because cell compartmentalization is disrupted and radioligands are exposed to enzymes which they do not normally encounter in systemic circulation.<a onclick="showRef(event, 'ref19 ref44'); return false;" href="javascript:void(0);" class="ref ref19 ref44">(19,44)</a> In view of the above, the metabolic stability of [<sup>99m</sup>Tc]<b>1</b> mimics was tested in peripheral blood 5 min after intravenous administration of the radiotracers. The percentage of intact radioligand detected was in the range of 45–75%. The Gly<sup>11</sup>-to-<span class="smallcaps smallerCapital">d</span>Ala<sup>11</sup> replacement improved metabolic stability ([<sup>99m</sup>Tc]<b>5</b>, 75% intact), as well as the use of the PEG<sub>2</sub> linker ([<sup>99m</sup>Tc]<b>3</b>, 70% intact), while the absence of linker deteriorated stability ([<sup>99m</sup>Tc]<b>2</b>, 45% intact). Additional Gln<sup>7</sup>-to-<span class="smallcaps smallerCapital">d</span>Gln<sup>11</sup> replacement undertaken based on previous studies on the high potency of similarly bis-substituted BBN(7–14) analogs<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> led to a drop in stability ([<sup>99m</sup>Tc]<b>6</b>, 60% intact). Currently ongoing studies are expected to reveal the role of neutral endopeptidase or other peptidase(s) operating alone or together in the in vivo catabolism of these analogs,<a onclick="showRef(event, 'ref44 ref47 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref44 ref47 ref49 ref50">(44,47,49,50)</a> as suggested by the discrepancies observed in radiometabolite patterns.</div><div class="NLM_p">The much faster in vivo degradation [<sup>99m</sup>Tc]<b>1</b> compared to previously reported results from in vitro mouse plasma incubates (>85% intact at 1 h)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> is in agreement with recent reports on the limited relevance of such studies to reliably evaluate radiopeptide stability. Similar observations may be deduced by comparing the metabolic stability of [<sup>99m</sup>Tc]<b>4</b> determined in vivo in mice (60% intact at 5 min pi; <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D) and in vitro in mouse plasma incubates included in this work for further comparison purposes (>67% intact at 30 min; <a href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf" class="ext-link">Figure S1C</a>). Both [<sup>99m</sup>Tc]<b>1</b> and [<sup>99m</sup>Tc]<b>4</b> were excreted predominantly in the form of radiometabolites in the urine of mice at 30 min pi (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf" class="ext-link">Figure S2C</a>). However, the observed complete degradation of [<sup>99m</sup>Tc]<b>4</b> in the urine (and also [<sup>99m</sup>Tc]<b>1</b>)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> should be rather assigned to the action of enzymes encountered after glomerular filtration of the tracer in the kidneys and should be not erroneously linked to the actual metabolic stability of circulating [<sup>99m</sup>Tc]<b>4</b> at later time points. This assumption is strongly supported by the fast degradation of [<sup>99m</sup>Tc]<b>4</b> in mouse kidney homogenates observed in vitro (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf" class="ext-link">Figure S2B</a>).</div><div class="NLM_p">In mice bearing human PC-3 xenografts, all analogs showed GRPR-specific tumor uptake and rapid clearance from background tissues. However, tumor uptake significantly differed at 1 h pi across analogs as a combined result of individual cell binding capacity assessed in vitro and bioavailability. Notably, the highest cell-associating member with an acceptable in vivo metabolic stability [<sup>99m</sup>Tc]<b>4</b> exceeded the lead compound [<sup>99m</sup>Tc]<b>1</b> in tumor uptake, whereas the least cell-binding and least in vivo stable member [<sup>99m</sup>Tc]<b>2</b> displayed the lowest tumor uptake. Remarkably, [<sup>99m</sup>Tc]<b>4</b> was the only member in this series displaying not only the highest tumor uptake at 1 h pi (28.80 ± 4.13%ID/g) but also the longest retention at 24 h pi (16.32 ± 1.82%ID/g). Similar tumor retention values were reported in the same animal model for another <sup>99m</sup>Tc labeled tetraamine-functionalized tracer based on a C-terminal Sta<sup>13</sup>-Leu<sup>14</sup>-NH<sub>2</sub> GRPR antagonist.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> By achieving significantly improved tumor values at 24 h pi compared to [<sup>99m</sup>Tc]<b>1</b> (5.38 ± 0.72%ID/g), [<sup>99m</sup>Tc]<b>4</b> represents a promising candidate for further validation in man. In comparison to the [<sup>99m</sup>Tc]<b>1</b> reference, longer retention of [<sup>99m</sup>Tc]<b>4</b> is observed in mouse pancreas even at 24 h pi, but at this stage it is difficult to predict if and to what extent this attribute will be translated in human. Furthermore, the radioactivity patterns of [<sup>99m</sup>Tc]<b>4</b> and [<sup>99m</sup>Tc]<b>1</b> at 15 h pi in a preclinical SPECT/CT camera appeared to be comparable. Interestingly, the uptake in the PC-3 tumor was superior for [<sup>99m</sup>Tc]<b>4</b> despite the technical limitations not allowing a later-point imaging and/or a reliable quantitative comparison. In this regard, it is interesting to compare the respective quantitative tumor-to-background ratios of [<sup>99m</sup>Tc]<b>1</b> mimics over time (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf" class="ext-link">Figure S3</a>). In most cases, [<sup>99m</sup>Tc]<b>4</b> resulted not only in superior absolute tumor-uptake but in higher tumor-to-background ratio values too, especially at later time intervals. This observation is very promising for high quality imaging in patients.</div><div class="NLM_p last">This option becomes attractive when taking into account contemporary exciting technological advances in clinical SPECT instrumentation, including the development of state-of-the-art hybrid SPECT/CT and SPECT/MRI systems for hospitals.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The observed “renaissance” of SPECT is also reflected in latest efforts to enhance the production capacity of <sup>99</sup> Mo, and thus, its <sup>99m</sup>Tc-daughter adopting new processes to ensure unperturbed global supply of the preeminent SPECT radiometal, <sup>99m</sup>Tc.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> It is imperative that exciting evolutions in clinical imaging instrumentation are matched by new generation <sup>99m</sup>Tc radiotracers for high quality imaging of disease, as represented by [<sup>99m</sup>Tc]<b>4</b>. Furthermore, Tc and its congener Re are governed by similar chemistries and indeed acyclic tetraamines form isostructural Tc/Re chelates.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Thus, the option of making available [<sup>99m</sup>Tc]<b>4</b>/[<sup>186</sup>Re/<sup>188</sup>Re]<b>4</b> radiopeptide pairs for theranostic applications is particularly compelling and warrants further investigation.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70152" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70152" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">This structure–activity-relationships study has revealed the profound impact of minor linker variations on several biological parameters of this small library of [<sup>99m</sup>Tc]<b>1</b> mimics, which synergistically affect end-pharmacokinetics and in particular tumor uptake and retention. It has further revealed [<sup>99m</sup>Tc]<b>4</b> as the best candidate for clinical translation owing to its advantageously high uptake and prolonged retention in GRPR-expressing tumors, which significantly surpassed our “gold standard” [<sup>99m</sup>Tc]<b>1</b>, as well as to excellent tumor-to-background ratios that increased with time. These qualities, besides offering practical advantages in terms of time flexibility for conveniently completing diagnostic imaging in a clinical setting, provide further opportunities for later-time imaging, anticipated to result in advantageous higher-contrast images and enhanced diagnostic accuracy. They may also pave the way for theranostic patient management with the application of twin diagnostic [<sup>99m</sup>Tc]<b>4</b> and therapeutic [<sup>186</sup>Re/<sup>188</sup>Re]<b>4</b> pairs.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Materials and Instrumentation. Compounds and Radionuclides</h3><div class="NLM_p last">All chemicals used were reagent grade. Fmoc-O<sub>2</sub>-Oc-OH 8-(9-fluorenylmethyloxycarbonylamino)-3,6-dioxaoctanoic acid was purchased from Iris Biotech (Germany) and Fmoc-ethylindole AM resin as well as 4-hydroxymethyl benzoic acid AM resin from Novabiochem. BBN (Pyr-Gln-Arg-Phe-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub>) and [Tyr<sup>4</sup>]BBN were obtained from Bachem (Bubendorf, Switzerland). For radiolabeling, <sup>99m</sup>TcO<sub>4</sub><sup>–</sup> was eluted in normal saline from a commercial <sup>99</sup>Mo/<sup>99m</sup>Tc generator (Ultratechnekow, Tyco Healthcare, Petten, The Netherlands), while Na<sup>125</sup>I was purchased from MDS Nordion, SA (Canada) in a 10<sup>–5</sup> M NaOH solution (10 μL). Technetium-99g was purchased from Oak Ridge National Laboratories, USA, as NH<sub>4</sub><sup>99g</sup>TcO<sub>4</sub>. The impure black solid was purified prior to use by overnight treatment with H<sub>2</sub>O<sub>2</sub> and NH<sub>4</sub>OH in MeOH. Evaporation of the solvent afforded NH<sub>4</sub><sup>99g</sup>TcO<sub>4</sub> as a white powder.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Analysis, Radiochemistry</h3><div class="NLM_p last">MALDI-TOF mass spectrometry data were acquired from a MALDI-TOF spectrometer Kompact Kratos Axima Analytical, Shimadzu; Manchester, U.K. HPLC analyses and separations were conducted on a Waters RP-18 XTerra column (5 μm, 3.9 mm × 20 mm) using a Waters chromatograph with a 600 solvent delivery system coupled to a 996 photodiode array UV detector and a Gabi γ detector (Raytest RSM Analytische Instrumente GmbH, Germany). The Millennium Software was used for data processing and for controlling the HPLC system. An automated well-type γ counter [NaI(Tl) 3 in. crystal, Canberra Packard Auto-Gamma 5000 series instrument] calibrated for <sup>99m</sup>Tc or <sup>125</sup>I was used for radioactivity measurements.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of <b>1</b>–<b>8</b> on the Solid Support. Synthesis of <b>1</b></h3><div class="NLM_p last">Synthesis of <b>1</b> was carried out on an ethylindole AM resin (capacity 0.83 mmol/g) as solid support. First the Fmoc group was removed by incubation of the resin with a solution of piperidine in DMF in a ratio 30/70 v/v. Fmoc-Leu-OH was coupled on the resin by use of a 3-fold excess of the amino acid, <i>O</i>-(7-azabenzotriazolyl-1,1,3,3-tetramethylammonium hexafluorophosphate (HATU) and <i>N</i>-ethyldiisopropylamine (DIPEA) in DMF. After confirmation of the effective amino acid loading via UV absorption measurement of the Fmoc group, elongation of the sequence was performed on an automated synthesizer using a 10-fold excess of the respective Fmoc amino acid derivatives, <i>N</i>,<i>N</i>′-diisopropylcarbodiimide (DIC), 1-hydroxybenzatriazole (HOBt), and DIPEA in a 90:10 v/v mixture of <i>N</i>,<i>N</i>-dimethylformamide (DMF) and dichlormethane (DCM) as solvent. All used amino acids were protected with N<sup>α</sup> Fmoc, and His and Gln were protected with Trt in the side chain. Finally the tetra-Boc protected tetraamine chelator N<sub>4</sub>′ (<i>N,N</i>′<i>,Ν</i>″<i>,Ν</i>′′′-tetra-(<i>tert</i>-butoxycarbonyl)-6-{<i>p</i>-[(carboxymethoxy)acetyl]aminobenzyl}-1,4,8,11-tetraazaundecane) was coupled (in 3 equiv excess) to the assembled amino acid sequence on the resin in the presence of (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP) and DIPEA in DMF. Cleavage of <b>1</b> from the solid support was achieved by treatment with TFA. The crude product was precipitated with cold diethyl ether, collected, and dissolved in a MeCN/H<sub>2</sub>O mixture for lyophilization.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthesis of Ethylamides <b>2</b>–<b>6</b></h3><div class="NLM_p">Synthesis of <b>2</b>–<b>6</b> involved several steps. First the sequences, beginning with the C-terminal His and ending with N-terminal <span class="smallcaps smallerCapital">d</span>Phe, were built on a Fmoc-His(Trt)-trityl resin (substitution >0.15 mmol/g) following solid phase peptide synthesis (SPPS) methodologies. After Fmoc deprotection, anchoring of each amino acid was achieved with a 10-fold excess of the Fmoc amino acid derivative in the presence of DIC, HOBt, and DIPEA in a 90:10 v/v mixture of DMF and DCM. Coupling of Fmoc-O<sub>2</sub>Oc-OH 8-(9-fluorenylmethyloxycarbonylamino)-3,6-dioxaoctanoic acid (for <b>3</b>) and Fmoc-<i>p</i>-aminomethylaniline diglycolate (for <b>4</b>–<b>6</b>) to the N-terminal amine was completed in the presence of PyPOB and DIPEA in DMF, and Fmoc-deprotection was carried out with 30% piperidine in DMF. The tetra-Boc protected tetraamine chelator N<sub>4</sub> (<i>N</i>,<i>N</i>′,<i>Ν</i>″,<i>Ν</i>′′′-tetrakis(<i>tert</i>-butoxycarbonyl)-6-(carboxy)-1,4,8,11-tetraazaundecane) was then coupled to the assembled sequences with PyBOP and DIPEA in DMF, and the resin was subsequently treated for 15 min at ambient temperature with a mixture of 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), triethylsilane (TES), and DCM in a ratio 20/5/75 v/v/v. The solvent was removed by rotary evaporation in vacuum to afford the protected crude “His conjugates”.</div><div class="NLM_p last">The analogs were purified by RP-HPLC on an AKZO Nobel Kromasil Semi/Prep C18 column (250 mm × 20 mm). Fractions containing the desired analog were collected, and the solvent was removed by lyophilization. The protected conjugates were subsequently coupled with H-Leu-NHEt hydrochloride by addition of PyPOB and DIPEA in DMF. The reaction mixture was diluted with H<sub>2</sub>O and freeze-dried. A mixture of trifluoroacetic acid (TFA), 1,2-ethandithiole (EDT), thioanisole, and water in a ratio 90:4:4:2 v/v/v/v was added to the solid and incubated at ambient temperature for 1 h to remove all protecting groups. Transfer of the cocktail into ice-cooled diethyl ether led to precipitation of the crude ethylamides <b>2</b>–<b>6</b>, which were collected, dissolved in MeCN/H<sub>2</sub>O 40/60 v/v, and lyophilized.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis of Hydrazides <b>7</b> and <b>8</b></h3><div class="NLM_p">Synthesis of the C-terminal hydrazide analogs <b>7</b> and <b>8</b> was performed on a 4-hydroxymethylbenzoic acid AM resin (HMBA) with a capacity of 0.7 mmol/g. Coupling of Fmoc-Leu-OH to the resin was achieved by preswelling for 30 min at ambient temperature and subsequent addition of a cocktail of 10 equiv of Fmoc-Leu-OH and 5 equiv of DIC with respect to the loading in DMF, which was stirred 20 min at 0 °C in advance. After incubation of the reaction mixture at ambient temperature for 1 h the resin was filtered off and washed with DMF several times. The assembling of the peptide sequences and the coupling of diglycolate and the tetra-Boc protected tetraamine chelator N<sub>4</sub>′ (for <b>7</b>) or of Fmoc-<i>p</i>-aminomethylaniline diglycolate and the chelator N<sub>4</sub> (for <b>8</b>) were completed, as described above for <b>1</b> and <b>4</b>, respectively. A solution of 5% hydrazine hydrate in DMF was added to the resin, and the suspension was left to stand at ambient temperature for over 1 h. The resin was filtered off and washed with DMF. The liquid layer was lyophilized to remove the DMF, and the residue was treated with a mixture of TFA, EDT, thioanisole, and water in a ratio 90:4:4:2 v/v/v/v to remove all protective groups. Finally, the crude hydrazine derivatives were precipitated with cold diethyl ether, collected, dissolved in MeCN/water 50/50 v/v, and lyophilized.</div><div class="NLM_p last">Crude products for all above synthesized analogs <b>1</b>–<b>8</b> were purified by RP-HPLC on an AKZO Nobel Kromasil Semi/Prep C18 column (250 mm × 20 mm). Fractions containing the desired peptide were collected, and the solvent was removed by lyophilization. The compound purity was tested by analytical HPLC in two different systems: system 1, RP-HPLC with UV detection at 220 nm, and a Waters Xterra RP18 column (5 μm, 4.6 mm × 150 mm) eluted at a flow rate of 1 mL/min with linear gradient 15% B to 30% B in 30 min, with A = 0.1% TFA in H<sub>2</sub>O (v/v) and B = MeCN; system 2, an Agilent system with UV detection at 215 nm and with a Nucleosil-100 C18 column (5 μm, 150 mm × 4 mm) eluted at a flow rate of 1 mL/min with a linear gradient 0.1% TFA in MeCN (from 10% to 90% in 15 min) and 0.1% aqueous TFA as complementary phase. Analytical RP-HPLC data acquired from two separate HPLC systems (system 1 and system 2) confirmed the ≥95% purity of all analogs and are included in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, along with MALDI-TOF MS results, consistent with the expected formulas.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Radiolabeling and Quality Control</h3><div class="NLM_p">The lyophilized peptide analogs were dissolved in 50 mM acetic acid/EtOH 8/2 v/v to a final 1 mM concentration and stored at −20 °C in 50 μL aliquots. For <sup>99m</sup>Tc-labeling the following solutions were added into an Eppendorf tube containing 0.5 M phosphate buffer, pH 11.5 (25 μL): 0.1 M sodium citrate (3 μL), [<sup>99m</sup>Tc]NaTcO<sub>4</sub> (210 μL, 140–280 MBq) generator eluate, <b>1</b>–<b>8</b> stock solution (7.5 μL, 7.5 nmol), and finally fresh SnCl<sub>2</sub> solution in EtOH (5 μg, 5 μL). After 30 min incubation at ambient temperature the reaction mixture was neutralized by addition of 1 M HCl (4 μL), and EtOH was added (25 μL). Quality control comprised radioanalytical HPLC and instant thin-layer chromatography (ITLC). HPLC analyses were performed on a Waters chromatograph coupled to a 996 photodiode array UV detector (Waters, Vienna, Austria) and a Gabi γ detector (Raytest RSM Analytische Instrumente GmbH, Germany). For analysis, a Waters RP-8 XTerra cartridge column was eluted at a 1.0 mL/min flow rate with the following gradient: 0% B to 40% B in 20 min, where A = 0.1% aq TFA, B = MeCN (system 3). Under these conditions <sup>99m</sup>TcO<sub>4</sub><sup>–</sup> eluted at 1.8 min and [<sup>99m</sup>Tc]<b>1</b> mimics with a <i>t</i><sub>R</sub> > 13 min. For the detection of reduced hydrolyzed technetium (<sup>99m</sup>TcO<sub>2</sub>·<i>x</i>H<sub>2</sub>O) ITLC was conducted on ITLC-SG strips (Pall Corporation, NY/USA), as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">[<sup>99g</sup>Tc]<b>4</b> was prepared by following a similar protocol as its [<sup>99m</sup>Tc]<b>4</b> counterpart at tracer level. Due to the higher mass of [<sup>99g</sup>Tc]NH<sub>4</sub>TcO<sub>4</sub> utilized (0.9 μg, 5 nmol), an increased amount of SnCl<sub>2</sub> (20 μg, 0.1 μmol) was required for complete reduction of Tc(VII) to Tc(V). The peptide was purified by RP-HPLC adopting binary γ and photometric detection modes. A Waters Symmetry Shield RP-18 cartridge column (5 μm, 3.9 mm × 20 mm) was eluted at 1 mL/min flow rate with the following gradient system: 0–1 min 0% to 15% B, 1–31 min 15% to 30% B, with A = 0.1% TFA and B = MeCN. Under these conditions, [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b> (<i>t</i><sub>R</sub> = 17.6 min; both γ and UV trace) was easily separated as a single species from nonmetalated <b>4</b> (<i>t</i><sub>R</sub> = 13.6; min UV trace). Triplicates in the 10<sup>–12</sup>–10<sup>–6</sup> M concentration range were prepared and used for saturation binding experiments, as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Radioiodination of [Tyr<sup>4</sup>]BBN was accomplished following the chloramine-T method. The forming sulfoxide (Met<sup>14</sup>═O) was reduced by dithiothreitol, and [<sup>125</sup>I-Tyr<sup>4</sup>]BBN was isolated in a highly pure form by HPLC.<a onclick="showRef(event, 'ref22 ref54'); return false;" href="javascript:void(0);" class="ref ref22 ref54">(22,54)</a> Methionine was added to the purified radioligand solution to prevent oxidation of Met<sup>14</sup> to the corresponding sulfoxide, and the resulting stock solution in 0.1% BSA-PBS was kept at −20 °C; aliquots thereof were used in competition binding assays (74 GBq /μmol).</div><div class="NLM_p last">All manipulations with β (e.g., the pseudostable long-lived <sup>99g</sup>Tc, β<sup>–</sup> 294 keV, <i>t</i><sub>1/2</sub> = 2.1 × 10<sup>5</sup> years) and γ emitting (e.g., <sup>99m</sup>Tc, <i>t</i><sub>1/2</sub> = 6 h, monoenergetic γ photons 140 keV) radionuclides and their solutions were performed behind suitable shielding in dedicated laboratories in compliance with national and international radiation safety guidelines and supervised by the Greek Atomic Energy Commission.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Cell Culture</h3><div class="NLM_p last">Human androgen-independent prostate adenocarcinoma PC-3 cells endogenously expressing the GRPR (by LGC Promochem, Teddington, U.K.)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and HEK293 cells transfected to stably express the HA epitope-tagged human GRPR<a onclick="showRef(event, 'ref24 ref56'); return false;" href="javascript:void(0);" class="ref ref24 ref56">(24,56)</a> were used in this study. All culture media were purchased from Gibco BRL, Life Technologies (Grand Island, NY, USA), and supplements were supplied by Biochrom KG Seromed (Berlin, Germany). PC-3 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) with GlutaMAX-I supplemented with 10% (v/v) fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin. HEK293-GRPR cells were grown in DMEM with GlutaMAX-I supplemented with 10% (v/v) FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 750 μg/mL G418. Cells were kept in a controlled humidified air containing 5% CO<sub>2</sub> at 37 °C. Splitting of cells with a ratio of 1:3 to 1:5 was performed when approaching confluency using a trypsin/EDTA solution (0.05%/0.02% w/v).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> In Vitro Assays. Competition Binding Assays with <b>1</b>–<b>8</b> in PC-3 Cell Membranes</h3><div class="NLM_p last">PC-3 cell membrane homogenates were prepared as previously described.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The [<sup>125</sup>I-Tyr<sup>4</sup>]BBN radioligand (∼40 000 cpm per assay tube, at a 50 pM concentration) was incubated at 22 °C for 45 min in triplicates in PC-3 cell membrane homogenates and increasing concentrations of test peptide, either each of unlabeled analogs <b>1</b>–<b>8</b> or [Tyr<sup>4</sup>]BBN as reference, in a total volume of 300 μL binding buffer (BB, 50 mM HEPES, pH 7.4, 1% BSA, 5.5 mM MgCl<sub>2</sub>, 35 μM bacitracin) in an incubator–orbital shaker (MPM Instr. SrI, Italy). Binding was interrupted by ice-cold washing buffer (WB, 10 mM HEPES, pH 7.4, 150 mM NaCl) and rapid filtration (Whatman GF/B filters presoaked in BB) on a Brandel cell harvester (Adi Hassel Ing. Büro, Munich, Germany). Filters were washed with ice-cold WB and counted in the γ counter. The half maximal inhibitory concentration (IC<sub>50</sub>) values were calculated using nonlinear regression according to a one-site model applying the PRISM 2 program (Graph Pad Software, San Diego, CA).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Immunofluorescence Microscopy-Based Internalization Assay with <b>4</b> and <b>8</b></h3><div class="NLM_p last">Immunofluorescence microscopy-based internalization assays with HEK293-GRPR cells were performed as previously described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In brief, HEK293-GRPR cells were grown on poly-<span class="smallcaps smallerCapital">d</span>-lysine (20 μg/mL) (Sigma-Aldrich, St. Louis, MO) coated 35 mm four-well plates (Cellstar, Greiner Bio-One GmbH, Frickenhausen, Germany). For the experiment, cells were treated either with vehicle alone (no peptide) or with 10 nM BBN or 1 μM unlabeled analog <b>4</b> or <b>8</b> alone, or (to evaluate potential antagonistic properties) with 10 nM BBN in the presence of 1 μM <b>4</b> or <b>8</b> for 30 min at 37 °C and 5% CO<sub>2</sub> in growth medium, and then they were processed for immunofluorescence microscopy using a mouse monoclonal HA-epitope antibody (Covance; Berkeley, CA) at a dilution of 1:1000 as first antibody and Alexa Fluor 488 goat anti-mouse IgG (H+L) (Molecular Probes, Inc.; Eugene, OR) at a dilution of 1:600 as secondary antibody. The cells were imaged using a Leica DM RB immunofluorescence microscope and an Olympus DP10 camera.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Cell-Association/Internalization of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> in PC-3 Cells</h3><div class="NLM_p last">Confluent PC-3 cells were seeded in six-well plates ((1.0–1.5) × 10<sup>6</sup> cells per well) and were incubated for 24 h. Cells were rinsed twice with ice-cold internalization medium containing DMEM GlutaMAX-I supplemented with 1% (v/v) FBS, and then fresh internalization medium (37 °C) was added (1.2 mL). Approximately 300 000 cpm of test radioligand (∼200 fmol total peptide in 150 μL of 0.5% BSA PBS) was added per well, and the experiment was performed after 1 h incubation at 37 °C, as previously described. Nonspecific cell-binding was determined by a parallel triplicate series containing 1 μM [Tyr<sup>4</sup>]BBN. Surface bound radioligand was separated from the internalized radioactivity by treatment of the cells with acidic buffer (50 mM glycine buffer, pH 2.8, 0.1 M NaCl). Samples were measured for their radioactivity content, and the percent total cell bound, surface-bound, and internalized radioactivity could be calculated.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Saturation Binding of [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b> in PC-3 Cell Membranes</h3><div class="NLM_p last">For saturation binding experiments two sets of [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b> triplicates of different radioligand concentrations were prepared for total and nonspecific binding. Each assay tube contained 50 μL of binding buffer (50 mM HEPES, pH 7.6 containing 0.3% BSA, 10 mM MgCl<sub>2</sub>, 14 mg/L bacitracin), 50 μL of [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b> solution of the corresponding concentration (final concentration series in the range of 0.01–10 nM), and 200 μL of PC-3 cell membrane homogenates containing 40 μg of protein. For the nonspecific series, instead of 50 μL of binding buffer 20 μL of binding buffer plus 30 μL of 10 μM [Tyr<sup>4</sup>]BBN solution was used. Tubes were incubated at ambient temperature for 1 h and binding was interrupted by addition of ice-cold buffer (10 mM HEPES, 150 mM NaCl, pH 7.6) and rapid filtration through glass fiber filters (Whatman GF/B, presoaked in 0.3% BSA) on the Brandel cell harvester. Filter activity was measured on the γ counter. Nonspecific binding was defined as the amount of activity binding in the presence of 1 μM [Tyr<sup>4</sup>]BBN, and the equilibrium dissociation constant (<i>K</i><sub>d</sub>) was calculated after fitting the data to a one-site model.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Metabolic Stability. In Vivo Stability of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> in Healthy Mice</h3><div class="NLM_p last">A bolus of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> (100 μL, 50–60 MBq, 3 nmol total peptide; in saline/EtOH 9/1 v/v) was injected in the tail vein of male Swiss albino mice (30 ± 5 g, NCSR “Demokritos” Animal House Facility). Blood withdrawn 5 min pi was directly placed in prechilled polypropylene tubes containing EDTA on ice. Samples were centrifuged (10 min, 2000<i>g</i>/4 °C, in a Hettich, Universal 320R centrifuge, Tüttlingen, Germany), the plasma was collected, mixed with chilled MeCN in a 1/1 v/v ratio, and centrifuged again (10 min, 5000<i>g</i>/4 °C). Supernatants were concentrated to a small volume under a gentle N<sub>2</sub> flux at 40 °C, diluted with physiological saline (400 μL), and filtered through a Millex GV filter (0.22 μm). Aliquots thereof were analyzed by HPLC (system 4) on a Waters RP-18 Symmetry Shield column (5 μm, 3.9 mm × 150 mm) adopting the following gradient: 100% A/0% B to 40% A/60% B within 60 min (A = 0.1% aqueous TFA and B = MeCN) at a flow rate of 1 mL/min; the <i>t</i><sub>R</sub> of intact [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> was determined by co-injection of a parent radioligand sample. ITLC-SG was performed in parallel using acetone as the eluent to detect traces of <sup>99m</sup>TcO<sub>4</sub><sup>–</sup> release (<sup>99m</sup>TcO<sub>4</sub><sup>–</sup><i>R</i><sub>f</sub> = 0.9).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Biodistribution in SCID Mice Bearing Human PC-3 Xenografts</h3><div class="NLM_p">Suspensions of freshly harvested PC-3 cells (∼150 μL, 1.4 × 10<sup>7</sup>) in saline were subcutaneously injected in the flanks of female SCID mice (15 ± 3 g, 6 weeks of age animals at the day of arrival were employed, NCSR “Demokritos” Animal House Facility). The animals were kept under aseptic conditions and 3 weeks later developed well-palpable tumors at the inoculation site (80–150 mg). On the day of the experiment, each of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> was injected as a bolus (100 μL, 185 kBq, 10 pmol total peptide; in saline/EtOH 9/1 v/v) in the tail vein of mice; for in vivo GRPR blockade separate 4 h animal groups were co-injected with excess [Tyr<sup>4</sup>]BBN (20 nmol). Animals were euthanized in groups of four at 1, 4, and 24 h pi; samples of blood were immediately collected, and tissues of interest and tumors were excised, weighed, and counted for radioactivity in the γ counter. Data were calculated as percent injected dose per gram tissue (%ID/g) with the aid of suitable standards of the injected dose and are presented as mean ± sd. The unpaired two tailed Student’s <i>t</i> test of GraphPad Prism Software (San Diego, CA) was applied to evaluate statistically significant differences. <i>P</i> values of <0.05 were considered to be statistically significant.</div><div class="NLM_p last">These animal experiments were performed in compliance with national and European guidelines and approved by national authorities (approved No. 6461 Protocol, in No. EL 25 BIO 021 facility; Prefecture of Athens).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> SPECT/CT Imaging</h3><div class="NLM_p">Female athymic Nude-Foxn1<sup>nu</sup> mice (Envigo, The Netherlands, 4- to 6-weeks old) were inoculated subcutaneously in their right shoulders with a freshly prepared suspension of 1 × 10<sup>7</sup> PC-3 cells in 100 μL of sterile isotonic saline. PC-3 tumor xenografts grew within 12–14 days and were imaged using a nanoSPECT/CT system (Bioscan), 15 h after bolus injection of [<sup>99m</sup>Tc]<b>1</b> or [<sup>99m</sup>Tc]<b>4</b> (100 μL/20 MBq/200 pmol total peptide; in saline/EtOH 9/1 v/v). In addition, PC-3 tumor xenografts were imaged 1 h after injection of [<sup>99m</sup>Tc]<b>4</b> (100 μL/20 pmol/2.4 MBq total peptide; in saline/EtOH 9/1 v/v) with or without co-injection of [Tyr<sup>4</sup>]BBN in excess (20 nmol) for in vivo GRPR blockade. The mice were euthanatized before being placed on the scanner. SPECT/CT images were acquired as follows. A helical CT scan was obtained with the following parameters: current, 177 μA; voltage, 45 kVp; pitch, 1. A helical SPECT scan was achieved using multipurpose pinhole collimators (APT1), 20% energy window width centered symmetrically over the 140 keV γ-peak of <sup>99m</sup>Tc, 24 projections, and 1800 s per projection. CT and SPECT images were reconstructed and filtered using the manufacturer’s algorithm, resulting in a pixel size of 0.3 mm for the SPECT and of 0.2 mm for the CT. The SPECT/CT images were displayed using the same color scale for direct comparison.</div><div class="NLM_p last">Animals were housed and cared for according to Swiss regulations on animal experimentation (Approval No. 789).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00177" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00177" class="ext-link">10.1021/acs.jmedchem.8b00177</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Radiochromatograms of [<sup>99m</sup>Tc]<b>4</b> incubates in fresh mouse plasma at 37 °C over time (Figure S1), radiochromatograms of [<sup>99m</sup>Tc]<b>4</b> incubates in fresh kidney homogenates at 37 °C and in urine (Figure S2), and tumor-to-nontarget tissue ratios for [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> at 1, 4, and 24 h pi (Figure S3) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf">jm8b00177_si_001.pdf (426.32 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_002.csv">jm8b00177_si_002.csv (2.24 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00177" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theodosia Maina</span> - <span class="hlFld-Affiliation affiliation">Molecular Radiopharmacy,
INRASTES, National Center for Scientific
Research “Demokritos”, GR-153 10 Athens, Greece</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1123-2486" title="Orcid link">http://orcid.org/0000-0002-1123-2486</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c7aaa6aea9a698b3afa2a687afa8b3aaa6aeabe9a4a8aa"><span class="__cf_email__" data-cfemail="8fe2eee6e1eed0fbe7eaeecfe7e0fbe2eee6e3a1ece0e2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Berthold A. Nock</span> - <span class="hlFld-Affiliation affiliation">Molecular Radiopharmacy,
INRASTES, National Center for Scientific
Research “Demokritos”, GR-153 10 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Charalambidis</span> - <span class="hlFld-Affiliation affiliation">Molecular Radiopharmacy,
INRASTES, National Center for Scientific
Research “Demokritos”, GR-153 10 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Werner Sallegger</span> - <span class="hlFld-Affiliation affiliation">piCHEM, A-8045 Graz, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatrice Waser</span> - <span class="hlFld-Affiliation affiliation">Cell Biology and Experimental
Cancer Research, Institute of Pathology, University of Berne, CH-3010 Berne, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosalba Mansi</span> - <span class="hlFld-Affiliation affiliation">Divisions of Radiopharmaceutical Chemistry and , University Hospital Basel, CH-4031 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guillaume P. Nicolas</span> - <span class="hlFld-Affiliation affiliation">Nuclear Medicine and , University Hospital Basel, CH-4031 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eleni Ketani</span> - <span class="hlFld-Affiliation affiliation">Molecular Radiopharmacy,
INRASTES, National Center for Scientific
Research “Demokritos”, GR-153 10 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anastasia Nikolopoulou</span> - <span class="hlFld-Affiliation affiliation">Molecular Radiopharmacy,
INRASTES, National Center for Scientific
Research “Demokritos”, GR-153 10 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melpomeni Fani</span> - <span class="hlFld-Affiliation affiliation">Divisions of Radiopharmaceutical Chemistry and , University Hospital Basel, CH-4031 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Claude Reubi</span> - <span class="hlFld-Affiliation affiliation">Cell Biology and Experimental
Cancer Research, Institute of Pathology, University of Berne, CH-3010 Berne, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions by all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Biomedica Life Sciences S. A,  for financial support of this project.</p></div><table summary="" class="NLM_def-list" id="DEF-LIST-d169e4445-autogenerated"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">GRPR</td><td class="NLM_def"><p class="first last">gastrin releasing peptide receptor</p></td></tr><tr><td class="NLM_term">BBN</td><td class="NLM_def"><p class="first last">bombesin, Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">GRP</td><td class="NLM_def"><p class="first last">gastrin releasing peptide, H-Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">NMC</td><td class="NLM_def"><p class="first last">neuromedin C, Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">N<sub>4</sub>́</td><td class="NLM_def"><p class="first last">6-{<i>p</i>-[(carboxymethoxy)acetyl]aminobenzyl}-1,4,8,11-tetraazaundecane</p></td></tr><tr><td class="NLM_term">N<sub>4</sub></td><td class="NLM_def"><p class="first last">6-(carboxyl)-1,4,8,11-tetraazaundecane</p></td></tr><tr><td class="NLM_term">PEG<sub>2</sub></td><td class="NLM_def"><p class="first last">8-amino-3,6-dioxaoctanoic acid</p></td></tr><tr><td class="NLM_term">AMA-DGA</td><td class="NLM_def"><p class="first last">aminomethylaniline diglycolate</p></td></tr><tr><td class="NLM_term">DOTA</td><td class="NLM_def"><p class="first last">1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid phase peptide synthesis</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">MALDI-TOF</td><td class="NLM_def"><p class="first last">matrix-assisted laser desorption/ionization time-of-flight</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">SPECT</td><td class="NLM_def"><p class="first last">single photon emission computed tomography</p></td></tr><tr><td class="NLM_term">Lu-AMBA</td><td class="NLM_def"><p class="first last"><sup>177</sup>Lu-DOTA-Gly-4-aminobenzoyl-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">CT</td><td class="NLM_def"><p class="first last">computed tomography</p></td></tr><tr><td class="NLM_term">MRI</td><td class="NLM_def"><p class="first last">magnetic resonance imaging.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroog, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battey, J. F.</span></span> <span> </span><span class="NLM_article-title">Mammalian bombesin receptors</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1002/med.2610150502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fmed.2610150502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=8531502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADyaK2MXosFegtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=389-417&issue=5&author=G.+S.+Kroogauthor=R.+T.+Jensenauthor=J.+F.+Battey&title=Mammalian+bombesin+receptors&doi=10.1002%2Fmed.2610150502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian bombesin receptors</span></div><div class="casAuthors">Kroog, Glenn S.; Jensen, Robert T.; Battey, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-417</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 142 refs.  Topics discussed include: the identification and cloning of bombesin receptors, tissue distribution of the bombesin family of receptors, ligand binding, bombesin-induced 2nd messengers, interaction with GTP-binding proteins, and bombesin receptor desensitization in relation to internalization and loss of cell surface receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruYNcnewntVLVg90H21EOLACvtfcHk0lggmUFemvAMVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosFegtbw%253D&md5=350f9dbb0ad390d93ada88c99cfe33dc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610150502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610150502%26sid%3Dliteratum%253Aachs%26aulast%3DKroog%26aufirst%3DG.%2BS.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26aulast%3DBattey%26aufirst%3DJ.%2BF.%26atitle%3DMammalian%2520bombesin%2520receptors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1995%26volume%3D15%26issue%3D5%26spage%3D389%26epage%3D417%26doi%3D10.1002%2Fmed.2610150502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Markwalder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=1152-1159&issue=5&author=R.+Markwalderauthor=J.+C.+Reubi&title=Gastrin-releasing+peptide+receptors+in+the+human+prostate%3A+relation+to+neoplastic+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkwalder%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DGastrin-releasing%2520peptide%2520receptors%2520in%2520the%2520human%2520prostate%253A%2520relation%2520to%2520neoplastic%2520transformation%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D5%26spage%3D1152%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Körner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Early over-expression of GRP receptors in prostatic carcinogenesis</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1002/pros.22743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fpros.22743" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=217-224&issue=2&author=M.+K%C3%B6rnerauthor=B.+Waserauthor=R.+Rehmannauthor=J.+C.+Reubi&title=Early+over-expression+of+GRP+receptors+in+prostatic+carcinogenesis&doi=10.1002%2Fpros.22743"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fpros.22743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22743%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6rner%26aufirst%3DM.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DRehmann%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DEarly%2520over-expression%2520of%2520GRP%2520receptors%2520in%2520prostatic%2520carcinogenesis%26jtitle%3DProstate%26date%3D2014%26volume%3D74%26issue%3D2%26spage%3D217%26epage%3D224%26doi%3D10.1002%2Fpros.22743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hany, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermanns, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muntener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristiansen, G.</span></span> <span> </span><span class="NLM_article-title">Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1002/pros.21434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fpros.21434" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=318-325&issue=3&author=M.+Beerauthor=M.+Montaniauthor=J.+Gerhardtauthor=P.+J.+Wildauthor=T.+F.+Hanyauthor=T.+Hermannsauthor=M.+Muntenerauthor=G.+Kristiansen&title=Profiling+gastrin-releasing+peptide+receptor+in+prostate+tissues%3A+clinical+implications+and+molecular+correlates&doi=10.1002%2Fpros.21434"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fpros.21434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.21434%26sid%3Dliteratum%253Aachs%26aulast%3DBeer%26aufirst%3DM.%26aulast%3DMontani%26aufirst%3DM.%26aulast%3DGerhardt%26aufirst%3DJ.%26aulast%3DWild%26aufirst%3DP.%2BJ.%26aulast%3DHany%26aufirst%3DT.%2BF.%26aulast%3DHermanns%26aufirst%3DT.%26aulast%3DMuntener%26aufirst%3DM.%26aulast%3DKristiansen%26aufirst%3DG.%26atitle%3DProfiling%2520gastrin-releasing%2520peptide%2520receptor%2520in%2520prostate%2520tissues%253A%2520clinical%2520implications%2520and%2520molecular%2520correlates%26jtitle%3DProstate%26date%3D2012%26volume%3D72%26issue%3D3%26spage%3D318%26epage%3D325%26doi%3D10.1002%2Fpros.21434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gugger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>155</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2076</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)65525-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2FS0002-9440%2810%2965525-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10595936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1Knsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1999&pages=2067-2076&issue=6&author=M.+Guggerauthor=J.+C.+Reubi&title=Gastrin-releasing+peptide+receptors+in+non-neoplastic+and+neoplastic+human+breast&doi=10.1016%2FS0002-9440%2810%2965525-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast</span></div><div class="casAuthors">Gugger, Mathias; Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2067-2076</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The regulatory peptide gastrin-releasing peptide (GRP) may play a role in human cancer as a stimulatory growth factor.  To understand the potential role of GRP in human breast cancer, the authors have evaluated GRP receptor expression in human non-neoplastic and neoplastic breast tissues and in axillary lymph node metastases, using in vitro receptor autoradiog. on tissue sections with [125I]Tyr4-bombesin and with [125I]D-Tyr6, β Ala11, Phe13, Nle14-bombesin(6-14) as radioligands.  GRP receptors were detected, often in high d., in neoplastic epithelial mammary cells in 29 of 46 invasive ductal carcinomas, in 11 of 17 ductal carcinomas in situ, in 1 of 4 invasive lobular carcinomas, in 1 of 2 lobular carcinomas in situ, and in 1 mucinous and 1 tubular carcinoma.  A heterogeneous GRP receptor distribution was found in the neoplastic tissue samples in 32 of 52 cases with invasive carcinoma and 12 of 19 cases with carcinoma in situ.  The lymph node metastases from those primary carcinomas expressing GRP receptors were all pos., whereas surrounding lymphoreticular tissue was neg.  GRP receptors were also present in high d. but with heterogeneous distribution in ducts and lobules from all available breast tissue samples.  All of the receptors corresponded to the GRP receptor subtype of bombesin receptors, having high affinity for GRP and bombesin and lower affinity for neuromedin B.  All tissues expressing GRP receptors were identified similarly with both radioligands.  These data describe not only a high percentage of GRP receptor-pos. neoplastic breast tissues but also for the first time a ubiquitous GRP receptor expression in nonneoplastic human breast tissue.  Apart from suggesting a role of GRP in breast physiol., these data represent the mol. basis for potential clin. applications of GRP analogs such as GRP receptor scintigraphy, radiotherapy, or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7FaVfPA8ChLVg90H21EOLACvtfcHk0lhqEjdFkn1cvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Knsg%253D%253D&md5=c9033e2188ac6f5abee5ba4c97cc4531</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965525-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965525-3%26sid%3Dliteratum%253Aachs%26aulast%3DGugger%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DGastrin-releasing%2520peptide%2520receptors%2520in%2520non-neoplastic%2520and%2520neoplastic%2520human%2520breast%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D155%26issue%3D6%26spage%3D2067%26epage%3D2076%26doi%3D10.1016%2FS0002-9440%2810%2965525-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittliff, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span> <span> </span><span class="NLM_article-title">Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">287</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=280-287&issue=2&author=G.+Halmosauthor=J.+L.+Wittliffauthor=A.+V.+Schally&title=Characterization+of+bombesin%2Fgastrin-releasing+peptide+receptors+in+human+breast+cancer+and+their+relationship+to+steroid+receptor+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalmos%26aufirst%3DG.%26aulast%3DWittliff%26aufirst%3DJ.%2BL.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DCharacterization%2520of%2520bombesin%252Fgastrin-releasing%2520peptide%2520receptors%2520in%2520human%2520breast%2520cancer%2520and%2520their%2520relationship%2520to%2520steroid%2520receptor%2520expression%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26issue%3D2%26spage%3D280%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalm, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieuwerts, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Deurzen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelewijn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Blois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.2967/jnumed.114.153023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.114.153023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=752-757&issue=5&author=S.+U.+Dalmauthor=J.+W.+Martensauthor=A.+M.+Sieuwertsauthor=C.+H.+van+Deurzenauthor=S.+J.+Koelewijnauthor=E.+de+Bloisauthor=T.+Mainaauthor=B.+A.+Nockauthor=L.+Brunelauthor=J.+A.+Fehrentzauthor=J.+Martinezauthor=M.+de+Jongauthor=M.+Melis&title=In+vitro+and+in+vivo+application+of+radiolabeled+gastrin-releasing+peptide+receptor+ligands+in+breast+cancer&doi=10.2967%2Fjnumed.114.153023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.153023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.153023%26sid%3Dliteratum%253Aachs%26aulast%3DDalm%26aufirst%3DS.%2BU.%26aulast%3DMartens%26aufirst%3DJ.%2BW.%26aulast%3DSieuwerts%26aufirst%3DA.%2BM.%26aulast%3Dvan%2BDeurzen%26aufirst%3DC.%2BH.%26aulast%3DKoelewijn%26aufirst%3DS.%2BJ.%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DBrunel%26aufirst%3DL.%26aulast%3DFehrentz%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DMelis%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520application%2520of%2520radiolabeled%2520gastrin-releasing%2520peptide%2520receptor%2520ligands%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26issue%3D5%26spage%3D752%26epage%3D757%26doi%3D10.2967%2Fjnumed.114.153023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achcar, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batlle, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groshong, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulczynski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Lago, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunetto, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartsmann, G.</span></span> <span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptor expression in lung cancer</span>. <i>Arch. Pathol. Lab. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.5858/arpa.2012-0679-OA</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.5858%2Farpa.2012-0679-OA" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=24377816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2014&pages=98-104&issue=1&author=J.+Matteiauthor=R.+D.+Achcarauthor=C.+H.+Canoauthor=B.+R.+Macedoauthor=L.+Meurerauthor=B.+S.+Batlleauthor=S.+D.+Groshongauthor=J.+M.+Kulczynskiauthor=R.+Roeslerauthor=L.+Dal+Lagoauthor=A.+T.+Brunettoauthor=G.+Schwartsmann&title=Gastrin-releasing+peptide+receptor+expression+in+lung+cancer&doi=10.5858%2Farpa.2012-0679-OA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-releasing peptide receptor expression in lung cancer</span></div><div class="casAuthors">Mattei, Jane; Achcar, Rosane; Cano, Carlos H.; Macedo, Bruno R.; Meurer, Luise; Batlle, Brenda S.; Groshong, Steve D.; Kulczynski, Jane M.; Roesler, Rafael; Dal Lago, Lissandra; Brunetto, Andre T.; Schwarstsmann, Gilberto</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pathology & Laboratory Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-104</span>CODEN:
                <span class="NLM_cas:coden">APLMAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-9985</span>.
    
            (<span class="NLM_cas:orgname">College of American Pathologists</span>)
        </div><div class="casAbstract">Gastrin-releasing peptide receptors (GRPRs) activate mitogen-activated protein kinase signaling pathway primarily through epidermal growth factor receptor activation and are under investigation as a mol. target because they are overexpressed in several solid tumors.  Objective.-To det. GRPR expression in both non-small cell lung carcinoma and small cell lung carcinoma, comparing results with clin. stages and demog. data.  Design.-We analyzed the immunohistochem. expression of GRPR in 200 non-small cell lung carcinoma and 38 small cell lung carcinoma archival cases from 2004 to 2008.  Results.-Non-small cell lung carcinoma cases tended to be higher GRPR expressers at a rate of 62.5% (weak, moderate, and strong expression in 41.5%, 13.5%, and 7.5%, resp.), compared with 52.62% in small cell lung carcinoma cases (weak, moderate, and strong expression in 34.21%, 15.78%, and 2.63%, resp.; P = .30).  In non-small cell lung carcinoma there was a trend for higher percentages of strong expression in adenocarcinoma cases (10%; P = .67), and in patients with advanced stages (III and IV; 9.43% and 6.9%; P = .01).  Conclusions.-To the best of our knowledge, this is the first study to demonstrate GRPR tissue expression in a large population of patients with lung cancer.  Although GRPR expression was similar in small cell and non-small cell carcinoma, the expression was more pronounced in an advanced-stage lung cancer, particularly in adenocarcinoma cases, and may represent a potential target for the development of new treatment approaches in this population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5PjaDjbkMx7Vg90H21EOLACvtfcHk0lhqEjdFkn1cvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlClurs%253D&md5=0d0675bafcd3d2f1bfc423f93177a278</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.5858%2Farpa.2012-0679-OA&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5858%252Farpa.2012-0679-OA%26sid%3Dliteratum%253Aachs%26aulast%3DMattei%26aufirst%3DJ.%26aulast%3DAchcar%26aufirst%3DR.%2BD.%26aulast%3DCano%26aufirst%3DC.%2BH.%26aulast%3DMacedo%26aufirst%3DB.%2BR.%26aulast%3DMeurer%26aufirst%3DL.%26aulast%3DBatlle%26aufirst%3DB.%2BS.%26aulast%3DGroshong%26aufirst%3DS.%2BD.%26aulast%3DKulczynski%26aufirst%3DJ.%2BM.%26aulast%3DRoesler%26aufirst%3DR.%26aulast%3DDal%2BLago%26aufirst%3DL.%26aulast%3DBrunetto%26aufirst%3DA.%2BT.%26aulast%3DSchwartsmann%26aufirst%3DG.%26atitle%3DGastrin-releasing%2520peptide%2520receptor%2520expression%2520in%2520lung%2520cancer%26jtitle%3DArch.%2520Pathol.%2520Lab.%2520Med.%26date%3D2014%26volume%3D138%26issue%3D1%26spage%3D98%26epage%3D104%26doi%3D10.5858%2Farpa.2012-0679-OA" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmuckli-Maurer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaer, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugger, M.</span></span> <span> </span><span class="NLM_article-title">Bombesin receptor subtypes in human cancers: detection with the universal radioligand <sup>125</sup>I-[D-Tyr<sup>6</sup>,beta-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin(6–14)</span>. <i>Clin. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1139</span>– <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=11948125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsF2lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1139-1146&issue=4&author=J.+C.+Reubiauthor=S.+Wengerauthor=J.+Schmuckli-Maurerauthor=J.+C.+Schaerauthor=M.+Gugger&title=Bombesin+receptor+subtypes+in+human+cancers%3A+detection+with+the+universal+radioligand+125I-%5BD-Tyr6%2Cbeta-Ala11%2CPhe13%2CNle14%5Dbombesin%286%E2%80%9314%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin receptor subtypes in human cancers: detection with the universal radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14] bombesin(6-14)</span></div><div class="casAuthors">Reubi, Jean Claude; Wenger, Sandra; Schmuckli-Maurer, Jacqueline; Schaer, Jean-Claude; Gugger, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1139-1146</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bombesin and bombesin receptors have been shown to play a role in cancer.  Whereas the gastrin-releasing peptide (GRP) receptor is a bombesin receptor subtype frequently expressed by tumors, the other three subtypes, the neuromedin B (NMB), BB3, and BB4 receptors, have been poorly investigated in human tissues.  We investigated 161 human tumors for their bombesin receptor subtype expression using in vitro receptor autoradiog. with the universal bombesin radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14]bombesin(6-14) in displacement expts. with unlabeled GRP, bombesin, NMB, and [D-Tyr6, β-Ala11, Phe13, Nle14]bombesin(6-14).  The distinct rank order of potencies of these analogs for each receptor subtype allows us to identify the predominant subtype expressed by each tumor.  Twelve of 12 prostate cancers, 41 of 57 breast cancers, and 5 of 5 gastrinomas expressed predominantly GRP receptors; 11 of 24 intestinal, 1 of 26 bronchial, and 1 of 1 thymic carcinoids had preferentially NMB receptors; 9 of 26 bronchial carcinoids, 1 large cell neuroendocrine lung carcinoma, and 4 of 9 small cell lung carcinomas had preferentially BB3 receptors, whereas 3 of 9 small cell lung carcinomas had GRP receptors.  Renal cell carcinomas had GRP receptors in 6 of 16 cases and BB3 receptors in 4 of 16 cases.  Finally, 2 of 10 Ewing sarcomas had BB3 receptors.  In situ hybridization detected BB3 receptor mRNA in neuroendocrine tumors expressing the BB3 protein.  This is the first study detecting the proteins of BB3, NMB, and GRP receptors in a group of human tumors using differential binding techniques.  Particularly relevant is the BB3 expression in lung carcinoids and other neuroendocrine lung tumors, whereas gastrointestinal carcinoids preferably express NMB receptors.  These tumors may be targets for diagnostic and radiotherapeutic applications of subtype-selective bombesin analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRfYyxkp7qw7Vg90H21EOLACvtfcHk0ljfsXNpVWA6aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsF2lt7w%253D&md5=a50d221d981065374b9facaae5744ee7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWenger%26aufirst%3DS.%26aulast%3DSchmuckli-Maurer%26aufirst%3DJ.%26aulast%3DSchaer%26aufirst%3DJ.%2BC.%26aulast%3DGugger%26aufirst%3DM.%26atitle%3DBombesin%2520receptor%2520subtypes%2520in%2520human%2520cancers%253A%2520detection%2520with%2520the%2520universal%2520radioligand%2520125I-%255BD-Tyr6%252Cbeta-Ala11%252CPhe13%252CNle14%255Dbombesin%25286%25E2%2580%259314%2529%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2002%26volume%3D8%26issue%3D4%26spage%3D1139%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Körner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzucchelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, L.</span></span> <span> </span><span class="NLM_article-title">High expression of peptide receptors as a novel target in gastrointestinal stromal tumours</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">803</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1007/s00259-004-1476-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-004-1476-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=14985869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVensLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=803-810&issue=6&author=J.+C.+Reubiauthor=M.+K%C3%B6rnerauthor=B.+Waserauthor=L.+Mazzucchelliauthor=L.+Guillou&title=High+expression+of+peptide+receptors+as+a+novel+target+in+gastrointestinal+stromal+tumours&doi=10.1007%2Fs00259-004-1476-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">High expression of peptide receptors as a novel target in gastrointestinal stromal tumours</span></div><div class="casAuthors">Reubi, Jean Claude; Koerner, Meike; Waser, Beatrice; Mazzucchelli, Luca; Guillou, Louis</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-810</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Recent significant advances in understanding the biol. of gastrointestinal stromal tumors (GIST) have led to the introduction of a new targeted therapy (imatinib mesylate, Glivec).  Hopes of a new era of a specific cancer therapy, however, have been tempered by the recognition that a significant proportion of patients who initially respond to the drug eventually become resistant to it.  Given the successful development of peptide receptor scintigraphy and radiotherapy for neuroendocrine tumors, we postulated that a similar approach could offer a valid alternative in the diagnosis and therapy of GIST.  Using in vitro receptor autoradiog. to measure peptide receptors, we found that 16/19 GIST expressed bombesin subtype 2 receptors, 16/19 expressed vasoactive intestinal peptide subtype 2 receptors (VPAC2) and 12/19 expressed cholecystokinin subtype 2 receptors, in most cases in extremely high densities.  All GIST metastases were shown to express two or more of these peptide receptors in very high d.  Receptors were also expressed in non-responders to Glivec or after chemo-embolization.  Conversely, somatostatin subtype 2, cholecystokinin subtype 1, bombesin subtype 1 and 3, and neuropeptide Y subtype Y1 and Y2 receptors were not or only rarely expressed.  These data represent a strong mol. basis for the use of radiolabeled bombesin, vasoactive intestinal peptide and/or cholecystokinin analogs as targeting agents to localize GIST tumors in patients by in vivo scintigraphy and/or to perform targeted radiotherapy to destroy GIST primaries, metastases and recurrences, including those resistant to Glivec.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8m05Q69YNn7Vg90H21EOLACvtfcHk0ljfsXNpVWA6aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVensLY%253D&md5=da4ac9e0312a7f82fc6bc7be3e46fe10</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00259-004-1476-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-004-1476-2%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DK%25C3%25B6rner%26aufirst%3DM.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DMazzucchelli%26aufirst%3DL.%26aulast%3DGuillou%26aufirst%3DL.%26atitle%3DHigh%2520expression%2520of%2520peptide%2520receptors%2520as%2520a%2520novel%2520target%2520in%2520gastrointestinal%2520stromal%2520tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2004%26volume%3D31%26issue%3D6%26spage%3D803%26epage%3D810%26doi%3D10.1007%2Fs00259-004-1476-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleischmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms</span>. <i>Cell Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=17726264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFWju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=421-433&issue=5&author=A.+Fleischmannauthor=B.+Waserauthor=J.+C.+Reubi&title=Overexpression+of+gastrin-releasing+peptide+receptors+in+tumor-associated+blood+vessels+of+human+ovarian+neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms</span></div><div class="casAuthors">Fleischmann, Achim; Waser, Beatrice; Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-433</span>CODEN:
                <span class="NLM_cas:coden">COENCD</span>;
        ISSN:<span class="NLM_cas:issn">1570-5870</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: Peptide receptors, overexpressed in specific cancers, represent new diagnostic and therapeutic targets.  In this study, receptors for the gastrin-releasing peptide (GRP), and other members of the bombesin-family of peptides, were evaluated in ovarian neoplasms.  Methods: 75 primary, secondary and metastatic ovarian tumors were investigated for their bombesin-receptor subtype expression, incidence, localization and d. using in vitro autoradiog. on tissue sections with the universal radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14]-bombesin(6-14) and the GRP-receptor subtype-preferring 125I-[Tyr4]-bombesin.  Results: GRP-receptors were detected in 42/61 primary ovarian tumors; other bombesin-receptor subtypes (BB1, bb3) were rarely present (3/61).  Two different tissue compartments expressed GRP-receptors: the tumoral vasculature was the predominant site of GRP-receptor expression (38/61), whereas neoplastic cells more rarely expressed GRP-receptors (14/61).  GRP-receptor pos. vessels were present in the various classes of ovarian tumors; generally, malignant tumors had a higher incidence of GRP-receptor pos. vessels compared to their benign counterparts.  The prevalence of such vessels was particularly high in ovarian carcinomas (16/19) and their metastases (5/5).  The GRP-receptors were expressed in high d. in the muscular vessel wall.  Normal ovary (n = 10) lacked GRP-receptors.  Conclusions: The large amts. of GRP-receptors in ovarian tumor vessels suggest a role in tumoral vasculature and possibly angiogenesis.  Further, these vessels might be targeted in vivo with bombesin analogs for diagnosis or for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSuCVAqLwIu7Vg90H21EOLACvtfcHk0ljfsXNpVWA6aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFWju70%253D&md5=22caddb91a0f63efc73b351a079852f7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFleischmann%26aufirst%3DA.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DOverexpression%2520of%2520gastrin-releasing%2520peptide%2520receptors%2520in%2520tumor-associated%2520blood%2520vessels%2520of%2520human%2520ovarian%2520neoplasms%26jtitle%3DCell%2520Oncol.%26date%3D2007%26volume%3D29%26issue%3D5%26spage%3D421%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, S.</span></span> <span> </span><span class="NLM_article-title">Targeting prostate cancer with radiolabelled bombesins</span>. <i>Cancer Imaging</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1102/1470-7330.2006.0025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1102%2F1470-7330.2006.0025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=153-157&author=T.+Mainaauthor=B.+Nockauthor=S.+Mather&title=Targeting+prostate+cancer+with+radiolabelled+bombesins&doi=10.1102%2F1470-7330.2006.0025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1102%2F1470-7330.2006.0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1102%252F1470-7330.2006.0025%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMather%26aufirst%3DS.%26atitle%3DTargeting%2520prostate%2520cancer%2520with%2520radiolabelled%2520bombesins%26jtitle%3DCancer%2520Imaging%26date%3D2006%26volume%3D6%26spage%3D153%26epage%3D157%26doi%3D10.1102%2F1470-7330.2006.0025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span> <span> </span><span class="NLM_article-title">From bench to bed: new gastrin-releasing peptide receptor-directed radioligands and their use in prostate cancer</span>. <i>PET Clin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1016/j.cpet.2016.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2Fj.cpet.2016.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=28267454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADC%252BC1czjs1Sitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=205-217&issue=2&author=T.+Mainaauthor=B.+A.+Nock&title=From+bench+to+bed%3A+new+gastrin-releasing+peptide+receptor-directed+radioligands+and+their+use+in+prostate+cancer&doi=10.1016%2Fj.cpet.2016.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">From Bench to Bed: New Gastrin-Releasing Peptide Receptor-Directed Radioligands and Their Use in Prostate Cancer</span></div><div class="casAuthors">Maina Theodosia; Nock Berthold A</div><div class="citationInfo"><span class="NLM_cas:title">PET clinics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-217</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gastrin-releasing peptide receptors (GRPRs) are overexpressed in prostate and breast cancer, and are therefore attractive molecular targets for diagnosis and therapy with radiolabeled GRPR-directed peptide probes.  The amphibian tetradecapeptide bombesin or the mammalian gastrin-releasing peptide and neuromedin C have been modified with a variety of chelators.  As a result, labeling with radiometals attractive for SPECT or PET imaging and for radionuclide therapy has led to the development of peptide radioligands suitable for in vivo targeting of prostate cancer.  A shift of paradigm from internalizing GRPR-agonists to antagonists has occurred owing to the higher biosafety and superior pharmacokinetics of radioantagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8kZQs422J5rjnyZkbE8yXfW6udTcc2eaPjpc8QJZV97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czjs1Sitg%253D%253D&md5=da743260b2950b940d5df67c980e3128</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cpet.2016.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cpet.2016.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%2BA.%26atitle%3DFrom%2520bench%2520to%2520bed%253A%2520new%2520gastrin-releasing%2520peptide%2520receptor-directed%2520radioligands%2520and%2520their%2520use%2520in%2520prostate%2520cancer%26jtitle%3DPET%2520Clin.%26date%3D2017%26volume%3D12%26issue%3D2%26spage%3D205%26epage%3D217%26doi%3D10.1016%2Fj.cpet.2016.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos-Alvarez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1517/14728222.2016.1164694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1517%2F14728222.2016.1164694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=26981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlOks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=1055-1073&issue=9&author=P.+Morenoauthor=I.+Ramos-Alvarezauthor=T.+W.+Moodyauthor=R.+T.+Jensen&title=Bombesin+related+peptides%2Freceptors+and+their+promising+therapeutic+roles+in+cancer+imaging%2C+targeting+and+treatment&doi=10.1517%2F14728222.2016.1164694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment</span></div><div class="casAuthors">Moreno, Paola; Ramos-Alvarez, Irene; Moody, Terry W.; Jensen, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1055-1073</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Despite remarkable advances in tumor treatment, many patients still die from common tumors (breast, prostate, lung, CNS, colon, and pancreas), and thus, new approaches are needed.  Many of these tumors synthesize bombesin (Bn)-related peptides and over-express their receptors (BnRs), hence functioning as autocrine-growth-factors.  Recent studies support the conclusion that Bn-peptides/BnRs are well-positioned for numerous novel antitumor treatments, including interrupting autocrine-growth and the use of over-expressed receptors for imaging and targeting cytotoxic-compds., either by direct-coupling or combined with nanoparticle-technol.  The unique ability of common neoplasms to synthesize, secrete, and show a growth/proliferative/differentiating response due to BnR over-expression, is reviewed, both in general and with regard to the most frequently investigated neoplasms (breast, prostate, lung, and CNS).  Particular attention is paid to advances in the recent years.  Also considered are the possible therapeutic approaches to the growth/differentiation effect of Bn-peptides, as well as the therapeutic implication of the frequent BnR over-expression for tumor-imaging and/or targeted-delivery.  Given that Bn-related-peptides/BnRs are so frequently ectopically-expressed by common tumors, which are often malignant and become refractory to conventional treatments, therapeutic interventions using novel approaches to Bn-peptides and receptors are being explored.  Of particular interest is the potential of reproducing with BnRs in common tumors the recent success of utilizing overexpression of somatostatin-receptors by neuroendocrine-tumors to provide the most sensitive imaging methods and targeted delivery of cytotoxic-compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRQJtC-I7OeLVg90H21EOLACvtfcHk0lhl74zzwLR8HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlOks7s%253D&md5=0861d12da0993c6bd32f2dba1dd2f955</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F14728222.2016.1164694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2016.1164694%26sid%3Dliteratum%253Aachs%26aulast%3DMoreno%26aufirst%3DP.%26aulast%3DRamos-Alvarez%26aufirst%3DI.%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DBombesin%2520related%2520peptides%252Freceptors%2520and%2520their%2520promising%2520therapeutic%2520roles%2520in%2520cancer%2520imaging%252C%2520targeting%2520and%2520treatment%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2016%26volume%3D20%26issue%3D9%26spage%3D1055%26epage%3D1073%26doi%3D10.1517%2F14728222.2016.1164694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delle Fave, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annibale, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Magistris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruzzone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puoti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torsoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erspamer, V.</span></span> <span> </span><span class="NLM_article-title">Bombesin effects on human GI functions</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">Suppl. 3</span>),  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/0196-9781(85)90360-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0196-9781%2885%2990360-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1985&pages=113-116&issue=Suppl.+3&author=G.+Delle+Faveauthor=B.+Annibaleauthor=L.+de+Magistrisauthor=C.+Severiauthor=R.+Bruzzoneauthor=M.+Puotiauthor=P.+Melchiorriauthor=A.+Torsoliauthor=V.+Erspamer&title=Bombesin+effects+on+human+GI+functions&doi=10.1016%2F0196-9781%2885%2990360-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0196-9781%2885%2990360-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0196-9781%252885%252990360-2%26sid%3Dliteratum%253Aachs%26aulast%3DDelle%2BFave%26aufirst%3DG.%26aulast%3DAnnibale%26aufirst%3DB.%26aulast%3Dde%2BMagistris%26aufirst%3DL.%26aulast%3DSeveri%26aufirst%3DC.%26aulast%3DBruzzone%26aufirst%3DR.%26aulast%3DPuoti%26aufirst%3DM.%26aulast%3DMelchiorri%26aufirst%3DP.%26aulast%3DTorsoli%26aufirst%3DA.%26aulast%3DErspamer%26aufirst%3DV.%26atitle%3DBombesin%2520effects%2520on%2520human%2520GI%2520functions%26jtitle%3DPeptides%26date%3D1985%26volume%3D6%26issue%3DSuppl.%25203%26spage%3D113%26epage%3D116%26doi%3D10.1016%2F0196-9781%2885%2990360-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruzzone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburrano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauceri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annibale, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Magistris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delle Fave, G.</span></span> <span> </span><span class="NLM_article-title">Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man</span>. <i>J. Clin. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1210/jcem-56-4-643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1210%2Fjcem-56-4-643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=6339534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADyaL3sXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1983&pages=643-647&issue=4&author=R.+Bruzzoneauthor=G.+Tamburranoauthor=A.+Lalaauthor=M.+Mauceriauthor=B.+Annibaleauthor=C.+Severiauthor=L.+de+Magistrisauthor=F.+Leonettiauthor=G.+Delle+Fave&title=Effect+of+bombesin+on+plasma+insulin%2C+pancreatic+glucagon%2C+and+gut+glucagon+in+man&doi=10.1210%2Fjcem-56-4-643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man</span></div><div class="casAuthors">Bruzzone, R.; Tamburrano, G.; Lala, A.; Mauceri, M.; Annibale, B.; Severi, Carola; De Magistris, Laura; Leonetti, Frida; Delle Fave, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">643-7</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">The effect of bombesin [31362-50-2] on insulin [9004-10-8], pancreatic glucagon [9007-92-5], and gut glucagon [62340-29-8] was investigated in healthy volunteers and pancreatectomized patients.  Bombesin (5 ng/kg/min, i.v) produced a sharp rise in the plasma insulin concn.  The peak was reached at 5 min (26 μU/mL); followed by a prolonged decrease in blood glucose.  Pancreatic glucagon rapidly rose to a maximal value of 80.5 pmol/L.  In contrast with the prompt increase in insulin and glucagon plasma levels, the peak in gut glucagon concn. (55.8 pmol/L) was reached 30 min after bombesin infusion was discontinued.  In the 2 pancreatectomized patients, bombesin induced an increase in gut glucagon concns. only.  Apparently, bombesin acts directly on the A and B cells of the pancreas, influencing glucose homeostasis; however, more complex mechanisms seem to be involved in gut glucagon secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjsKsC2G2cp7Vg90H21EOLACvtfcHk0lg1E5hwJFCRXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXktFKqt7c%253D&md5=7144703b752a0b3b4d49173aeea43f21</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1210%2Fjcem-56-4-643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-56-4-643%26sid%3Dliteratum%253Aachs%26aulast%3DBruzzone%26aufirst%3DR.%26aulast%3DTamburrano%26aufirst%3DG.%26aulast%3DLala%26aufirst%3DA.%26aulast%3DMauceri%26aufirst%3DM.%26aulast%3DAnnibale%26aufirst%3DB.%26aulast%3DSeveri%26aufirst%3DC.%26aulast%3Dde%2BMagistris%26aufirst%3DL.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DDelle%2BFave%26aufirst%3DG.%26atitle%3DEffect%2520of%2520bombesin%2520on%2520plasma%2520insulin%252C%2520pancreatic%2520glucagon%252C%2520and%2520gut%2520glucagon%2520in%2520man%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1983%26volume%3D56%26issue%3D4%26spage%3D643%26epage%3D647%26doi%3D10.1210%2Fjcem-56-4-643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bitar, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. X.</span></span> <span> </span><span class="NLM_article-title">Expression of bombesin-receptor subtypes and their differential regulation of colonic smooth muscle contraction</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1672</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1016/0016-5085(93)91062-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0016-5085%2893%2991062-M" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1993&pages=1672-1680&issue=6&author=K.+N.+Bitarauthor=X.+X.+Zhu&title=Expression+of+bombesin-receptor+subtypes+and+their+differential+regulation+of+colonic+smooth+muscle+contraction&doi=10.1016%2F0016-5085%2893%2991062-M"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0016-5085%2893%2991062-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0016-5085%252893%252991062-M%26sid%3Dliteratum%253Aachs%26aulast%3DBitar%26aufirst%3DK.%2BN.%26aulast%3DZhu%26aufirst%3DX.%2BX.%26atitle%3DExpression%2520of%2520bombesin-receptor%2520subtypes%2520and%2520their%2520differential%2520regulation%2520of%2520colonic%2520smooth%2520muscle%2520contraction%26jtitle%3DGastroenterology%26date%3D1993%26volume%3D105%26issue%3D6%26spage%3D1672%26epage%3D1680%26doi%3D10.1016%2F0016-5085%2893%2991062-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scardino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiberini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bufi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Cobelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paganelli, G.</span></span> <span> </span><span class="NLM_article-title"><sup>177</sup>Lu-AMBA bombesin analogue in hormone refractory prostate cancer patients: a phase I escalation study with single-cycle administrations</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">S221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=S221&issue=Suppl.+2&author=L.+Bodeiauthor=M.+Ferrariauthor=A.+Nunnauthor=J.+Llullauthor=M.+Cremonesiauthor=L.+Martanoauthor=G.+Lauroraauthor=E.+Scardinoauthor=S.+Tiberiniauthor=G.+Bufiauthor=S.+Eatonauthor=O.+de+Cobelliauthor=G.+Paganelli&title=177Lu-AMBA+bombesin+analogue+in+hormone+refractory+prostate+cancer+patients%3A+a+phase+I+escalation+study+with+single-cycle+administrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodei%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DNunn%26aufirst%3DA.%26aulast%3DLlull%26aufirst%3DJ.%26aulast%3DCremonesi%26aufirst%3DM.%26aulast%3DMartano%26aufirst%3DL.%26aulast%3DLaurora%26aufirst%3DG.%26aulast%3DScardino%26aufirst%3DE.%26aulast%3DTiberini%26aufirst%3DS.%26aulast%3DBufi%26aufirst%3DG.%26aulast%3DEaton%26aufirst%3DS.%26aulast%3Dde%2BCobelli%26aufirst%3DO.%26aulast%3DPaganelli%26aufirst%3DG.%26atitle%3D177Lu-AMBA%2520bombesin%2520analogue%2520in%2520hormone%2520refractory%2520prostate%2520cancer%2520patients%253A%2520a%2520phase%2520I%2520escalation%2520study%2520with%2520single-cycle%2520administrations%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2007%26volume%3D34%26issue%3DSuppl.%25202%26spage%3DS221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiotellis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loudos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maintas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span> <span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1007/s00259-002-1040-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-002-1040-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=12552343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1CntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=247-258&issue=2&author=B.+Nockauthor=A.+Nikolopoulouauthor=E.+Chiotellisauthor=G.+Loudosauthor=D.+Maintasauthor=J.+C.+Reubiauthor=T.+Maina&title=%5B99mTc%5DDemobesin+1%2C+a+novel+potent+bombesin+analogue+for+GRP+receptor-targeted+tumour+imaging&doi=10.1007%2Fs00259-002-1040-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging</span></div><div class="casAuthors">Nock, Berthold; Nikolopoulou, Anastasia; Chiotellis, Efstratios; Loudos, George; Maintas, Dimitrios; Reubi, Jean Claude; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Demobesin 1 is a potent new GRP-R-selective bombesin (BN) analog contg. an open chain tetraamine chelator for stable technetium-99m binding.  Following a convenient labeling protocol, the radiopeptide, [99mTc]Demobesin 1, formed in nearly quant. yields and with high specific activities.  Both unlabeled and labeled peptide demonstrated high-affinity binding in membrane prepns. of the human androgen-independent prostate adenocarcinoma PC-3 cell line.  The IC50 values detd. for Demobesin 1 and [Tyr4]BN were 0.70±0.08 nM and 1.5±0.20 nM, resp., while the Kd defined for [99mTc/99gTc]Demobesin 1 was 0.67±0.10 nM. [99mTc]Demobesin 1 was rather stable in murine plasma, whereas it degraded rapidly in kidney and liver homogenates.  After injection in healthy Swiss albino mice, [99mTc]Demobesin 1 accumulated very efficiently in the target organs (pancreas, intestinal tract) via a GRP-R-mediated process, as shown by in vivo receptor blocking expts.  An equally high and GRP-R-mediated uptake was exhibited by [99mTc]Demobesin 1 after injection in PC-3 tumor-bearing athymic mice.  The initial high radioligand uptake of 16.2±3.1%ID/g in the PC-3 xenografts at 1 h p.i. remained at a similar level (15.61±1.19%ID/g) at 4 h p.i.  Even after 24 h p.i., when the radioactivity had cleared from all other tissues, a value of 5.24±0.67%ID/g was still obsd. in the tumor.  The high and prolonged localization of [99mTc]Demobesin 1 at the tumor site and its rapid background clearance are very promising qualities for GRP-R-targeted tumor imaging in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_PXKboVxArVg90H21EOLACvtfcHk0lg1E5hwJFCRXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1CntA%253D%253D&md5=19ebcbebcf11cac029412ad304113f77</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-1040-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-1040-x%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DChiotellis%26aufirst%3DE.%26aulast%3DLoudos%26aufirst%3DG.%26aulast%3DMaintas%26aufirst%3DD.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3D%255B99mTc%255DDemobesin%25201%252C%2520a%2520novel%2520potent%2520bombesin%2520analogue%2520for%2520GRP%2520receptor-targeted%2520tumour%2520imaging%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26issue%3D2%26spage%3D247%26epage%3D258%26doi%3D10.1007%2Fs00259-002-1040-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantey, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frucht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1021/bi00455a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00455a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=616-622&issue=3&author=L.+H.+Wangauthor=D.+H.+Coyauthor=J.+E.+Taylorauthor=N.+Y.+Jiangauthor=S.+H.+Kimauthor=J.+P.+Moreauauthor=S.+C.+Huangauthor=S.+A.+Manteyauthor=H.+Fruchtauthor=R.+T.+Jensen&title=Desmethionine+alkylamide+bombesin+analogues%3A+a+new+class+of+bombesin+receptor+antagonists+with+potent+antisecretory+activity+in+pancreatic+acini+and+antimitotic+activity+in+Swiss+3T3+cells&doi=10.1021%2Fbi00455a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbi00455a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00455a004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DTaylor%26aufirst%3DJ.%2BE.%26aulast%3DJiang%26aufirst%3DN.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DMoreau%26aufirst%3DJ.%2BP.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DMantey%26aufirst%3DS.%2BA.%26aulast%3DFrucht%26aufirst%3DH.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DDesmethionine%2520alkylamide%2520bombesin%2520analogues%253A%2520a%2520new%2520class%2520of%2520bombesin%2520receptor%2520antagonists%2520with%2520potent%2520antisecretory%2520activity%2520in%2520pancreatic%2520acini%2520and%2520antimitotic%2520activity%2520in%2520Swiss%25203T3%2520cells%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26issue%3D3%26spage%3D616%26epage%3D622%26doi%3D10.1021%2Fbi00455a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frucht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haffar, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title"><i>des</i>-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>265</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">15695</span>– <span class="NLM_lpage">15703</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=15695-15703&issue=26&author=L.+H.+Wangauthor=D.+H.+Coyauthor=J.+E.+Taylorauthor=N.+Y.+Jiangauthor=J.+P.+Moreauauthor=S.+C.+Huangauthor=H.+Fruchtauthor=B.+M.+Haffarauthor=R.+T.+Jensen&title=des-Met+carboxyl-terminally+modified+analogues+of+bombesin+function+as+potent+bombesin+receptor+antagonists%2C+partial+agonists%2C+or+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DTaylor%26aufirst%3DJ.%2BE.%26aulast%3DJiang%26aufirst%3DN.%2BY.%26aulast%3DMoreau%26aufirst%3DJ.%2BP.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DFrucht%26aufirst%3DH.%26aulast%3DHaffar%26aufirst%3DB.%2BM.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3Ddes-Met%2520carboxyl-terminally%2520modified%2520analogues%2520of%2520bombesin%2520function%2520as%2520potent%2520bombesin%2520receptor%2520antagonists%252C%2520partial%2520agonists%252C%2520or%2520agonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26issue%3D26%26spage%3D15695%26epage%3D15703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordopatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span> <span> </span><span class="NLM_article-title">Potent bombesin-like peptides for GRP-receptor targeting of tumors with <sup>99m</sup>Tc: a preclinical study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1021/jm049437y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049437y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=100-110&issue=1&author=B.+A.+Nockauthor=A.+Nikolopoulouauthor=A.+Galanisauthor=P.+Cordopatisauthor=B.+Waserauthor=J.+C.+Reubiauthor=T.+Maina&title=Potent+bombesin-like+peptides+for+GRP-receptor+targeting+of+tumors+with+99mTc%3A+a+preclinical+study&doi=10.1021%2Fjm049437y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm049437y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049437y%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DGalanis%26aufirst%3DA.%26aulast%3DCordopatis%26aufirst%3DP.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DPotent%2520bombesin-like%2520peptides%2520for%2520GRP-receptor%2520targeting%2520of%2520tumors%2520with%252099mTc%253A%2520a%2520preclinical%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D1%26spage%3D100%26epage%3D110%26doi%3D10.1021%2Fjm049437y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mather, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobnack, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colebrook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halberrt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szysko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powles, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avril, N.</span></span> <span> </span><span class="NLM_article-title">GRP receptor imaging of prostate cancer using [<sup>99m</sup>Tc]Demobesin 4: a first-in-man study</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">895</span>, <span class="refDoi"> DOI: 10.1007/s11307-014-0754-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs11307-014-0754-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=24915934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADC%252BC2cfhtVCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=888-895&issue=6&author=S.+J.+Matherauthor=B.+A.+Nockauthor=T.+Mainaauthor=V.+Gibsonauthor=D.+Ellisonauthor=I.+Murrayauthor=R.+Sobnackauthor=S.+Colebrookauthor=S.+Wanauthor=G.+Halberrtauthor=T.+Szyskoauthor=T.+Powlesauthor=N.+Avril&title=GRP+receptor+imaging+of+prostate+cancer+using+%5B99mTc%5DDemobesin+4%3A+a+first-in-man+study&doi=10.1007%2Fs11307-014-0754-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">GRP receptor imaging of prostate cancer using [(99m)Tc]Demobesin 4: a first-in-man study</span></div><div class="casAuthors">Mather Stephen J; Nock Berthold A; Maina Theodosia; Gibson Vickie; Ellison David; Murray Iain; Sobnack Ravin; Colebrook Steve; Wan Susan; Halberrt Gavin; Szysko Teresa; Powles Thomas; Avril Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">888-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  We explored the imaging of bombesin receptors and evaluated the clinical use of [(99m)Tc]Demobesin 4 ([(99m)Tc]DB4) in prostate cancer patients.  PROCEDURES:  [(99m)Tc]DB4 was prepared according to Good Manufacturing Practice.  Patients with prostate cancer underwent serial planar and SPECT imaging up to 3 h after administration.  Blood and urine samples were taken to assess pharmacokinetics.  RESULTS:  [(99m)Tc]DB4 is safe and clears rapidly from the bloodstream via the kidneys resulting in low background activity.  The tracer binds strongly to the gastrin-releasing peptide receptor (GRPR) in vivo as indicated by the high uptake in the pancreas seen in all patients.  In patients who had undergone hormone therapy, [(99m)Tc]DB4 did not efficiently image metastatic prostate cancer.  In contrast, in newly diagnosed patients local disease was visualised.  CONCLUSIONS:  The GRPR is an unsuitable target for imaging refractory prostate cancer but may be useful in untreated disease. [(99m)Tc]DB4 is a promising radiopharmaceutical which merits further exploration in this specific group of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSccUKpYUtPKd-cVm4E2RlLfW6udTcc2eYe6TenW9kyeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfhtVCltg%253D%253D&md5=c473b529191f8d6c6d8251e29e891755</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11307-014-0754-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-014-0754-z%26sid%3Dliteratum%253Aachs%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DGibson%26aufirst%3DV.%26aulast%3DEllison%26aufirst%3DD.%26aulast%3DMurray%26aufirst%3DI.%26aulast%3DSobnack%26aufirst%3DR.%26aulast%3DColebrook%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DS.%26aulast%3DHalberrt%26aufirst%3DG.%26aulast%3DSzysko%26aufirst%3DT.%26aulast%3DPowles%26aufirst%3DT.%26aulast%3DAvril%26aufirst%3DN.%26atitle%3DGRP%2520receptor%2520imaging%2520of%2520prostate%2520cancer%2520using%2520%255B99mTc%255DDemobesin%25204%253A%2520a%2520first-in-man%2520study%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2014%26volume%3D16%26issue%3D6%26spage%3D888%26epage%3D895%26doi%3D10.1007%2Fs11307-014-0754-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charalambidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccand, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Bombesin receptor antagonists may be preferable to agonists for tumor targeting</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.2967/jnumed.107.045054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.107.045054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=18199616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVOltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=318-326&issue=2&author=R.+Cescatoauthor=T.+Mainaauthor=B.+Nockauthor=A.+Nikolopoulouauthor=D.+Charalambidisauthor=V.+Piccandauthor=J.+C.+Reubi&title=Bombesin+receptor+antagonists+may+be+preferable+to+agonists+for+tumor+targeting&doi=10.2967%2Fjnumed.107.045054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin receptor antagonists may be preferable to agonists for tumor targeting</span></div><div class="casAuthors">Cescato, Renzo; Maina, Theodosia; Nock, Berthold; Nikolopoulou, Anastasia; Charalambidis, David; Piccand, Veronique; Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-326</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Two bombesin analogs, Demobesin 4 and Demobesin 1, were characterized in vitro as gastrin-releasing peptide (GRP) receptor agonist and antagonist, resp., and were compared as 99mTc-labeled ligands for their in vitro and in vivo tumor-targeting properties.  N4-[Pro1,Tyr4,Nle14]Bombesin (Demobesin 4) and N4-[D-Phe6,Leu-NHEt13,des-Met14]bombesin(6-14) (Demobesin 1) were characterized in vitro for their binding properties with GRP receptor autoradiog. using GRP receptor-transfected HEK293 cells, PC3 cells, and human prostate cancer specimens.  Their ability to modulate calcium mobilization in PC3 and transfected HEK293 cells was analyzed as well as their ability to trigger internalization of the GRP receptor in transfected HEK293 cells, as detd. qual. by immunofluorescence microscopy and quant. by ELISA.  Further, their internalization properties as 99mTc-labeled radioligands were tested in vitro in both cell lines.  Finally, their biodistribution was analyzed in PC3 tumor-bearing mice.  A comparable binding affinity with the 50% inhibitory concn. (IC50) in the nanomolar range was measured for Demobesin 4 and Demobesin 1 in all tested tissues.  Demobesin 4 behaved as an agonist by strongly stimulating calcium mobilization and by triggering GRP receptor internalization.  Demobesin 1 was ineffective in stimulating calcium mobilization and in triggering GRP receptor internalization.  However, in these assays, it behaved as a competitive antagonist as it reversed completely the agonist-induced effects in both systems.  99mTc-Labeled Demobesin 1 was only weakly taken up by PC3 cells or GRP receptor-transfected HEK293 cells (10% and 5%, resp., of total added radioactivity) compared with 99mTc-labeled Demobesin 4 (45% of total added radioactivity in both cell lines).  Remarkably, the biodistribution study revealed a much more pronounced uptake at 1, 4, and 24 h after injection of 99mTc-labeled Demobesin 1 in vivo into PC3 tumors than 99mTc-labeled Demobesin 4.  In vivo competition expts. demonstrated a specific uptake in PC3 tumors and in physiol. GRP receptor-expressing tissues.  The tumor-to-kidney ratios were 0.7 for Demobesin 4 and 5.2 for Demobesin 1 at 4 h.  This comparative in vitro/in vivo study with Demobesin 1 and Demobesin 4 indicates that GRP receptor antagonists may be superior targeting agents to GRP receptor agonists, suggesting a change of paradigm in the field of bombesin radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXs6GzVpy9Z7Vg90H21EOLACvtfcHk0liqG_JJkThXhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVOltb8%253D&md5=bfa0cc7efd90357b7061b39c9722b58a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.107.045054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.107.045054%26sid%3Dliteratum%253Aachs%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DCharalambidis%26aufirst%3DD.%26aulast%3DPiccand%26aufirst%3DV.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DBombesin%2520receptor%2520antagonists%2520may%2520be%2520preferable%2520to%2520agonists%2520for%2520tumor%2520targeting%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26issue%3D2%26spage%3D318%26epage%3D326%26doi%3D10.2967%2Fjnumed.107.045054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamma, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1021/jm5012066</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=682-691&issue=2&author=R.+Mansiauthor=K.+Abirajauthor=X.+Wangauthor=M.+L.+Tammaauthor=E.+Gourniauthor=R.+Cescatoauthor=S.+Berndtauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Evaluation+of+three+different+families+of+bombesin+receptor+radioantagonists+for+targeted+imaging+and+therapy+of+gastrin+releasing+peptide+receptor+%28GRP-R%29+positive+tumors&doi=10.1021%2Fjm5012066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm5012066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012066%26sid%3Dliteratum%253Aachs%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTamma%26aufirst%3DM.%2BL.%26aulast%3DGourni%26aufirst%3DE.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DBerndt%26aufirst%3DS.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DEvaluation%2520of%2520three%2520different%2520families%2520of%2520bombesin%2520receptor%2520radioantagonists%2520for%2520targeted%2520imaging%2520and%2520therapy%2520of%2520gastrin%2520releasing%2520peptide%2520receptor%2520%2528GRP-R%2529%2520positive%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D2%26spage%3D682%26epage%3D691%26doi%3D10.1021%2Fjm5012066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charalambidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krenning, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, R. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [<sup>68</sup>Ga]SB3 and PET/CT</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">964</span>– <span class="NLM_lpage">973</span>, <span class="refDoi"> DOI: 10.1007/s00259-015-3232-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-015-3232-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=26631238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvF2nurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=964-973&issue=5&author=T.+Mainaauthor=H.+Bergsmaauthor=H.+R.+Kulkarniauthor=D.+Muellerauthor=D.+Charalambidisauthor=E.+P.+Krenningauthor=B.+A.+Nockauthor=M.+de+Jongauthor=R.+P.+Baum&title=Preclinical+and+first+clinical+experience+with+the+gastrin-releasing+peptide+receptor-antagonist+%5B68Ga%5DSB3+and+PET%2FCT&doi=10.1007%2Fs00259-015-3232-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT</span></div><div class="casAuthors">Maina, Theodosia; Bergsma, Hendrik; Kulkarni, Harshad R.; Mueller, Dirk; Charalambidis, David; Krenning, Eric P.; Nock, Berthold A.; de Jong, Marion; Baum, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">964-973</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Gastrin-releasing peptide receptors (GRPR) represent attractive targets for tumor diagnosis and therapy because of their overexpression in major human cancers.  Internalizing GRPR agonists were initially proposed for prolonged lesion retention, but a shift of paradigm to GRPR antagonists has recently been made.  Surprisingly, radioantagonists, such as [99mTc]DB1 (99mTc-N4'-DPhe6,Leu-NHEt13BBN(6-13)), displayed better pharmacokinetics than radioagonists, in addn. to their higher inherent biosafety.  We introduce here [68Ga]SB3, a [99mTc]DB1 mimic-carrying, instead of the 99mTc-binding tetraamine, the chelator DOTA for labeling with the PET radiometal 68Ga.  Competition binding assays of SB3 and [natGa]SB3 were conducted against [125I-Tyr4]BBN in PC-3 cell membranes.  Blood samples collected 5 min postinjection (pi) of the [67Ga]SB3 surrogate in mice were analyzed using high-performance liq. chromatog. (HPLC) for degrdn. products.  Likewise, biodistribution was performed after injection of [67Ga]SB3 (37 kBq, 100 μL, 10 pmol peptide) in severe combined immunodeficiency (SCID) mice bearing PC-3 xenografts.  Eventually, [68Ga]SB3 (283 ± 91 MBq, 23 ± 7 nmol) was injected into 17 patients with breast (8) and prostate (9) cancer.  All patients had disseminated disease and had received previous therapies.  PET/CT fusion images were acquired 60-115 min pi.  SB3 and [natGa]SB3 bound to the human GRPR with high affinity (IC50: 4.6 ± 0.5 nM and 1.5 ± 0.3 nM, resp.).  [67Ga]SB3 displayed good in vivo stability (>85 % intact at 5 min pi).  [67Ga]SB3 showed high, GRPR-specific and prolonged retention in PC-3 xenografts (33.1 ± 3.9%ID/g at 1 h pi - 27.0 ± 0.9%ID/g at 24 h pi), but much faster clearance from the GRPR-rich pancreas (≈160%ID/g at 1 h pi to <17%ID/g at 24 h pi) in mice.  In patients, [68Ga]SB3 elicited no adverse effects and clearly visualized cancer lesions.  Thus, 4 out of 8 (50 %) breast cancer and 5 out of 9 (55 %) prostate cancer patients showed pathol. uptake on PET/CT with [68Ga]SB3.  [67Ga]SB3 showed excellent pharmacokinetics in PC-3 tumor-bearing mice, while [68Ga]SB3 PET/CT visualized lesions in about 50 % of patients with advanced and metastasized prostate and breast cancer.  We expect imaging with [68Ga]SB3 to be superior in patients with primary breast or prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJWrBrBlHv_7Vg90H21EOLACvtfcHk0liqG_JJkThXhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvF2nurzF&md5=ad4cff527edd17d41dc10cec4092ed1b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00259-015-3232-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-015-3232-1%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DBergsma%26aufirst%3DH.%26aulast%3DKulkarni%26aufirst%3DH.%2BR.%26aulast%3DMueller%26aufirst%3DD.%26aulast%3DCharalambidis%26aufirst%3DD.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBaum%26aufirst%3DR.%2BP.%26atitle%3DPreclinical%2520and%2520first%2520clinical%2520experience%2520with%2520the%2520gastrin-releasing%2520peptide%2520receptor-antagonist%2520%255B68Ga%255DSB3%2520and%2520PET%252FCT%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2016%26volume%3D43%26issue%3D5%26spage%3D964%26epage%3D973%26doi%3D10.1007%2Fs00259-015-3232-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaloudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lymperis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giarika, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klette, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krenning, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, R. P.</span></span> <span> </span><span class="NLM_article-title">Theranostic perspectives in prostate cancer with the gastrin-releasing peptide receptor antagonist NeoBOMB1: preclinical and first clinical results</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.2967/jnumed.116.178889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.116.178889" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=75-80&issue=1&author=B.+A.+Nockauthor=A.+Kaloudiauthor=E.+Lymperisauthor=A.+Giarikaauthor=H.+R.+Kulkarniauthor=I.+Kletteauthor=A.+Singhauthor=E.+P.+Krenningauthor=M.+de+Jongauthor=T.+Mainaauthor=R.+P.+Baum&title=Theranostic+perspectives+in+prostate+cancer+with+the+gastrin-releasing+peptide+receptor+antagonist+NeoBOMB1%3A+preclinical+and+first+clinical+results&doi=10.2967%2Fjnumed.116.178889"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.116.178889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.116.178889%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DKaloudi%26aufirst%3DA.%26aulast%3DLymperis%26aufirst%3DE.%26aulast%3DGiarika%26aufirst%3DA.%26aulast%3DKulkarni%26aufirst%3DH.%2BR.%26aulast%3DKlette%26aufirst%3DI.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DBaum%26aufirst%3DR.%2BP.%26atitle%3DTheranostic%2520perspectives%2520in%2520prostate%2520cancer%2520with%2520the%2520gastrin-releasing%2520peptide%2520receptor%2520antagonist%2520NeoBOMB1%253A%2520preclinical%2520and%2520first%2520clinical%2520results%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2017%26volume%3D58%26issue%3D1%26spage%3D75%26epage%3D80%26doi%3D10.2967%2Fjnumed.116.178889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatalic, K. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konijnenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonnekens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Blois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeben, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ridder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gent, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Weerden, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span> <span> </span><span class="NLM_article-title">In vivo stabilization of gastrin-releasing peptide receptor antagonist enhances PET imaging and radionuclide therapy of prostate cancer in preclinical studies</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.7150/thno.13580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.7150%2Fthno.13580" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=104-117&issue=1&author=K.+L.+S.+Chatalicauthor=M.+Konijnenbergauthor=J.+Nonnekensauthor=E.+de+Bloisauthor=S.+Hoebenauthor=C.+de+Ridderauthor=L.+Brunelauthor=J.+A.+Fehrentzauthor=J.+Martinezauthor=D.+C.+van+Gentauthor=B.+A.+Nockauthor=T.+Mainaauthor=W.+M.+van+Weerdenauthor=M.+de+Jong&title=In+vivo+stabilization+of+gastrin-releasing+peptide+receptor+antagonist+enhances+PET+imaging+and+radionuclide+therapy+of+prostate+cancer+in+preclinical+studies&doi=10.7150%2Fthno.13580"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.7150%2Fthno.13580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.13580%26sid%3Dliteratum%253Aachs%26aulast%3DChatalic%26aufirst%3DK.%2BL.%2BS.%26aulast%3DKonijnenberg%26aufirst%3DM.%26aulast%3DNonnekens%26aufirst%3DJ.%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DHoeben%26aufirst%3DS.%26aulast%3Dde%2BRidder%26aufirst%3DC.%26aulast%3DBrunel%26aufirst%3DL.%26aulast%3DFehrentz%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3Dvan%2BGent%26aufirst%3DD.%2BC.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3Dvan%2BWeerden%26aufirst%3DW.%2BM.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DIn%2520vivo%2520stabilization%2520of%2520gastrin-releasing%2520peptide%2520receptor%2520antagonist%2520enhances%2520PET%2520imaging%2520and%2520radionuclide%2520therapy%2520of%2520prostate%2520cancer%2520in%2520preclinical%2520studies%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26issue%3D1%26spage%3D104%26epage%3D117%26doi%3D10.7150%2Fthno.13580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kähkönen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jambor, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemppainen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gronroos, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuisma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luoto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipila, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolvanen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alanen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallajoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roivainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schibli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johayem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borkowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minn, H.</span></span> <span> </span><span class="NLM_article-title">In vivo imaging of prostate cancer using [<sup>68</sup>Ga]-labeled bombesin analog BAY86-7548</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5434</span>– <span class="NLM_lpage">5443</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1158%2F1078-0432.CCR-12-3490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=23935037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADC%252BC3sfosFOlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=5434-5443&issue=19&author=E.+K%C3%A4hk%C3%B6nenauthor=I.+Jamborauthor=J.+Kemppainenauthor=K.+Lehtioauthor=T.+J.+Gronroosauthor=A.+Kuismaauthor=P.+Luotoauthor=H.+J.+Sipilaauthor=T.+Tolvanenauthor=K.+Alanenauthor=J.+Silenauthor=M.+Kallajokiauthor=A.+Roivainenauthor=N.+Schaferauthor=R.+Schibliauthor=M.+Dragicauthor=A.+Johayemauthor=R.+Valenciaauthor=S.+Borkowskiauthor=H.+Minn&title=In+vivo+imaging+of+prostate+cancer+using+%5B68Ga%5D-labeled+bombesin+analog+BAY86-7548&doi=10.1158%2F1078-0432.CCR-12-3490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548</span></div><div class="casAuthors">Kahkonen Esa; Jambor Ivan; Kemppainen Jukka; Lehtio Kaisa; Gronroos Tove J; Kuisma Anna; Luoto Pauliina; Sipila Henri J; Tolvanen Tuula; Alanen Kalle; Silen Jonna; Kallajoki Markku; Roivainen Anne; Schafer Niklaus; Schibli Roger; Dragic Martina; Johayem Anass; Valencia Ray; Borkowski Sandra; Minn Heikki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5434-43</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">PURPOSE:  A novel [(68)Ga]-labeled DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 peptide (BAY86-7548) having high affinity to bombesin receptor subtype II to detect primary and metastatic prostate carcinoma using positron emission tomography/computed tomography (PET/CT) was synthesized and evaluated for prostate cancer.  EXPERIMENTAL DESIGN:  In this first human study with BAY86-7548, 14 men scheduled for radical prostatectomy (n = 11) or with biochemical recurrence after surgery or hormonal therapy (n = 3) were enrolled.  The patients received an intravenous injection of BAY86-7548 followed by over 60-minute dynamic imaging of prostate gland (n = 10) and/or subsequent whole-body imaging (n = 14).  The visual assessment of PET/CT images included evaluation of intraprostatic (12 subsextants) and pelvic nodal uptake of BAY86-7548 in 11 surgical patients and detection of potential metastatic foci in all patients.  In patients with biochemical recurrence, results were compared with those of either [(11)C]-acetate (n = 2) or [(18)F]-fluoromethylcholine (n = 1) PET/CT.  RESULTS:  We found a sensitivity, specificity, and accuracy of 88%, 81% and 83%, respectively, for detection of primary PCa and sensitivity of 70% for metastatic lymph nodes using histology as gold standard.  BAY86-7548 correctly detected local recurrence in prostate bed and showed nodal relapse in accordance with [(11)C]-acetate PET/CT in 2 patients with biochemical relapse.  In the third hormone refractory patient, BAY86-7548 failed to show multiple bone metastases evident on [(18)F]-fluoromethylcholine PET/CT.  CONCLUSION:  BAY86-7548 PET/CT is a promising molecular imaging technique for detecting intraprostatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_j6Lp9PxEt6e0F5ixvZgXfW6udTcc2eb_ZOBpycgw_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfosFOlsQ%253D%253D&md5=726d236135632416999951b75b76e9a0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3490%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25A4hk%25C3%25B6nen%26aufirst%3DE.%26aulast%3DJambor%26aufirst%3DI.%26aulast%3DKemppainen%26aufirst%3DJ.%26aulast%3DLehtio%26aufirst%3DK.%26aulast%3DGronroos%26aufirst%3DT.%2BJ.%26aulast%3DKuisma%26aufirst%3DA.%26aulast%3DLuoto%26aufirst%3DP.%26aulast%3DSipila%26aufirst%3DH.%2BJ.%26aulast%3DTolvanen%26aufirst%3DT.%26aulast%3DAlanen%26aufirst%3DK.%26aulast%3DSilen%26aufirst%3DJ.%26aulast%3DKallajoki%26aufirst%3DM.%26aulast%3DRoivainen%26aufirst%3DA.%26aulast%3DSchafer%26aufirst%3DN.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DDragic%26aufirst%3DM.%26aulast%3DJohayem%26aufirst%3DA.%26aulast%3DValencia%26aufirst%3DR.%26aulast%3DBorkowski%26aufirst%3DS.%26aulast%3DMinn%26aufirst%3DH.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520prostate%2520cancer%2520using%2520%255B68Ga%255D-labeled%2520bombesin%2520analog%2520BAY86-7548%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26issue%3D19%26spage%3D5434%26epage%3D5443%26doi%3D10.1158%2F1078-0432.CCR-12-3490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wieser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosu, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultze-Seemann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont-Walter, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, W. A.</span></span> <span> </span><span class="NLM_article-title">Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist–from mice to men</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.7150/thno.7324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.7150%2Fthno.7324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=412-419&issue=4&author=G.+Wieserauthor=R.+Mansiauthor=A.+L.+Grosuauthor=W.+Schultze-Seemannauthor=R.+A.+Dumont-Walterauthor=P.+T.+Meyerauthor=H.+R.+Maeckeauthor=J.+C.+Reubiauthor=W.+A.+Weber&title=Positron+emission+tomography+%28PET%29+imaging+of+prostate+cancer+with+a+gastrin+releasing+peptide+receptor+antagonist%E2%80%93from+mice+to+men&doi=10.7150%2Fthno.7324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.7150%2Fthno.7324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.7324%26sid%3Dliteratum%253Aachs%26aulast%3DWieser%26aufirst%3DG.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DGrosu%26aufirst%3DA.%2BL.%26aulast%3DSchultze-Seemann%26aufirst%3DW.%26aulast%3DDumont-Walter%26aufirst%3DR.%2BA.%26aulast%3DMeyer%26aufirst%3DP.%2BT.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26atitle%3DPositron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520of%2520prostate%2520cancer%2520with%2520a%2520gastrin%2520releasing%2520peptide%2520receptor%2520antagonist%25E2%2580%2593from%2520mice%2520to%2520men%26jtitle%3DTheranostics%26date%3D2014%26volume%3D4%26issue%3D4%26spage%3D412%26epage%3D419%26doi%3D10.7150%2Fthno.7324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span> <span> </span><span class="NLM_article-title">Progress in the development of potent bombesin receptor antagonists</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(91)90483-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0165-6147%2891%2990483-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=13-19&issue=1&author=R.+T.+Jensenauthor=D.+H.+Coy&title=Progress+in+the+development+of+potent+bombesin+receptor+antagonists&doi=10.1016%2F0165-6147%2891%2990483-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990483-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990483-9%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DR.%2BT.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520potent%2520bombesin%2520receptor%2520antagonists%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26issue%3D1%26spage%3D13%26epage%3D19%26doi%3D10.1016%2F0165-6147%2891%2990483-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dilworth, J. R.</span>; <span class="NLM_string-name">Pascu, S. I.</span></span> <span> </span><span class="NLM_article-title">The Radiopharmaceutical Chemistry of Technetium and Rhenium</span>. In  <i>The Chemistry of Molecular Imaging</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, N. L. W.-T.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">164</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2F9781118854754.ch6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=137-164&author=J.+R.+Dilworth&author=S.+I.+Pascuauthor=N.+L.+W.-T.+Wong&title=The+Chemistry+of+Molecular+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2F9781118854754.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118854754.ch6%26sid%3Dliteratum%253Aachs%26aulast%3DDilworth%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Radiopharmaceutical%2520Chemistry%2520of%2520Technetium%2520and%2520Rhenium%26btitle%3DThe%2520Chemistry%2520of%2520Molecular%2520Imaging%26aulast%3DWong%26aufirst%3DN.%2BL.%2BW.-T.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2014%26spage%3D137%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span> <span> </span><span class="NLM_article-title">Tetraamine-coupled peptides and resulting <sup>99m</sup>Tc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">2655</span>– <span class="NLM_lpage">2667</span>, <span class="refDoi"> DOI: 10.2174/1568026611212230003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2174%2F1568026611212230003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=23339761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=2655-2667&issue=23&author=B.+Nockauthor=T.+Maina&title=Tetraamine-coupled+peptides+and+resulting+99mTc-radioligands%3A+an+effective+route+for+receptor-targeted+diagnostic+imaging+of+human+tumors&doi=10.2174%2F1568026611212230003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Tetraamine-coupled peptides and resulting 99mTc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors</span></div><div class="casAuthors">Nock, Berthold A.; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2655-2667</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The successful application of OctreoScan ([111In-DTPA]octreotide) in the diagnosis of sst2-expressing neuroendocrine tumors (NETs), on one hand, and the manifestation of peptide receptor targets in a wide range of human cancers, on the other, have synergistically induced a booming emergence of numerous radiolabeled peptide (radiopeptide) probes for tumor diagnosis and therapy in man.  Definition of mol. targets and their relation to neoplastic disease has preceded peptide-based radiopharmaceutical design and development.  New criteria have been set to safeguard efficient localization of radionuclides on tumor-assocd. high affinity - low capacity peptide receptor systems.  New tech. and biol. terms, such as specific activity or receptor affinity and internalization, have invaded the Radiopharmacy domain and have irrevocably altered our concept of radiopharmaceutical design.  Nonetheless, 99mTc remains the gold std. of diagnostic nuclear medicine as a result of ideal nuclear characteristics, cost-effectiveness and wide availability in high purity and high specific activity by means of com. 99Mo/99mTc-generators.  The evolution of conventional 99mTc-perfusion agents into modern state-of-the-art mol. radiopharmaceuticals has been a challenge addressed by several researchers.  The present review summarizes recent advances in the development of 99mTc-labeled peptides for in vivo targeting of neoplastic disease, and, in particular, those functionalized with acyclic tetraamines.  Conclusions on their applicability in non-invasive diagnosis and staging of cancer patients are drawn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5hbozbNVAzLVg90H21EOLACvtfcHk0lg76TIlvLo2wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlGqs70%253D&md5=f7464c81a9bfcc9b0d0b273431df9d72</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F1568026611212230003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611212230003%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DTetraamine-coupled%2520peptides%2520and%2520resulting%252099mTc-radioligands%253A%2520an%2520effective%2520route%2520for%2520receptor-targeted%2520diagnostic%2520imaging%2520of%2520human%2520tumors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26issue%3D23%26spage%3D2655%26epage%3D2667%26doi%3D10.2174%2F1568026611212230003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vigna, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantyh, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraud, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantyh, P. W.</span></span> <span> </span><span class="NLM_article-title">Localization of specific binding sites for bombesin in the canine gastrointestinal tract</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.1016/0016-5085(87)90257-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0016-5085%2887%2990257-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1987&pages=1287-1295&issue=6&author=S.+R.+Vignaauthor=C.+R.+Mantyhauthor=A.+S.+Giraudauthor=A.+H.+Sollauthor=J.+H.+Walshauthor=P.+W.+Mantyh&title=Localization+of+specific+binding+sites+for+bombesin+in+the+canine+gastrointestinal+tract&doi=10.1016%2F0016-5085%2887%2990257-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0016-5085%2887%2990257-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0016-5085%252887%252990257-5%26sid%3Dliteratum%253Aachs%26aulast%3DVigna%26aufirst%3DS.%2BR.%26aulast%3DMantyh%26aufirst%3DC.%2BR.%26aulast%3DGiraud%26aufirst%3DA.%2BS.%26aulast%3DSoll%26aufirst%3DA.%2BH.%26aulast%3DWalsh%26aufirst%3DJ.%2BH.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26atitle%3DLocalization%2520of%2520specific%2520binding%2520sites%2520for%2520bombesin%2520in%2520the%2520canine%2520gastrointestinal%2520tract%26jtitle%3DGastroenterology%26date%3D1987%26volume%3D93%26issue%3D6%26spage%3D1287%26epage%3D1295%26doi%3D10.1016%2F0016-5085%2887%2990257-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Old and new peptide receptor targets in cancer: future directions</span>. <i>Recent Results Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1007/978-3-642-27994-2_34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2F978-3-642-27994-2_34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=22918784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVehtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2013&pages=567-576&author=J.+C.+Reubi&title=Old+and+new+peptide+receptor+targets+in+cancer%3A+future+directions&doi=10.1007%2F978-3-642-27994-2_34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Old and New Peptide Receptor Targets in Cancer: Future Directions</span></div><div class="casAuthors">Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Recent Results in Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">Theranostics, Gallium-68, and Other Radionuclides</span>),
    <span class="NLM_cas:pages">567-576</span>CODEN:
                <span class="NLM_cas:coden">RRCRBU</span>;
        ISSN:<span class="NLM_cas:issn">0080-0015</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  A precise definition of the tumor tissue targets to be selected for in vivo peptide receptor targeting, namely to know which peptide receptor is expressed in which type of cancer, is an important prerequisite for successful clin. application of this technol.  In this short review, I give three selected examples of new and promising peptide receptor targets.  In the somatostatin receptor field, based on in vitro receptor autoradiog. expts. showing that much more sst2 binding sites are detected in tumors using a177 Lu-labeled sst2 antagonist than a177 Lu-labeled agonist, it can be proposed that, in addn. to neuroendocrine tumors, nonneuroendocrine tumors with lower sst2 levels such as breast carcinomas, renal cell carcinomas, and non-Hodgkin lymphomas may become potential candidates for sst2 antagonist targeting.  In the gastrin-releasing peptide receptor field, recent in vitro data show that not only tumor cells may overexpress gastrin-releasing peptide receptors but also neoangiogenic tumoral vessels, making tumors expressing high levels of gastrin-releasing peptide receptors in tumor vessels, such as ovarian or urinary tract cancers, attractive new candidates for gastrin-releasing peptide receptor targeting.  In the incretin receptor field, it was found in vitro that, apart from glucagon-like peptide 1 receptors overexpressed in benign insulinomas, incretin receptors, esp. the glucose-dependent insulinotropic polypeptide receptors, can be overexpressed in medullary thyroid cancers, an unexpected finding making also these tumors potential novel candidates for incretin receptor targeting.  Due to the abundance of peptide receptors in various cancers, it may be possible in the future to define for each tumor type a corresponding overexpressed peptide receptor suitable for targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Nx3l_MlZS7Vg90H21EOLACvtfcHk0lg76TIlvLo2wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVehtbo%253D&md5=61aa71c7dd4b59b0f44b0e2dcf909c61</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-27994-2_34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-27994-2_34%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DOld%2520and%2520new%2520peptide%2520receptor%2520targets%2520in%2520cancer%253A%2520future%2520directions%26jtitle%3DRecent%2520Results%2520Cancer%2520Res.%26date%3D2013%26volume%3D194%26spage%3D567%26epage%3D576%26doi%3D10.1007%2F978-3-642-27994-2_34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baum, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, H. R.</span></span> <span> </span><span class="NLM_article-title">THERANOSTICS: from molecular imaging using Ga-68 labeled tracers and PET/CT to personalized radionuclide therapy - the Bad Berka experience</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.7150/thno.3645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.7150%2Fthno.3645" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=437-447&issue=5&author=R.+P.+Baumauthor=H.+R.+Kulkarni&title=THERANOSTICS%3A+from+molecular+imaging+using+Ga-68+labeled+tracers+and+PET%2FCT+to+personalized+radionuclide+therapy+-+the+Bad+Berka+experience&doi=10.7150%2Fthno.3645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.7150%2Fthno.3645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.3645%26sid%3Dliteratum%253Aachs%26aulast%3DBaum%26aufirst%3DR.%2BP.%26aulast%3DKulkarni%26aufirst%3DH.%2BR.%26atitle%3DTHERANOSTICS%253A%2520from%2520molecular%2520imaging%2520using%2520Ga-68%2520labeled%2520tracers%2520and%2520PET%252FCT%2520to%2520personalized%2520radionuclide%2520therapy%2520-%2520the%2520Bad%2520Berka%2520experience%26jtitle%3DTheranostics%26date%3D2012%26volume%3D2%26issue%3D5%26spage%3D437%26epage%3D447%26doi%3D10.7150%2Fthno.3645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleischmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laderach, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friess, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Bombesin receptors in distinct tissue compartments of human pancreatic diseases</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1807</span>– <span class="NLM_lpage">1817</span>, <span class="refDoi"> DOI: 10.1038/labinvest.3780192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1038%2Flabinvest.3780192" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2000&pages=1807-1817&issue=12&author=A.+Fleischmannauthor=U.+Laderachauthor=H.+Friessauthor=M.+W.+Buechlerauthor=J.+C.+Reubi&title=Bombesin+receptors+in+distinct+tissue+compartments+of+human+pancreatic+diseases&doi=10.1038%2Flabinvest.3780192"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.3780192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.3780192%26sid%3Dliteratum%253Aachs%26aulast%3DFleischmann%26aufirst%3DA.%26aulast%3DLaderach%26aufirst%3DU.%26aulast%3DFriess%26aufirst%3DH.%26aulast%3DBuechler%26aufirst%3DM.%2BW.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DBombesin%2520receptors%2520in%2520distinct%2520tissue%2520compartments%2520of%2520human%2520pancreatic%2520diseases%26jtitle%3DLab.%2520Invest.%26date%3D2000%26volume%3D80%26issue%3D12%26spage%3D1807%26epage%3D1817%26doi%3D10.1038%2Flabinvest.3780192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lantry, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappelletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddalena, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalfe, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattuada, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedle, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A. D.</span></span> <span> </span><span class="NLM_article-title"><sup>177</sup>Lu-AMBA: synthesis and characterization of a selective <sup>177</sup>Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1144-1152&issue=7&author=L.+E.+Lantryauthor=E.+Cappellettiauthor=M.+E.+Maddalenaauthor=J.+S.+Foxauthor=W.+Fengauthor=J.+Chenauthor=R.+Thomasauthor=S.+M.+Eatonauthor=N.+J.+Bogdanauthor=T.+Arunachalamauthor=J.+C.+Reubiauthor=N.+Rajuauthor=E.+C.+Metcalfeauthor=L.+Lattuadaauthor=K.+E.+Linderauthor=R.+E.+Swensonauthor=M.+F.+Tweedleauthor=A.+D.+Nunn&title=177Lu-AMBA%3A+synthesis+and+characterization+of+a+selective+177Lu-labeled+GRP-R+agonist+for+systemic+radiotherapy+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLantry%26aufirst%3DL.%2BE.%26aulast%3DCappelletti%26aufirst%3DE.%26aulast%3DMaddalena%26aufirst%3DM.%2BE.%26aulast%3DFox%26aufirst%3DJ.%2BS.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DEaton%26aufirst%3DS.%2BM.%26aulast%3DBogdan%26aufirst%3DN.%2BJ.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DMetcalfe%26aufirst%3DE.%2BC.%26aulast%3DLattuada%26aufirst%3DL.%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DSwenson%26aufirst%3DR.%2BE.%26aulast%3DTweedle%26aufirst%3DM.%2BF.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26atitle%3D177Lu-AMBA%253A%2520synthesis%2520and%2520characterization%2520of%2520a%2520selective%2520177Lu-labeled%2520GRP-R%2520agonist%2520for%2520systemic%2520radiotherapy%2520of%2520prostate%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26issue%3D7%26spage%3D1144%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Castiglione, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gozzini, L.</span></span> <span> </span><span class="NLM_article-title">Bombesin receptor antagonists</span>. <i>Crit. Rev. Oncol. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/1040-8428(96)00220-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F1040-8428%2896%2900220-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=8889369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADyaK2s%252FksVaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1996&pages=117-151&issue=2&author=R.+de+Castiglioneauthor=L.+Gozzini&title=Bombesin+receptor+antagonists&doi=10.1016%2F1040-8428%2896%2900220-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin receptor antagonists</span></div><div class="casAuthors">de Castiglione R; Gozzini L</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-51</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLOfsJIimRp0mhnSqMnvzDfW6udTcc2eYAdAxVGEdi8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FksVaqug%253D%253D&md5=1963743fcadc113b98822d5a10c57d85</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F1040-8428%2896%2900220-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1040-8428%252896%252900220-X%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCastiglione%26aufirst%3DR.%26aulast%3DGozzini%26aufirst%3DL.%26atitle%3DBombesin%2520receptor%2520antagonists%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D1996%26volume%3D24%26issue%3D2%26spage%3D117%26epage%3D151%26doi%3D10.1016%2F1040-8428%2896%2900220-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moody, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantey, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuselier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">23580</span>– <span class="NLM_lpage">23589</span>, <span class="refDoi"> DOI: 10.1074/jbc.M401938200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1074%2Fjbc.M401938200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=23580-23589&issue=22&author=T.+W.+Moodyauthor=S.+A.+Manteyauthor=T.+K.+Pradhanauthor=M.+Schumannauthor=T.+Nakagawaauthor=A.+Martinezauthor=J.+Fuselierauthor=D.+H.+Coyauthor=R.+T.+Jensen&title=Development+of+high+affinity+camptothecin-bombesin+conjugates+that+have+targeted+cytotoxicity+for+bombesin+receptor-containing+tumor+cells&doi=10.1074%2Fjbc.M401938200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M401938200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M401938200%26sid%3Dliteratum%253Aachs%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DMantey%26aufirst%3DS.%2BA.%26aulast%3DPradhan%26aufirst%3DT.%2BK.%26aulast%3DSchumann%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DFuselier%26aufirst%3DJ.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DDevelopment%2520of%2520high%2520affinity%2520camptothecin-bombesin%2520conjugates%2520that%2520have%2520targeted%2520cytotoxicity%2520for%2520bombesin%2520receptor-containing%2520tumor%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D22%26spage%3D23580%26epage%3D23589%26doi%3D10.1074%2Fjbc.M401938200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stangelberger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szepeshazi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, G.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=15671527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVehtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=49-57&issue=1&author=A.+Stangelbergerauthor=A.+V.+Schallyauthor=J.+L.+Vargaauthor=M.+Zarandiauthor=K.+Szepeshaziauthor=P.+Armatisauthor=G.+Halmos&title=Inhibitory+effect+of+antagonists+of+bombesin+and+growth+hormone-releasing+hormone+on+orthotopic+and+intraosseous+growth+and+invasiveness+of+PC-3+human+prostate+cancer+in+nude+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice</span></div><div class="casAuthors">Stangelberger, Anton; Schally, Andrew V.; Varga, Jozsef L.; Zarandi, Marta; Szepeshazi, Karoly; Armatis, Patricia; Halmos, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-57</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To det. whether antagonists of growth hormone-releasing hormone (GHRH) and bombesin/gastrin-releasing peptide (BN/GRP) can inhibit the orthotopic and metastatic growth of PC-3 human androgen-independent prostate cancers.  The effects of administration of GHRH antagonist MZ-J-7-118, BN/GRP antagonist RC-3940-II, and their combination on the growth and metastatic spread of PC-3 tumors implanted orthotopically into nude mice were evaluated.  The efficacy of this treatment on PC-3 tumors implanted intratibially and s.c. was also detd.  Treatment with MZ-J-7-118, RC-3940-II, or their combination significantly inhibited the growth of PC-3 tumors implanted orthotopically, intraosseously, and s.c.  The combination of the two antagonists had the greatest effect, inhibiting orthotopic tumor growth by 77%, intratibially implanted tumors by 86%, and s.c. tumors by 86%.  The therapy with BN/GRP and GHRH antagonists, esp. in combination, also reduced the local tumor spread and distant metastases in animals bearing orthotopic tumors.  Combination therapy was likewise the most effective in reducing the incidence and severity of tibial osteolytic lesions and pathol. fractures in intraosseously implanted tumors.  High-affinity binding sites for BN/GRP and GHRH were found in s.c. and orthotopic PC-3 tumor samples.  MZ-J-7-118, RC-3940-II, and the combination of both compds. inhibited in vitro growth of PC-3 cells.  Our findings show the efficacy of BN/GRP antagonists and GHRH antagonists for the treatment of advanced prostate cancer in preclin. metastatic models.  As BN/GRP antagonists are already in clin. trials and GHRH antagonists are effective in androgen-independent prostate cancer models, these analogs could be considered for the management of advanced prostate carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor8D9MdDfWC7Vg90H21EOLACvtfcHk0ljuN25JxrzPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVehtbY%253D&md5=819759d7579729e83c7f044006916a20</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStangelberger%26aufirst%3DA.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26aulast%3DVarga%26aufirst%3DJ.%2BL.%26aulast%3DZarandi%26aufirst%3DM.%26aulast%3DSzepeshazi%26aufirst%3DK.%26aulast%3DArmatis%26aufirst%3DP.%26aulast%3DHalmos%26aufirst%3DG.%26atitle%3DInhibitory%2520effect%2520of%2520antagonists%2520of%2520bombesin%2520and%2520growth%2520hormone-releasing%2520hormone%2520on%2520orthotopic%2520and%2520intraosseous%2520growth%2520and%2520invasiveness%2520of%2520PC-3%2520human%2520prostate%2520cancer%2520in%2520nude%2520mice%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26issue%3D1%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamharzi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szepeshazi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, R. Z.</span></span> <span> </span><span class="NLM_article-title">Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(97)10123-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2FS0959-8049%2897%2910123-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=710-717&issue=5&author=M.+Miyazakiauthor=N.+Lamharziauthor=A.+V.+Schallyauthor=G.+Halmosauthor=K.+Szepeshaziauthor=K.+Grootauthor=R.+Z.+Cai&title=Inhibition+of+growth+of+MDA-MB-231+human+breast+cancer+xenografts+in+nude+mice+by+bombesin%2Fgastrin-releasing+peptide+%28GRP%29+antagonists+RC-3940-II+and+RC-3095&doi=10.1016%2FS0959-8049%2897%2910123-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2897%2910123-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252897%252910123-X%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DLamharzi%26aufirst%3DN.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26aulast%3DHalmos%26aufirst%3DG.%26aulast%3DSzepeshazi%26aufirst%3DK.%26aulast%3DGroot%26aufirst%3DK.%26aulast%3DCai%26aufirst%3DR.%2BZ.%26atitle%3DInhibition%2520of%2520growth%2520of%2520MDA-MB-231%2520human%2520breast%2520cancer%2520xenografts%2520in%2520nude%2520mice%2520by%2520bombesin%252Fgastrin-releasing%2520peptide%2520%2528GRP%2529%2520antagonists%2520RC-3940-II%2520and%2520RC-3095%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1998%26volume%3D34%26issue%3D5%26spage%3D710%26epage%3D717%26doi%3D10.1016%2FS0959-8049%2897%2910123-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamma, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akyel, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2115</span>– <span class="NLM_lpage">2124</span>, <span class="refDoi"> DOI: 10.1002/chem.200902011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fchem.200902011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=20066690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2115-2124&issue=7&author=K.+Abirajauthor=R.+Mansiauthor=M.+L.+Tammaauthor=F.+Forrerauthor=R.+Cescatoauthor=J.+C.+Reubiauthor=K.+G.+Akyelauthor=H.+R.+Maecke&title=Tetraamine-derived+bifunctional+chelators+for+technetium-99m+labelling%3A+synthesis%2C+bioconjugation+and+evaluation+as+targeted+SPECT+imaging+probes+for+GRP-receptor-positive+tumours&doi=10.1002%2Fchem.200902011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Tetraamine-Derived Bifunctional Chelators for Technetium-99m Labelling: Synthesis, Bioconjugation and Evaluation as Targeted SPECT Imaging Probes for GRP-Receptor-Positive Tumours</span></div><div class="casAuthors">Abiraj, Keelara; Mansi, Rosalba; Tamma, Maria-Luisa; Forrer, Flavio; Cescato, Renzo; Reubi, Jean Claude; Akyel, Kayhan G.; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2115-2124</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Owing to its optimal nuclear properties, ready availability, low cost and favorable dosimetry, 99mTc continues to be the ideal radioisotope for medical-imaging applications.  Bifunctional chelators based on a tetraamine framework exhibit facile complexation with Tc(V)O2 to form monocationic species with high in vivo stability and significant hydrophilicity, which leads to favorable pharmacokinetics.  The synthesis of a series of 1,4,8,11-tetraazaundecane derivs. (01-06) contg. different functional groups at the 6-position for the conjugation of biomols. and subsequent labeling with 99mTc is described herein.  The chelator 01 was used as a starting material for the facile synthesis of chelators functionalised with OH (02), N3 (04) and O-succinyl ester (05) groups.  A straightforward and easy synthesis of carboxyl-functionalised tetraamine-based chelator 06 was achieved by using inexpensive and com. available starting materials.  Conjugation of 06 to a potent bombesin-antagonist peptide and subsequent labeling with 99mTc afforded the radiotracer 99mTc-N4-BB-ANT, with radiolabelling yields of >97 % at a specific activity of 37 GBq μmol-1.  An IC50 value of (3.7±1.3) nM was obtained, which confirmed the high affinity of the conjugate to the gastrin-releasing-peptide receptor (GRPr).  Immunofluorescence and calcium mobilisation assays confirmed the strong antagonist properties of the conjugate.  In vivo pharmacokinetic studies of 99mTc-N4-BB-ANT showed high and specific uptake in PC3 xenografts and in other GRPr-pos. organs.  The tumor uptake was (22.5±2.6) % injected activity per g (% IA g-1) at 1 h post injection (p.i.). and increased to (29.9±4.0) % IA g-1 at 4 h p.i.  The SPECT/computed tomog. (CT) images showed high tumor uptake, clear background and negligible radioactivity in the abdomen.  The promising preclin. results of 99mTc-N4-BB-ANT warrant its potential candidature for clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEM2EgIx-abVg90H21EOLACvtfcHk0ljuN25JxrzPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKrtbs%253D&md5=6579350a00c7e81c0eaf3725b59d1e3b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fchem.200902011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200902011%26sid%3Dliteratum%253Aachs%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DTamma%26aufirst%3DM.%2BL.%26aulast%3DForrer%26aufirst%3DF.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DAkyel%26aufirst%3DK.%2BG.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DTetraamine-derived%2520bifunctional%2520chelators%2520for%2520technetium-99m%2520labelling%253A%2520synthesis%252C%2520bioconjugation%2520and%2520evaluation%2520as%2520targeted%2520SPECT%2520imaging%2520probes%2520for%2520GRP-receptor-positive%2520tumours%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26issue%3D7%26spage%3D2115%26epage%3D2124%26doi%3D10.1002%2Fchem.200902011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krenning, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span> <span> </span><span class="NLM_article-title">“To serve and protect”: enzyme inhibitors as radiopeptide escorts promote tumor targeting</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.2967/jnumed.113.129411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.113.129411" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=121-127&issue=1&author=B.+A.+Nockauthor=T.+Mainaauthor=E.+P.+Krenningauthor=M.+de+Jong&title=%E2%80%9CTo+serve+and+protect%E2%80%9D%3A+enzyme+inhibitors+as+radiopeptide+escorts+promote+tumor+targeting&doi=10.2967%2Fjnumed.113.129411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.129411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.129411%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3D%25E2%2580%259CTo%2520serve%2520and%2520protect%25E2%2580%259D%253A%2520enzyme%2520inhibitors%2520as%2520radiopeptide%2520escorts%2520promote%2520tumor%2520targeting%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26issue%3D1%26spage%3D121%26epage%3D127%26doi%3D10.2967%2Fjnumed.113.129411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oçak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helbok, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peitl, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosabowski, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeman, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decristoforo, C.</span></span> <span> </span><span class="NLM_article-title">Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1426</span>– <span class="NLM_lpage">1435</span>, <span class="refDoi"> DOI: 10.1007/s00259-011-1818-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-011-1818-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=21528387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2mtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=1426-1435&issue=8&author=M.+O%C3%A7akauthor=A.+Helbokauthor=C.+Ranggerauthor=P.+K.+Peitlauthor=B.+A.+Nockauthor=G.+Morelliauthor=A.+Eekauthor=J.+K.+Sosabowskiauthor=W.+A.+Breemanauthor=J.+C.+Reubiauthor=C.+Decristoforo&title=Comparison+of+biological+stability+and+metabolism+of+CCK2+receptor+targeting+peptides%2C+a+collaborative+project+under+COST+BM0607&doi=10.1007%2Fs00259-011-1818-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607</span></div><div class="casAuthors">Ocak, Meltem; Helbok, Anna; Rangger, Christine; Peitl, Petra Kolenc; Nock, Berthold A.; Morelli, Giancarlo; Eek, Annemarie; Sosabowski, Jane K.; Breeman, Wout A. P.; Reubi, Jean Claude; Decristoforo, Clemens</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1426-1435</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Stability of radiolabeled cholecystokinin 2 (CCK2) receptor targeting peptides has been a major limitation in the use of such radiopharmaceuticals esp. for targeted radionuclide therapy applications, e.g. for treatment of medullary thyroid carcinoma (MTC).  The purpose of this study was to compare the in vitro stability of a series of peptides binding to the CCK2 receptor [selected as part of the COST Action on Targeted Radionuclide Therapy (BM0607)] and to identify major cleavage sites.  Methods: Twelve different 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-minigastrin/CCK conjugates were provided within an European COST Action (BM0607) by different labs. and radiolabeled with 177Lu.  Their in vitro stabilities were tested in fresh human serum.  Radiochem. yields (RCY) and intact radioligands for half-life calcns. were detd. by radio-HPLC.  Matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) anal. of metabolites was performed to identify cleavage products using conjugates labeled with excess stable natLu, incubated in serum at 37°C.  Urine metabolite anal. after injection in normal mice was performed by radio-HPLC anal.  Results: Variable stability in human serum was found for the different peptides with calcd. half-lives between 4.5 ± 0.1 h and 198 ± 0.1 h (n = 2).  In urine of normal mice only metabolised peptide fragments were detected even at short times after injection for all peptides.  MALDI-TOF MS revealed a major cleavage site of all minigastrin derivs. between Asp and Phe-NH2 at the C-terminal end.  Conclusion: Development of CCK2 receptor ligands esp. for therapeutic purposes in patients with MTC or small cell lung cancer (SCLC) is still ongoing in different labs.  This comparative study provided valuable insight into the importance of biol. stability esp. in the context of other results of this comparative trial within the COST Action BM0607.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpom7RrjISX8bVg90H21EOLACvtfcHk0ljcZ11ft4E0ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2mtLk%253D&md5=01062dcc0b2bfb5cebe770d1763433d8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs00259-011-1818-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-011-1818-9%26sid%3Dliteratum%253Aachs%26aulast%3DO%25C3%25A7ak%26aufirst%3DM.%26aulast%3DHelbok%26aufirst%3DA.%26aulast%3DRangger%26aufirst%3DC.%26aulast%3DPeitl%26aufirst%3DP.%2BK.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMorelli%26aufirst%3DG.%26aulast%3DEek%26aufirst%3DA.%26aulast%3DSosabowski%26aufirst%3DJ.%2BK.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DDecristoforo%26aufirst%3DC.%26atitle%3DComparison%2520of%2520biological%2520stability%2520and%2520metabolism%2520of%2520CCK2%2520receptor%2520targeting%2520peptides%252C%2520a%2520collaborative%2520project%2520under%2520COST%2520BM0607%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2011%26volume%3D38%26issue%3D8%26spage%3D1426%26epage%3D1435%26doi%3D10.1007%2Fs00259-011-1818-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linder, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalfe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantry, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, R. E.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1171</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1021/bc9000189</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9000189" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1171-1178&issue=6&author=K.+E.+Linderauthor=E.+Metcalfeauthor=T.+Arunachalamauthor=J.+Chenauthor=S.+M.+Eatonauthor=W.+Fengauthor=H.+Fanauthor=N.+Rajuauthor=A.+Cagnoliniauthor=L.+E.+Lantryauthor=A.+D.+Nunnauthor=R.+E.+Swenson&title=In+vitro+and+in+vivo+metabolism+of+Lu-AMBA%2C+a+GRP-receptor+binding+compound%2C+and+the+synthesis+and+characterization+of+its+metabolites&doi=10.1021%2Fbc9000189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and in Vivo Metabolism of Lu-AMBA, a GRP-Receptor Binding Compound, and the Synthesis and Characterization of Its Metabolites</span></div><div class="casAuthors">Linder, Karen E.; Metcalfe, Edmund; Arunachalam, Thangavel; Chen, Jianqing; Eaton, Stephen M.; Feng, Weiwei; Fan, Hong; Raju, Natarajan; Cagnolini, Aldo; Lantry, Laura E.; Nunn, Adrian D.; Swenson, Rolf E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1171-1178</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metab. of 177Lu-AMBA (AMBA = DO3A-CH2CO-G-(4-aminobenzoyl)-QWAVGHLM-NH2), a radiotherapeutic compd. in clin. development that binds to GRP and NMB receptors, was studied in vitro (mouse, rat and human plasma, mouse kidney homogenate) and in vivo (by anal. of mouse and rat plasma and urine following IV injection of 177Lu-AMBA).  The primary metabolites were Lu-DO3A-CH2CO-G-Abz4-R, where R = -Q-OH (A), -QW-OH (B), and -QWAVGH-OH (C).  Minor amts. of (D) where R = -QWAVGHLM-OH and (E) -QWAVGHL-OH were also obsd.  Clearance of 177Lu-AMBA and of radioactivity from mouse and rat blood was rapid in vivo.  In mouse and rat urine, only metabolites Lu-A and Lu-B were found-no parent drug was excreted.  Unmetalated ligands and natLu and 177Lu complexes for Lu-AMBA metabolites A-E were synthesized, characterized by HPLC and MS, and used to perform in vitro competition and direct binding studies on GRP receptor-pos. PC-3 (human prostate) cancer cells.  Biodistribution studies with 177Lu-labeled metabolites A-E were performed in PC-3 tumor-bearing mice and the results compared with intact 177Lu-AMBA. IC50 values for unmetalated metabolite ligands A-E were >400 nM in PC-3 cells in competition binding studies against 177Lu-AMBA.  No direct binding to PC-3 cells was obsd. with 177Lu-labeled A-C, confirming IC50 results. 177Lu-labeled metabolites A-E showed no uptake in GRP-receptor pos. tumor or pancreas in PC-3 tumor bearing mice.  All metabolites were rapidly excreted via the renal route (∼78-87%) within 1 h.  These results demonstrate that the tumor uptake obsd. with 177Lu-AMBA is due to parent drug and not due to any of its identified metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqAOuUWHaErVg90H21EOLACvtfcHk0ljcZ11ft4E0ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFGlsLY%253D&md5=da849967f62a36434ddaeae9a2f972eb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbc9000189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9000189%26sid%3Dliteratum%253Aachs%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DMetcalfe%26aufirst%3DE.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DS.%2BM.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DCagnolini%26aufirst%3DA.%26aulast%3DLantry%26aufirst%3DL.%2BE.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26aulast%3DSwenson%26aufirst%3DR.%2BE.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520metabolism%2520of%2520Lu-AMBA%252C%2520a%2520GRP-receptor%2520binding%2520compound%252C%2520and%2520the%2520synthesis%2520and%2520characterization%2520of%2520its%2520metabolites%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26issue%3D6%26spage%3D1171%26epage%3D1178%26doi%3D10.1021%2Fbc9000189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roques, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauge, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournie-Zaluski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, A.</span></span> <span> </span><span class="NLM_article-title">Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=8475170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADyaK3sXktVems7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=87-146&issue=1&author=B.+P.+Roquesauthor=F.+Nobleauthor=V.+Daugeauthor=M.+C.+Fournie-Zaluskiauthor=A.+Beaumont&title=Neutral+endopeptidase+24.11%3A+structure%2C+inhibition%2C+and+experimental+and+clinical+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology</span></div><div class="casAuthors">Roques, Bernard P.; Noble, Florence; Dauge, Valerie; Fournie-Zaluski, Marie Claude; Beaumont, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-146</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    </div><div class="casAbstract">A review with ∼600 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ShbW5r3kwrVg90H21EOLACvtfcHk0ljcZ11ft4E0ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVems7g%253D&md5=880a50a3eb17ae3745cc6010949a8df3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoques%26aufirst%3DB.%2BP.%26aulast%3DNoble%26aufirst%3DF.%26aulast%3DDauge%26aufirst%3DV.%26aulast%3DFournie-Zaluski%26aufirst%3DM.%2BC.%26aulast%3DBeaumont%26aufirst%3DA.%26atitle%3DNeutral%2520endopeptidase%252024.11%253A%2520structure%252C%2520inhibition%252C%2520and%2520experimental%2520and%2520clinical%2520pharmacology%26jtitle%3DPharmacol.%2520Rev.%26date%3D1993%26volume%3D45%26issue%3D1%26spage%3D87%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Märki, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivier, J. E.</span></span> <span> </span><span class="NLM_article-title">Bombesin analogs: effects on thermoregulation and glucose metabolism</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/0196-9781(81)90027-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0196-9781%2881%2990027-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1981&pages=169-177&issue=Suppl.+2&author=W.+M%C3%A4rkiauthor=M.+Brownauthor=J.+E.+Rivier&title=Bombesin+analogs%3A+effects+on+thermoregulation+and+glucose+metabolism&doi=10.1016%2F0196-9781%2881%2990027-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0196-9781%2881%2990027-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0196-9781%252881%252990027-9%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4rki%26aufirst%3DW.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DRivier%26aufirst%3DJ.%2BE.%26atitle%3DBombesin%2520analogs%253A%2520effects%2520on%2520thermoregulation%2520and%2520glucose%2520metabolism%26jtitle%3DPeptides%26date%3D1981%26volume%3D2%26issue%3DSuppl.%25202%26spage%3D169%26epage%3D177%26doi%3D10.1016%2F0196-9781%2881%2990027-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shipp, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarr, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Switzer, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersh, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunday, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinherz, E. L.</span></span> <span> </span><span class="NLM_article-title">CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10662</span>– <span class="NLM_lpage">10666</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.23.10662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1073%2Fpnas.88.23.10662" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=10662-10666&issue=23&author=M.+A.+Shippauthor=G.+E.+Tarrauthor=C.+Y.+Chenauthor=S.+N.+Switzerauthor=L.+B.+Hershauthor=H.+Steinauthor=M.+E.+Sundayauthor=E.+L.+Reinherz&title=CD10%2Fneutral+endopeptidase+24.11+hydrolyzes+bombesin-like+peptides+and+regulates+the+growth+of+small+cell+carcinomas+of+the+lung&doi=10.1073%2Fpnas.88.23.10662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.23.10662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.23.10662%26sid%3Dliteratum%253Aachs%26aulast%3DShipp%26aufirst%3DM.%2BA.%26aulast%3DTarr%26aufirst%3DG.%2BE.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DSwitzer%26aufirst%3DS.%2BN.%26aulast%3DHersh%26aufirst%3DL.%2BB.%26aulast%3DStein%26aufirst%3DH.%26aulast%3DSunday%26aufirst%3DM.%2BE.%26aulast%3DReinherz%26aufirst%3DE.%2BL.%26atitle%3DCD10%252Fneutral%2520endopeptidase%252024.11%2520hydrolyzes%2520bombesin-like%2520peptides%2520and%2520regulates%2520the%2520growth%2520of%2520small%2520cell%2520carcinomas%2520of%2520the%2520lung%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26issue%3D23%26spage%3D10662%26epage%3D10666%26doi%3D10.1073%2Fpnas.88.23.10662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaloudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lymperis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krenning, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span> <span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labeled gastrins of varying peptide chain length: distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2016.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2Fj.nucmedbio.2016.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=27260775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVSmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=347-354&issue=6&author=A.+Kaloudiauthor=B.+A.+Nockauthor=E.+Lymperisauthor=E.+P.+Krenningauthor=M.+de+Jongauthor=T.+Maina&title=99mTc-labeled+gastrins+of+varying+peptide+chain+length%3A+distinct+impact+of+NEP%2FACE-inhibition+on+stability+and+tumor+uptake+in+mice&doi=10.1016%2Fj.nucmedbio.2016.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice</span></div><div class="casAuthors">Kaloudi, Aikaterini; Nock, Berthold A.; Lymperis, Emmanouil; Krenning, Eric P.; de Jong, Marion; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-354</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In situ inhibition of neutral endopeptidase (NEP) has been recently shown to impressively increase the bioavailability and tumor uptake of biodegradable gastrin radioligands.  Furthermore, angiotensin converting enzyme (ACE) has been previously shown to cleave gastrin analogs in vitro.  In the present study, we have assessed the effects induced by single or dual NEP/ACE-inhibition on the pharmacokinetic profile of three 99mTc-labeled gastrins of varying peptide chain length: [99mTc]SG6 ([99mTc-N4-Gln1]gastrin(1-17)), [99mTc]DG2 ([99mTc-N4-Gly4,DGlu5]gastrin(4-17)) and [99mTc]DG4 ([99mTc-N4-DGlu10]gastrin(10-17)).  Mouse blood samples were collected 5 min after injection of each of [99mTc]SG6/DG2/DG4 together with: (a) vehicle, (b) the NEP-inhibitor phosphoramidon (PA), (c) the ACE-inhibitor lisinopril (Lis), or (d) PA plus Lis and were analyzed by RP-HPLC for radiometabolite detection.  Biodistribution was studied in SCID mice bearing A431-CCK2R(+/-) xenografts at 4 h postinjection (pi). [99mTc]SG6 or [99mTc]DG4 was coinjected with either vehicle or the above described NEP/ACE-inhibitor regimens; for [99mTc]DG2 control and PA animal groups were only included.  Treatment of mice with PA induced significant stabilization of 99mTc-radiotracers in peripheral blood, while treatment with Lis or Lis + PA affected the stability of des(Glu)5 [99mTc]DG4 only.  In line with these findings, PA coinjection led to notable amplification of tumor uptake of radiopeptides compared to controls (P < 0.01).  Only [99mTc]DG4 profited by single Lis (2.06 ± 0.39%ID/g vs 0.99 ± 0.13%ID/g in controls) or combined Lis + PA coinjection (8.91 ± 1.61%ID/g vs 4.89 ± 1.33%ID/g in PA-group).  Furthermore, kidney uptake remained favorably low and unaffected by PA and/or Lis coinjection only in the case of [99mTc]DG4 (< 1.9%ID/g) resulting in the most optimal tumor-to-kidney ratios.  In situ NEP/ACE-inhibition diversely affected the in vivo profile of 99mTc-radioligands based on different-length gastrins.  Truncated [99mTc]DG4 exhibited overall the most attractive profile during combined NEP/ACE-inhibition in mouse models, providing new opportunities for CCK2R-expressing tumor imaging in man with SPECT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv__ZwhKqUzLVg90H21EOLACvtfcHk0liQRR8S8u-i7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVSmtbY%253D&md5=4d20b7eafbaa44cf42afb9721161f6de</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2016.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2016.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DKaloudi%26aufirst%3DA.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DLymperis%26aufirst%3DE.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3D99mTc-labeled%2520gastrins%2520of%2520varying%2520peptide%2520chain%2520length%253A%2520distinct%2520impact%2520of%2520NEP%252FACE-inhibition%2520on%2520stability%2520and%2520tumor%2520uptake%2520in%2520mice%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2016%26volume%3D43%26issue%3D6%26spage%3D347%26epage%3D354%26doi%3D10.1016%2Fj.nucmedbio.2016.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherry, S. R.</span></span> <span> </span><span class="NLM_article-title">Multimodality imaging: beyond PET/CT and SPECT/CT</span>. <i>Semin. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1053/j.semnuclmed.2009.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1053%2Fj.semnuclmed.2009.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=19646559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADC%252BD1MrivVKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=348-353&issue=5&author=S.+R.+Cherry&title=Multimodality+imaging%3A+beyond+PET%2FCT+and+SPECT%2FCT&doi=10.1053%2Fj.semnuclmed.2009.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodality imaging: beyond PET/CT and SPECT/CT</span></div><div class="casAuthors">Cherry Simon R</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Multimodality imaging with positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT has become commonplace in clinical practice and in preclinical and basic biomedical research.  Do other combinations of imaging modalities have a similar potential to impact medical science and clinical medicine? Presently, the combination of PET or SPECT with magnetic resonance imaging (MRI) is an area of active research, while other, perhaps less obvious combinations, including CT/MRI and PET/optical also are being studied.  In addition to the integration of the instrumentation, there are parallel developments in synthesizing imaging agents that can be viewed by multiple imaging modalities.  Is the fusion of PET and SPECT with CT the ultimate answer in multimodality imaging, or is it just the first example of a more general trend toward harnessing the complementary nature of the different modalities on integrated imaging platforms?</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxaXfvG57o1besJRIHUP1ofW6udTcc2eaGT93L54br67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrivVKqsA%253D%253D&md5=99bb34e6fe6bd598105df68df487ea67</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2009.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2009.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DS.%2BR.%26atitle%3DMultimodality%2520imaging%253A%2520beyond%2520PET%252FCT%2520and%2520SPECT%252FCT%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D39%26issue%3D5%26spage%3D348%26epage%3D353%26doi%3D10.1053%2Fj.semnuclmed.2009.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, F. F.,  Jr</span></span> <span> </span><span class="NLM_article-title">Diversification of <sup>99</sup>Mo/<sup>99m</sup>Tc separation: non-fission reactor production of <sup>99</sup>Mo as a strategy for enhancing <sup>99m</sup>Tc availability</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.2967/jnumed.114.149609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.114.149609" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=159-161&issue=1&author=M.+R.+Pillaiauthor=A.+Dashauthor=F.+F.+Knapp&title=Diversification+of+99Mo%2F99mTc+separation%3A+non-fission+reactor+production+of+99Mo+as+a+strategy+for+enhancing+99mTc+availability&doi=10.2967%2Fjnumed.114.149609"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.149609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.149609%26sid%3Dliteratum%253Aachs%26aulast%3DPillai%26aufirst%3DM.%2BR.%26aulast%3DDash%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DF.%2BF.%26atitle%3DDiversification%2520of%252099Mo%252F99mTc%2520separation%253A%2520non-fission%2520reactor%2520production%2520of%252099Mo%2520as%2520a%2520strategy%2520for%2520enhancing%252099mTc%2520availability%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26issue%3D1%26spage%3D159%26epage%3D161%26doi%3D10.2967%2Fjnumed.114.149609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, P. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of stable rhenium(V) dioxo complexes with acyclic tetraamine ligands, [LReO<sub>2</sub>]<sup>+</sup></span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">4127</span>– <span class="NLM_lpage">4130</span>, <span class="refDoi"> DOI: 10.1021/ic00296a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic00296a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1988&pages=4127-4130&issue=23&author=D.+Parkerauthor=P.+S.+Roy&title=Synthesis+and+characterization+of+stable+rhenium%28V%29+dioxo+complexes+with+acyclic+tetraamine+ligands%2C+%5BLReO2%5D%2B&doi=10.1021%2Fic00296a010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fic00296a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00296a010%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DD.%26aulast%3DRoy%26aufirst%3DP.%2BS.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520stable%2520rhenium%2528V%2529%2520dioxo%2520complexes%2520with%2520acyclic%2520tetraamine%2520ligands%252C%2520%255BLReO2%255D%252B%26jtitle%3DInorg.%2520Chem.%26date%3D1988%26volume%3D27%26issue%3D23%26spage%3D4127%26epage%3D4130%26doi%3D10.1021%2Fic00296a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mantey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frucht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=762-774&issue=5&author=S.+Manteyauthor=H.+Fruchtauthor=D.+H.+Coyauthor=R.+T.+Jensen&title=Characterization+of+bombesin+receptors+using+a+novel%2C+potent%2C+radiolabeled+antagonist+that+distinguishes+bombesin+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMantey%26aufirst%3DS.%26aulast%3DFrucht%26aufirst%3DH.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DCharacterization%2520of%2520bombesin%2520receptors%2520using%2520a%2520novel%252C%2520potent%252C%2520radiolabeled%2520antagonist%2520that%2520distinguishes%2520bombesin%2520receptor%2520subtypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26issue%3D5%26spage%3D762%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armatis, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span> <span> </span><span class="NLM_article-title">Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound <sup>125</sup>I-(Tyr<sup>4</sup>) bombesin by tumor cells</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1002/pros.2990250105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fpros.2990250105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=8022709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFKntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=29-38&issue=1&author=H.+Reileauthor=P.+E.+Armatisauthor=A.+V.+Schally&title=Characterization+of+high-affinity+receptors+for+bombesin%2Fgastrin+releasing+peptide+on+the+human+prostate+cancer+cell+lines+PC-3+and+DU-145%3A+internalization+of+receptor+bound+125I-%28Tyr4%29+bombesin+by+tumor+cells&doi=10.1002%2Fpros.2990250105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-[Tyr4]bombesin by tumor cells</span></div><div class="casAuthors">Reile, Herta; Armatis, Patricia E.; Schally, Andrew V.</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (New York, NY, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-38</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    </div><div class="casAbstract">Specific receptors for bombesin/gastrin releasing peptide (GRP) on the androgen-independent human prostate cancer cell lines PC-3 and DU-145 were characterized.  No specific binding of 125I-[Tyr4]bombesin to the androgen-dependent human prostate cancer cell line LNCaP was detectable.  The binding of 125I-[Tyr4]bombesin to PC-3 and DU-145 cells was time- and temp.-dependent, saturable, and reversible.  Scatchard anal. revealed a single class of binding sites with high affinity (Kd 9.8×10-11M for PC-3, and 9.1×10-11M for DU-145 cells at 25°) and with a binding capacity of 44,000 binding sites/cell and 19,000 binding sites/cell, resp.  Bound 125I-[Tyr4]bombesin was rapidly internalized by PC-3 cells.  The nonhydrolyzable GTP analog GTP-γ-S caused a dose-dependent inhibition of 125I-[Tyr4]bombesin binding to PC-3 and DU-145 cells, indicating that a G-protein couples the bombesin receptor to intracellular effector systems.  Bombesin and GRP(14-27) inhibited the binding of 125I-[Tyr4]-bombesin to both cell lines in a dose-dependent manner with inhibition consts. (Ki) of 0.5 nM and 0.4 nM, resp.  Both cell lines express the bombesin/GRP-preferring bombesin receptor subtype, since, in displacement studies, neuromedin B was >200-fold less potent than bombesin and GRP(14-27) in inhibiting the binding of 125I-[Tyr4]bombesin.  Two synthetic bombesin/GRP antagonists, RC 3095 and RC 3110, powerfully inhibited the specific binding of 125I-[Tyr4]bombesin with Ki 0.92 nM and 0.26 nM on PC-3 cells, and 3.3 nM and 0.89 nM on DU-145 cells, resp.  Apparently, the PC-3 and DU-145 human prostate cancer cell lines possess specific high-affinity receptors for bombesin/GRP, and are suitable models for the evaluation of the antineoplastic activity of new bombesin/GRP antagonists in the treatment of androgen-independent prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFBUt99JVPWLVg90H21EOLACvtfcHk0liitsl7jDXkug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFKntro%253D&md5=a5d894000e1c9873fb8558798f89425f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fpros.2990250105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.2990250105%26sid%3Dliteratum%253Aachs%26aulast%3DReile%26aufirst%3DH.%26aulast%3DArmatis%26aufirst%3DP.%2BE.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DCharacterization%2520of%2520high-affinity%2520receptors%2520for%2520bombesin%252Fgastrin%2520releasing%2520peptide%2520on%2520the%2520human%2520prostate%2520cancer%2520cell%2520lines%2520PC-3%2520and%2520DU-145%253A%2520internalization%2520of%2520receptor%2520bound%2520125I-%2528Tyr4%2529%2520bombesin%2520by%2520tumor%2520cells%26jtitle%3DProstate%26date%3D1994%26volume%3D25%26issue%3D1%26spage%3D29%26epage%3D38%26doi%3D10.1002%2Fpros.2990250105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graham, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Eb, A. J.</span></span> <span> </span><span class="NLM_article-title">A new technique for the assay of infectivity of human adenovirus 5 DNA</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1016/0042-6822(73)90341-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0042-6822%2873%2990341-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=4705382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADyaE3s7otVyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1973&pages=456-467&issue=2&author=F.+L.+Grahamauthor=A.+J.+van+der+Eb&title=A+new+technique+for+the+assay+of+infectivity+of+human+adenovirus+5+DNA&doi=10.1016%2F0042-6822%2873%2990341-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A new technique for the assay of infectivity of human adenovirus 5 DNA</span></div><div class="casAuthors">Graham F L; van der Eb A J</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">456-67</span>
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjgl3m-H_dRM25P7XSLhESfW6udTcc2ea14MYStKuT0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s7otVyhuw%253D%253D&md5=b6b045d16d2f8fd2d73de105d571fbaa</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0042-6822%2873%2990341-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0042-6822%252873%252990341-3%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DF.%2BL.%26aulast%3Dvan%2Bder%2BEb%26aufirst%3DA.%2BJ.%26atitle%3DA%2520new%2520technique%2520for%2520the%2520assay%2520of%2520infectivity%2520of%2520human%2520adenovirus%25205%2520DNA%26jtitle%3DVirology%26date%3D1973%26volume%3D52%26issue%3D2%26spage%3D456%26epage%3D467%26doi%3D10.1016%2F0042-6822%2873%2990341-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotiriou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loudos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maintas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordopatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiotellis, E.</span></span> <span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Demotate, a new <sup>99m</sup>Tc-based [Tyr<sup>3</sup>]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.1007/s00259-002-0782-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-002-0782-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=12029547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVWnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=742-753&issue=6&author=T.+Mainaauthor=B.+Nockauthor=A.+Nikolopoulouauthor=P.+Sotiriouauthor=G.+Loudosauthor=D.+Maintasauthor=P.+Cordopatisauthor=E.+Chiotellis&title=%5B99mTc%5DDemotate%2C+a+new+99mTc-based+%5BTyr3%5Doctreotate+analogue+for+the+detection+of+somatostatin+receptor-positive+tumours%3A+synthesis+and+preclinical+results&doi=10.1007%2Fs00259-002-0782-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">[99mTc]demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results</span></div><div class="casAuthors">Maina, Theodosia; Nock, Berthold; Nikolopoulou, Anastasia; Sotiriou, Petros; Loudos, George; Maintas, Dimitrios; Cordopatis, Paul; Chiotellis, Efstratios</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">742-753</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Demotate is a new tetraamine-functionalised [Tyr3]octreotate deriv. that binds technetium-99m with a high efficiency under mild conditions.  The resulting radioligand, [99mTc]Demotate, forms in a high purity and is stable for at least 6 h after labeling.  The affinity of the unlabeled peptide for somatostatin receptors is high (IC50=0.13 nM) and comparable to that of [Tyr3]octreotate or [Tyr3]octreotide, as demonstrated by competition binding expts. in rat brain cortex or AR42J cell membrane prepns.  An equally very high affinity (Kd=0.07 nM) was exhibited by [99mTc/99gTc]Demotate during satn. binding expts. using rat brain cortex membrane homogenates.  The radioligand resisted hydrolytic degrdn. in mouse plasma and was excreted intact in mouse urine.  In vivo, [99mTc]Demotate cleared very rapidly from non-target tissues into the bladder via the kidneys, while radioactivity uptake in target organs was very high.  In mice bearing the exptl. AR42J tumor, [99mTc]Demotate demonstrated a very high tumor uptake at 1 h p.i. (25%ID/g) that remained high (20%ID/g) at 4 h p.i.  This uptake could be effectively blocked by co-injection of a high dose of [Tyr3]octreotate together with the radioligand.  High-quality planar and single-photon emission tomog. images were acquired 1 h after injection of [99mTc]Demotate in tumor-bearing mice, illustrating the excellent properties of this agent for somatostatin receptor tumor imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIcan4zmFhrVg90H21EOLACvtfcHk0liitsl7jDXkug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVWnu7w%253D&md5=560a8036d7fda50be148fca8b586b592</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-0782-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-0782-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DSotiriou%26aufirst%3DP.%26aulast%3DLoudos%26aufirst%3DG.%26aulast%3DMaintas%26aufirst%3DD.%26aulast%3DCordopatis%26aufirst%3DP.%26aulast%3DChiotellis%26aufirst%3DE.%26atitle%3D%255B99mTc%255DDemotate%252C%2520a%2520new%252099mTc-based%2520%255BTyr3%255Doctreotate%2520analogue%2520for%2520the%2520detection%2520of%2520somatostatin%2520receptor-positive%2520tumours%253A%2520synthesis%2520and%2520preclinical%2520results%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2002%26volume%3D29%26issue%3D6%26spage%3D742%26epage%3D753%26doi%3D10.1007%2Fs00259-002-0782-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang  Xu</span>, <span class="hlFld-ContribAuthor ">Gang  Sheng</span>, <span class="hlFld-ContribAuthor ">Lu  Lu</span>, <span class="hlFld-ContribAuthor ">Cuirong  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Lili  Feng</span>, <span class="hlFld-ContribAuthor ">Lingtong  Meng</span>, <span class="hlFld-ContribAuthor ">Pengxiang  Min</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yijun  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Han</span>. </span><span class="cited-content_cbyCitation_article-title">GRPr-mediated photothermal and thermodynamic dual-therapy for prostate cancer with synergistic anti-apoptosis mechanism. </span><span class="cited-content_cbyCitation_journal-name">Nanoscale</span><span> <strong>2021,</strong> <em>13 </em>
                                    (7)
                                     , 4249-4261. <a href="https://doi.org/10.1039/D0NR07196J" title="DOI URL">https://doi.org/10.1039/D0NR07196J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NR07196J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NR07196J%26sid%3Dliteratum%253Aachs%26jtitle%3DNanoscale%26atitle%3DGRPr-mediated%252Bphotothermal%252Band%252Bthermodynamic%252Bdual-therapy%252Bfor%252Bprostate%252Bcancer%252Bwith%252Bsynergistic%252Banti-apoptosis%252Bmechanism%26aulast%3DXu%26aufirst%3DHang%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D7%26spage%3D4249%26epage%3D4261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayman  Abouzayed</span>, <span class="hlFld-ContribAuthor ">Sara S.  Rinne</span>, <span class="hlFld-ContribAuthor ">Hamideh  Sabahnoo</span>, <span class="hlFld-ContribAuthor ">Jens  Sörensen</span>, <span class="hlFld-ContribAuthor ">Vladimir  Chernov</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 182. <a href="https://doi.org/10.3390/pharmaceutics13020182" title="DOI URL">https://doi.org/10.3390/pharmaceutics13020182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13020182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13020182%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DPreclinical%252BEvaluation%252Bof%252B99mTc-Labeled%252BGRPR%252BAntagonists%252BmaSSS%25252FSES-PEG2-RM26%252Bfor%252BImaging%252Bof%252BProstate%252BCancer%26aulast%3DAbouzayed%26aufirst%3DAyman%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panagiotis  Kanellopoulos</span>, <span class="hlFld-ContribAuthor ">Emmanouil  Lymperis</span>, <span class="hlFld-ContribAuthor ">Aikaterini  Kaloudi</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Eric P.  Krenning</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>. </span><span class="cited-content_cbyCitation_article-title">[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3418. <a href="https://doi.org/10.3390/molecules25153418" title="DOI URL">https://doi.org/10.3390/molecules25153418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153418%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D%25255B99mTc%25255DTc-DB1%252BMimics%252Bwith%252BDifferent-Length%252BPEG%252BSpacers%25253A%252BPreclinical%252BComparison%252Bin%252BGRPR-Positive%252BModels%26aulast%3DKanellopoulos%26aufirst%3DPanagiotis%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Y. A.  Finogenova</span>, <span class="hlFld-ContribAuthor ">A. A.  Lipengolts</span>, <span class="hlFld-ContribAuthor ">A. V.  Smirnova</span>, <span class="hlFld-ContribAuthor ">E. Y.  Grigorieva</span>. </span><span class="cited-content_cbyCitation_article-title">NUCLEAR MEDICINE TECHNIQUES FOR IN VIVO ANIMAL IMAGING. </span><span class="cited-content_cbyCitation_journal-name">Siberian journal of oncology</span><span> <strong>2020,</strong> <em>19 </em>
                                    (3)
                                     , 137-145. <a href="https://doi.org/10.21294/1814-4861-2020-19-3-137-145" title="DOI URL">https://doi.org/10.21294/1814-4861-2020-19-3-137-145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.21294/1814-4861-2020-19-3-137-145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.21294%2F1814-4861-2020-19-3-137-145%26sid%3Dliteratum%253Aachs%26jtitle%3DSiberian%2520journal%2520of%2520oncology%26atitle%3DNUCLEAR%252BMEDICINE%252BTECHNIQUES%252BFOR%252BIN%252BVIVO%252BANIMAL%252BIMAGING%26aulast%3DFinogenova%26aufirst%3DY.%2BA.%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D3%26spage%3D137%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fariba  Maleki</span>, <span class="hlFld-ContribAuthor ">Arezou Masteri  Farahani</span>, <span class="hlFld-ContribAuthor ">Farzaneh  Rezazedeh</span>, <span class="hlFld-ContribAuthor ">Nourollah  Sadeghzadeh</span>. </span><span class="cited-content_cbyCitation_article-title">Structural modifications of amino acid sequences of radiolabeled peptides for targeted tumor imaging. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103802. <a href="https://doi.org/10.1016/j.bioorg.2020.103802" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103802</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103802%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructural%252Bmodifications%252Bof%252Bamino%252Bacid%252Bsequences%252Bof%252Bradiolabeled%252Bpeptides%252Bfor%252Btargeted%252Btumor%252Bimaging%26aulast%3DMaleki%26aufirst%3DFariba%26date%3D2020%26volume%3D99%26spage%3D103802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nkemakonam C.  Okoye</span>, <span class="hlFld-ContribAuthor ">Jakob E.  Baumeister</span>, <span class="hlFld-ContribAuthor ">Firouzeh  Najafi Khosroshahi</span>, <span class="hlFld-ContribAuthor ">Heather M.  Hennkens</span>, <span class="hlFld-ContribAuthor ">Silvia S.  Jurisson</span>. </span><span class="cited-content_cbyCitation_article-title">Chelators and metal complex stability for radiopharmaceutical applications. </span><span class="cited-content_cbyCitation_journal-name">Radiochimica Acta</span><span> <strong>2019,</strong> <em>107 </em>
                                    (9-11)
                                     , 1087-1120. <a href="https://doi.org/10.1515/ract-2018-3090" title="DOI URL">https://doi.org/10.1515/ract-2018-3090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/ract-2018-3090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fract-2018-3090%26sid%3Dliteratum%253Aachs%26jtitle%3DRadiochimica%2520Acta%26atitle%3DChelators%252Band%252Bmetal%252Bcomplex%252Bstability%252Bfor%252Bradiopharmaceutical%252Bapplications%26aulast%3DOkoye%26aufirst%3DNkemakonam%2BC.%26date%3D2019%26date%3D2019%26volume%3D107%26issue%3D9-11%26spage%3D1087%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanouil  Lymperis</span>, <span class="hlFld-ContribAuthor ">Aikaterini  Kaloudi</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Kanellopoulos</span>, <span class="hlFld-ContribAuthor ">Eric P.  Krenning</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative evaluation of the new GRPR-antagonist
              111
              In-SB9 and
              111
              In-AMBA in prostate cancer models: Implications of in vivo stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 646-655. <a href="https://doi.org/10.1002/jlcr.3733" title="DOI URL">https://doi.org/10.1002/jlcr.3733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3733%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DComparative%252Bevaluation%252Bof%252Bthe%252Bnew%252BGRPR-antagonist%252B111%252BIn-SB9%252Band%252B111%252BIn-AMBA%252Bin%252Bprostate%252Bcancer%252Bmodels%25253A%252BImplications%252Bof%252Bin%252Bvivo%252Bstability%26aulast%3DLymperis%26aufirst%3DEmmanouil%26date%3D2019%26date%3D2019%26volume%3D62%26issue%3D10%26spage%3D646%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farzaneh  Rezazadeh</span>, <span class="hlFld-ContribAuthor ">Nourollah  Sadeghzadeh</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor targeting with
              99m
              Tc radiolabeled peptides: Clinical application and recent development. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>93 </em>
                                    (3)
                                     , 205-221. <a href="https://doi.org/10.1111/cbdd.13413" title="DOI URL">https://doi.org/10.1111/cbdd.13413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13413%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DTumor%252Btargeting%252Bwith%252B99m%252BTc%252Bradiolabeled%252Bpeptides%25253A%252BClinical%252Bapplication%252Band%252Brecent%252Bdevelopment%26aulast%3DRezazadeh%26aufirst%3DFarzaneh%26date%3D2019%26date%3D2018%26volume%3D93%26issue%3D3%26spage%3D205%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanouil  Lymperis</span>, <span class="hlFld-ContribAuthor ">Aikaterini  Kaloudi</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Kanellopoulos</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Eric  Krenning</span>, <span class="hlFld-ContribAuthor ">Berthold  Nock</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>. </span><span class="cited-content_cbyCitation_article-title">Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (6)
                                     , 1015. <a href="https://doi.org/10.3390/molecules24061015" title="DOI URL">https://doi.org/10.3390/molecules24061015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24061015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24061015%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DComparing%252BGly11%25252FdAla11-Replacement%252Bvs.%252Bthe%252Bin-Situ%252BNeprilysin-Inhibition%252BApproach%252Bon%252Bthe%252BTumor-targeting%252BEfficacy%252Bof%252Bthe%252B111In-SB3%25252F111In-SB4%252BRadiotracer%252BPair%26aulast%3DLymperis%26aufirst%3DEmmanouil%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D6%26spage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical structures of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>8</b>, Including the Bifunctional Chelator N<sub>4</sub>′ (Blue) or N<sub>4</sub> (Green) Binding <sup>99m</sup>Tc, the Linker (Magenta), and the Peptide Chain with Modifications at Positions 7, 11, and the C-Terminal Highlighted (Red)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>No spacer is used in [<sup>99m</sup>Tc]<b>2</b>. *In the case of the two hydrazide analogs, labeling with <sup>99m</sup>Tc led to a mixture of unidentified species.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Displacement of [<sup>125</sup>I-Tyr<sup>4</sup>]BBN from GRPR binding sites in PC-3 cell membranes by increasing concentrations of <b>1</b> (∗, IC<sub>50</sub> = 0.70 ± 0.08 nM), <b>2</b> (▼  in magenta, IC<sub>50</sub> = 0.72 ± 0.06 nM), <b>3</b> (●  in blue, IC<sub>50</sub> = 0.93 ± 0.01 nM), and <b>4</b> (◆  in red, IC<sub>50</sub> = 0.26 ± 0.03 nM) and (B) of <b>5</b> (∗  in green, IC<sub>50</sub> = 0.56 ± 0.09 nM), <b>6</b> (▼ in violet, IC<sub>50</sub> = 0.71 ± 0.08 nM), <b>7</b> (●  in wine-red, IC<sub>50</sub> = 0.30 ± 0.03 nM), and <b>8</b> (◆ in greenish-blue, IC<sub>50</sub> = 0.17 ± 0.01 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The GRPR resides on the cell membrane of in HEK293-GRPR cells (A) in the absence of peptide in the medium, but (B) massive receptor-internalization is observed in the presence of 10 nM BBN. Analogs <b>4</b> (C) and <b>8</b> (E) were unable to trigger the internalization of GRPR in HEK293-GRPR cells at 1 μM but were effective (D and F, respectively) in preventing the stimulation of GRPR internalization by 10 nM BBN, as consistent with a receptor-antagonist profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (Α) Specific binding of [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> to PC-3 cells after 1 h incubation at 37 °C: percentage of specific cell-bound activity of total added = percentage of specific membrane bound fraction (solid colored bars) + percentage of specific internalized fraction (checkered color bars): gray, [<sup>99m</sup>Tc]<b>1</b> (12.87 ± 1.05); magenta, [<sup>99m</sup>Tc]<b>2</b> (2.19 ± 0.05); blue, [<sup>99m</sup>Tc]<b>3</b> (3.84 ± 0.39); red, [<sup>99m</sup>Tc]<b>4</b> (36.05 ± 0.43); green, [<sup>99m</sup>Tc]<b>5</b> (2.2 ± 0.1%); violet, [<sup>99m</sup>Tc]<b>6</b> (3.8 ± 0.4). (Β) Specific saturation binding curve of [<sup>99m</sup>Tc/<sup>99g</sup>Tc]<b>4</b> in PC-3 cell membranes (<i>K</i><sub>d</sub> = 0.24 ± 0.03 nM; <i>B</i><sub>max</sub> = 380 ± 25 fmol/mio cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Radiochromatograms (HPLC system 4) of mouse blood samples 5 min after injection of (A) [<sup>99m</sup>Tc]<b>1</b> (gray line, 60% intact radioligand), (B) [<sup>99m</sup>Tc]<b>2</b> (magenta line, 45% intact radioligand), (C) [<sup>99m</sup>Tc]<b>3</b> (blue line, 70% intact radioligand), (D) [<sup>99m</sup>Tc]<b>4</b> (red line, 60% intact radioligand), (E) [<sup>99m</sup>Tc]<b>5</b> (green line, 75% intact radioligand), and (F) [<sup>99m</sup>Tc]<b>6</b> (violet line, 60% intact radioligand). The <i>t</i><sub>R</sub> of the parent radioligand is indicated by the arrows.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/medium/jm-2018-00177y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Maximum intensity projection (MIP) SPECT/CT static images of mice bearing subcutaneous PC-3 xenografts on their right shoulders euthanized 15 h after injection of (A) [<sup>99m</sup>Tc]<b>1</b> or (B) [<sup>99m</sup>Tc]<b>4</b>; in both cases animals received 20 MBq radiotracer corresponding to 200 pmol of peptide conjugate. The GRPR specificity of tumor uptake could be demonstrated for [<sup>99m</sup>Tc]<b>4</b> by comparing the transaxial images of PC-3 tumors in mice euthanized 1 h after receiving 20 pmol/2.4 MBq [<sup>99m</sup>Tc]<b>4</b> (C) alone or (D) after coinjection of 20 nmol of [Tyr<sup>4</sup>]BBN.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00177/20180406/images/large/jm-2018-00177y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00177&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroog, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battey, J. F.</span></span> <span> </span><span class="NLM_article-title">Mammalian bombesin receptors</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1002/med.2610150502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fmed.2610150502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=8531502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADyaK2MXosFegtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=389-417&issue=5&author=G.+S.+Kroogauthor=R.+T.+Jensenauthor=J.+F.+Battey&title=Mammalian+bombesin+receptors&doi=10.1002%2Fmed.2610150502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian bombesin receptors</span></div><div class="casAuthors">Kroog, Glenn S.; Jensen, Robert T.; Battey, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-417</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 142 refs.  Topics discussed include: the identification and cloning of bombesin receptors, tissue distribution of the bombesin family of receptors, ligand binding, bombesin-induced 2nd messengers, interaction with GTP-binding proteins, and bombesin receptor desensitization in relation to internalization and loss of cell surface receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruYNcnewntVLVg90H21EOLACvtfcHk0liqiHxXJ1HUsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosFegtbw%253D&md5=350f9dbb0ad390d93ada88c99cfe33dc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610150502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610150502%26sid%3Dliteratum%253Aachs%26aulast%3DKroog%26aufirst%3DG.%2BS.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26aulast%3DBattey%26aufirst%3DJ.%2BF.%26atitle%3DMammalian%2520bombesin%2520receptors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1995%26volume%3D15%26issue%3D5%26spage%3D389%26epage%3D417%26doi%3D10.1002%2Fmed.2610150502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Markwalder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=1152-1159&issue=5&author=R.+Markwalderauthor=J.+C.+Reubi&title=Gastrin-releasing+peptide+receptors+in+the+human+prostate%3A+relation+to+neoplastic+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkwalder%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DGastrin-releasing%2520peptide%2520receptors%2520in%2520the%2520human%2520prostate%253A%2520relation%2520to%2520neoplastic%2520transformation%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D5%26spage%3D1152%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Körner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Early over-expression of GRP receptors in prostatic carcinogenesis</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1002/pros.22743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fpros.22743" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=217-224&issue=2&author=M.+K%C3%B6rnerauthor=B.+Waserauthor=R.+Rehmannauthor=J.+C.+Reubi&title=Early+over-expression+of+GRP+receptors+in+prostatic+carcinogenesis&doi=10.1002%2Fpros.22743"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fpros.22743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22743%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6rner%26aufirst%3DM.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DRehmann%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DEarly%2520over-expression%2520of%2520GRP%2520receptors%2520in%2520prostatic%2520carcinogenesis%26jtitle%3DProstate%26date%3D2014%26volume%3D74%26issue%3D2%26spage%3D217%26epage%3D224%26doi%3D10.1002%2Fpros.22743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hany, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermanns, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muntener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristiansen, G.</span></span> <span> </span><span class="NLM_article-title">Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1002/pros.21434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fpros.21434" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=318-325&issue=3&author=M.+Beerauthor=M.+Montaniauthor=J.+Gerhardtauthor=P.+J.+Wildauthor=T.+F.+Hanyauthor=T.+Hermannsauthor=M.+Muntenerauthor=G.+Kristiansen&title=Profiling+gastrin-releasing+peptide+receptor+in+prostate+tissues%3A+clinical+implications+and+molecular+correlates&doi=10.1002%2Fpros.21434"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fpros.21434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.21434%26sid%3Dliteratum%253Aachs%26aulast%3DBeer%26aufirst%3DM.%26aulast%3DMontani%26aufirst%3DM.%26aulast%3DGerhardt%26aufirst%3DJ.%26aulast%3DWild%26aufirst%3DP.%2BJ.%26aulast%3DHany%26aufirst%3DT.%2BF.%26aulast%3DHermanns%26aufirst%3DT.%26aulast%3DMuntener%26aufirst%3DM.%26aulast%3DKristiansen%26aufirst%3DG.%26atitle%3DProfiling%2520gastrin-releasing%2520peptide%2520receptor%2520in%2520prostate%2520tissues%253A%2520clinical%2520implications%2520and%2520molecular%2520correlates%26jtitle%3DProstate%26date%3D2012%26volume%3D72%26issue%3D3%26spage%3D318%26epage%3D325%26doi%3D10.1002%2Fpros.21434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gugger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>155</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2076</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)65525-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2FS0002-9440%2810%2965525-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10595936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1Knsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1999&pages=2067-2076&issue=6&author=M.+Guggerauthor=J.+C.+Reubi&title=Gastrin-releasing+peptide+receptors+in+non-neoplastic+and+neoplastic+human+breast&doi=10.1016%2FS0002-9440%2810%2965525-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast</span></div><div class="casAuthors">Gugger, Mathias; Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2067-2076</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The regulatory peptide gastrin-releasing peptide (GRP) may play a role in human cancer as a stimulatory growth factor.  To understand the potential role of GRP in human breast cancer, the authors have evaluated GRP receptor expression in human non-neoplastic and neoplastic breast tissues and in axillary lymph node metastases, using in vitro receptor autoradiog. on tissue sections with [125I]Tyr4-bombesin and with [125I]D-Tyr6, β Ala11, Phe13, Nle14-bombesin(6-14) as radioligands.  GRP receptors were detected, often in high d., in neoplastic epithelial mammary cells in 29 of 46 invasive ductal carcinomas, in 11 of 17 ductal carcinomas in situ, in 1 of 4 invasive lobular carcinomas, in 1 of 2 lobular carcinomas in situ, and in 1 mucinous and 1 tubular carcinoma.  A heterogeneous GRP receptor distribution was found in the neoplastic tissue samples in 32 of 52 cases with invasive carcinoma and 12 of 19 cases with carcinoma in situ.  The lymph node metastases from those primary carcinomas expressing GRP receptors were all pos., whereas surrounding lymphoreticular tissue was neg.  GRP receptors were also present in high d. but with heterogeneous distribution in ducts and lobules from all available breast tissue samples.  All of the receptors corresponded to the GRP receptor subtype of bombesin receptors, having high affinity for GRP and bombesin and lower affinity for neuromedin B.  All tissues expressing GRP receptors were identified similarly with both radioligands.  These data describe not only a high percentage of GRP receptor-pos. neoplastic breast tissues but also for the first time a ubiquitous GRP receptor expression in nonneoplastic human breast tissue.  Apart from suggesting a role of GRP in breast physiol., these data represent the mol. basis for potential clin. applications of GRP analogs such as GRP receptor scintigraphy, radiotherapy, or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7FaVfPA8ChLVg90H21EOLACvtfcHk0ligs8NcT7yBCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Knsg%253D%253D&md5=c9033e2188ac6f5abee5ba4c97cc4531</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965525-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965525-3%26sid%3Dliteratum%253Aachs%26aulast%3DGugger%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DGastrin-releasing%2520peptide%2520receptors%2520in%2520non-neoplastic%2520and%2520neoplastic%2520human%2520breast%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D155%26issue%3D6%26spage%3D2067%26epage%3D2076%26doi%3D10.1016%2FS0002-9440%2810%2965525-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittliff, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span> <span> </span><span class="NLM_article-title">Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">287</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=280-287&issue=2&author=G.+Halmosauthor=J.+L.+Wittliffauthor=A.+V.+Schally&title=Characterization+of+bombesin%2Fgastrin-releasing+peptide+receptors+in+human+breast+cancer+and+their+relationship+to+steroid+receptor+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalmos%26aufirst%3DG.%26aulast%3DWittliff%26aufirst%3DJ.%2BL.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DCharacterization%2520of%2520bombesin%252Fgastrin-releasing%2520peptide%2520receptors%2520in%2520human%2520breast%2520cancer%2520and%2520their%2520relationship%2520to%2520steroid%2520receptor%2520expression%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26issue%3D2%26spage%3D280%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalm, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieuwerts, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Deurzen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelewijn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Blois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.2967/jnumed.114.153023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.114.153023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=752-757&issue=5&author=S.+U.+Dalmauthor=J.+W.+Martensauthor=A.+M.+Sieuwertsauthor=C.+H.+van+Deurzenauthor=S.+J.+Koelewijnauthor=E.+de+Bloisauthor=T.+Mainaauthor=B.+A.+Nockauthor=L.+Brunelauthor=J.+A.+Fehrentzauthor=J.+Martinezauthor=M.+de+Jongauthor=M.+Melis&title=In+vitro+and+in+vivo+application+of+radiolabeled+gastrin-releasing+peptide+receptor+ligands+in+breast+cancer&doi=10.2967%2Fjnumed.114.153023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.153023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.153023%26sid%3Dliteratum%253Aachs%26aulast%3DDalm%26aufirst%3DS.%2BU.%26aulast%3DMartens%26aufirst%3DJ.%2BW.%26aulast%3DSieuwerts%26aufirst%3DA.%2BM.%26aulast%3Dvan%2BDeurzen%26aufirst%3DC.%2BH.%26aulast%3DKoelewijn%26aufirst%3DS.%2BJ.%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DBrunel%26aufirst%3DL.%26aulast%3DFehrentz%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DMelis%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520application%2520of%2520radiolabeled%2520gastrin-releasing%2520peptide%2520receptor%2520ligands%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26issue%3D5%26spage%3D752%26epage%3D757%26doi%3D10.2967%2Fjnumed.114.153023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achcar, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batlle, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groshong, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulczynski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Lago, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunetto, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartsmann, G.</span></span> <span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptor expression in lung cancer</span>. <i>Arch. Pathol. Lab. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.5858/arpa.2012-0679-OA</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.5858%2Farpa.2012-0679-OA" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=24377816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2014&pages=98-104&issue=1&author=J.+Matteiauthor=R.+D.+Achcarauthor=C.+H.+Canoauthor=B.+R.+Macedoauthor=L.+Meurerauthor=B.+S.+Batlleauthor=S.+D.+Groshongauthor=J.+M.+Kulczynskiauthor=R.+Roeslerauthor=L.+Dal+Lagoauthor=A.+T.+Brunettoauthor=G.+Schwartsmann&title=Gastrin-releasing+peptide+receptor+expression+in+lung+cancer&doi=10.5858%2Farpa.2012-0679-OA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-releasing peptide receptor expression in lung cancer</span></div><div class="casAuthors">Mattei, Jane; Achcar, Rosane; Cano, Carlos H.; Macedo, Bruno R.; Meurer, Luise; Batlle, Brenda S.; Groshong, Steve D.; Kulczynski, Jane M.; Roesler, Rafael; Dal Lago, Lissandra; Brunetto, Andre T.; Schwarstsmann, Gilberto</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pathology & Laboratory Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-104</span>CODEN:
                <span class="NLM_cas:coden">APLMAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-9985</span>.
    
            (<span class="NLM_cas:orgname">College of American Pathologists</span>)
        </div><div class="casAbstract">Gastrin-releasing peptide receptors (GRPRs) activate mitogen-activated protein kinase signaling pathway primarily through epidermal growth factor receptor activation and are under investigation as a mol. target because they are overexpressed in several solid tumors.  Objective.-To det. GRPR expression in both non-small cell lung carcinoma and small cell lung carcinoma, comparing results with clin. stages and demog. data.  Design.-We analyzed the immunohistochem. expression of GRPR in 200 non-small cell lung carcinoma and 38 small cell lung carcinoma archival cases from 2004 to 2008.  Results.-Non-small cell lung carcinoma cases tended to be higher GRPR expressers at a rate of 62.5% (weak, moderate, and strong expression in 41.5%, 13.5%, and 7.5%, resp.), compared with 52.62% in small cell lung carcinoma cases (weak, moderate, and strong expression in 34.21%, 15.78%, and 2.63%, resp.; P = .30).  In non-small cell lung carcinoma there was a trend for higher percentages of strong expression in adenocarcinoma cases (10%; P = .67), and in patients with advanced stages (III and IV; 9.43% and 6.9%; P = .01).  Conclusions.-To the best of our knowledge, this is the first study to demonstrate GRPR tissue expression in a large population of patients with lung cancer.  Although GRPR expression was similar in small cell and non-small cell carcinoma, the expression was more pronounced in an advanced-stage lung cancer, particularly in adenocarcinoma cases, and may represent a potential target for the development of new treatment approaches in this population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5PjaDjbkMx7Vg90H21EOLACvtfcHk0ligs8NcT7yBCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlClurs%253D&md5=0d0675bafcd3d2f1bfc423f93177a278</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.5858%2Farpa.2012-0679-OA&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5858%252Farpa.2012-0679-OA%26sid%3Dliteratum%253Aachs%26aulast%3DMattei%26aufirst%3DJ.%26aulast%3DAchcar%26aufirst%3DR.%2BD.%26aulast%3DCano%26aufirst%3DC.%2BH.%26aulast%3DMacedo%26aufirst%3DB.%2BR.%26aulast%3DMeurer%26aufirst%3DL.%26aulast%3DBatlle%26aufirst%3DB.%2BS.%26aulast%3DGroshong%26aufirst%3DS.%2BD.%26aulast%3DKulczynski%26aufirst%3DJ.%2BM.%26aulast%3DRoesler%26aufirst%3DR.%26aulast%3DDal%2BLago%26aufirst%3DL.%26aulast%3DBrunetto%26aufirst%3DA.%2BT.%26aulast%3DSchwartsmann%26aufirst%3DG.%26atitle%3DGastrin-releasing%2520peptide%2520receptor%2520expression%2520in%2520lung%2520cancer%26jtitle%3DArch.%2520Pathol.%2520Lab.%2520Med.%26date%3D2014%26volume%3D138%26issue%3D1%26spage%3D98%26epage%3D104%26doi%3D10.5858%2Farpa.2012-0679-OA" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmuckli-Maurer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaer, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugger, M.</span></span> <span> </span><span class="NLM_article-title">Bombesin receptor subtypes in human cancers: detection with the universal radioligand <sup>125</sup>I-[D-Tyr<sup>6</sup>,beta-Ala<sup>11</sup>,Phe<sup>13</sup>,Nle<sup>14</sup>]bombesin(6–14)</span>. <i>Clin. Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1139</span>– <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=11948125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsF2lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1139-1146&issue=4&author=J.+C.+Reubiauthor=S.+Wengerauthor=J.+Schmuckli-Maurerauthor=J.+C.+Schaerauthor=M.+Gugger&title=Bombesin+receptor+subtypes+in+human+cancers%3A+detection+with+the+universal+radioligand+125I-%5BD-Tyr6%2Cbeta-Ala11%2CPhe13%2CNle14%5Dbombesin%286%E2%80%9314%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin receptor subtypes in human cancers: detection with the universal radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14] bombesin(6-14)</span></div><div class="casAuthors">Reubi, Jean Claude; Wenger, Sandra; Schmuckli-Maurer, Jacqueline; Schaer, Jean-Claude; Gugger, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1139-1146</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bombesin and bombesin receptors have been shown to play a role in cancer.  Whereas the gastrin-releasing peptide (GRP) receptor is a bombesin receptor subtype frequently expressed by tumors, the other three subtypes, the neuromedin B (NMB), BB3, and BB4 receptors, have been poorly investigated in human tissues.  We investigated 161 human tumors for their bombesin receptor subtype expression using in vitro receptor autoradiog. with the universal bombesin radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14]bombesin(6-14) in displacement expts. with unlabeled GRP, bombesin, NMB, and [D-Tyr6, β-Ala11, Phe13, Nle14]bombesin(6-14).  The distinct rank order of potencies of these analogs for each receptor subtype allows us to identify the predominant subtype expressed by each tumor.  Twelve of 12 prostate cancers, 41 of 57 breast cancers, and 5 of 5 gastrinomas expressed predominantly GRP receptors; 11 of 24 intestinal, 1 of 26 bronchial, and 1 of 1 thymic carcinoids had preferentially NMB receptors; 9 of 26 bronchial carcinoids, 1 large cell neuroendocrine lung carcinoma, and 4 of 9 small cell lung carcinomas had preferentially BB3 receptors, whereas 3 of 9 small cell lung carcinomas had GRP receptors.  Renal cell carcinomas had GRP receptors in 6 of 16 cases and BB3 receptors in 4 of 16 cases.  Finally, 2 of 10 Ewing sarcomas had BB3 receptors.  In situ hybridization detected BB3 receptor mRNA in neuroendocrine tumors expressing the BB3 protein.  This is the first study detecting the proteins of BB3, NMB, and GRP receptors in a group of human tumors using differential binding techniques.  Particularly relevant is the BB3 expression in lung carcinoids and other neuroendocrine lung tumors, whereas gastrointestinal carcinoids preferably express NMB receptors.  These tumors may be targets for diagnostic and radiotherapeutic applications of subtype-selective bombesin analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRfYyxkp7qw7Vg90H21EOLACvtfcHk0liRwjSpP2fKTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsF2lt7w%253D&md5=a50d221d981065374b9facaae5744ee7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWenger%26aufirst%3DS.%26aulast%3DSchmuckli-Maurer%26aufirst%3DJ.%26aulast%3DSchaer%26aufirst%3DJ.%2BC.%26aulast%3DGugger%26aufirst%3DM.%26atitle%3DBombesin%2520receptor%2520subtypes%2520in%2520human%2520cancers%253A%2520detection%2520with%2520the%2520universal%2520radioligand%2520125I-%255BD-Tyr6%252Cbeta-Ala11%252CPhe13%252CNle14%255Dbombesin%25286%25E2%2580%259314%2529%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2002%26volume%3D8%26issue%3D4%26spage%3D1139%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Körner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzucchelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, L.</span></span> <span> </span><span class="NLM_article-title">High expression of peptide receptors as a novel target in gastrointestinal stromal tumours</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">803</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1007/s00259-004-1476-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-004-1476-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=14985869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVensLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=803-810&issue=6&author=J.+C.+Reubiauthor=M.+K%C3%B6rnerauthor=B.+Waserauthor=L.+Mazzucchelliauthor=L.+Guillou&title=High+expression+of+peptide+receptors+as+a+novel+target+in+gastrointestinal+stromal+tumours&doi=10.1007%2Fs00259-004-1476-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">High expression of peptide receptors as a novel target in gastrointestinal stromal tumours</span></div><div class="casAuthors">Reubi, Jean Claude; Koerner, Meike; Waser, Beatrice; Mazzucchelli, Luca; Guillou, Louis</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-810</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Recent significant advances in understanding the biol. of gastrointestinal stromal tumors (GIST) have led to the introduction of a new targeted therapy (imatinib mesylate, Glivec).  Hopes of a new era of a specific cancer therapy, however, have been tempered by the recognition that a significant proportion of patients who initially respond to the drug eventually become resistant to it.  Given the successful development of peptide receptor scintigraphy and radiotherapy for neuroendocrine tumors, we postulated that a similar approach could offer a valid alternative in the diagnosis and therapy of GIST.  Using in vitro receptor autoradiog. to measure peptide receptors, we found that 16/19 GIST expressed bombesin subtype 2 receptors, 16/19 expressed vasoactive intestinal peptide subtype 2 receptors (VPAC2) and 12/19 expressed cholecystokinin subtype 2 receptors, in most cases in extremely high densities.  All GIST metastases were shown to express two or more of these peptide receptors in very high d.  Receptors were also expressed in non-responders to Glivec or after chemo-embolization.  Conversely, somatostatin subtype 2, cholecystokinin subtype 1, bombesin subtype 1 and 3, and neuropeptide Y subtype Y1 and Y2 receptors were not or only rarely expressed.  These data represent a strong mol. basis for the use of radiolabeled bombesin, vasoactive intestinal peptide and/or cholecystokinin analogs as targeting agents to localize GIST tumors in patients by in vivo scintigraphy and/or to perform targeted radiotherapy to destroy GIST primaries, metastases and recurrences, including those resistant to Glivec.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8m05Q69YNn7Vg90H21EOLACvtfcHk0liRwjSpP2fKTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVensLY%253D&md5=da4ac9e0312a7f82fc6bc7be3e46fe10</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00259-004-1476-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-004-1476-2%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DK%25C3%25B6rner%26aufirst%3DM.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DMazzucchelli%26aufirst%3DL.%26aulast%3DGuillou%26aufirst%3DL.%26atitle%3DHigh%2520expression%2520of%2520peptide%2520receptors%2520as%2520a%2520novel%2520target%2520in%2520gastrointestinal%2520stromal%2520tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2004%26volume%3D31%26issue%3D6%26spage%3D803%26epage%3D810%26doi%3D10.1007%2Fs00259-004-1476-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleischmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms</span>. <i>Cell Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=17726264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFWju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=421-433&issue=5&author=A.+Fleischmannauthor=B.+Waserauthor=J.+C.+Reubi&title=Overexpression+of+gastrin-releasing+peptide+receptors+in+tumor-associated+blood+vessels+of+human+ovarian+neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms</span></div><div class="casAuthors">Fleischmann, Achim; Waser, Beatrice; Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-433</span>CODEN:
                <span class="NLM_cas:coden">COENCD</span>;
        ISSN:<span class="NLM_cas:issn">1570-5870</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: Peptide receptors, overexpressed in specific cancers, represent new diagnostic and therapeutic targets.  In this study, receptors for the gastrin-releasing peptide (GRP), and other members of the bombesin-family of peptides, were evaluated in ovarian neoplasms.  Methods: 75 primary, secondary and metastatic ovarian tumors were investigated for their bombesin-receptor subtype expression, incidence, localization and d. using in vitro autoradiog. on tissue sections with the universal radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14]-bombesin(6-14) and the GRP-receptor subtype-preferring 125I-[Tyr4]-bombesin.  Results: GRP-receptors were detected in 42/61 primary ovarian tumors; other bombesin-receptor subtypes (BB1, bb3) were rarely present (3/61).  Two different tissue compartments expressed GRP-receptors: the tumoral vasculature was the predominant site of GRP-receptor expression (38/61), whereas neoplastic cells more rarely expressed GRP-receptors (14/61).  GRP-receptor pos. vessels were present in the various classes of ovarian tumors; generally, malignant tumors had a higher incidence of GRP-receptor pos. vessels compared to their benign counterparts.  The prevalence of such vessels was particularly high in ovarian carcinomas (16/19) and their metastases (5/5).  The GRP-receptors were expressed in high d. in the muscular vessel wall.  Normal ovary (n = 10) lacked GRP-receptors.  Conclusions: The large amts. of GRP-receptors in ovarian tumor vessels suggest a role in tumoral vasculature and possibly angiogenesis.  Further, these vessels might be targeted in vivo with bombesin analogs for diagnosis or for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSuCVAqLwIu7Vg90H21EOLACvtfcHk0liRwjSpP2fKTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFWju70%253D&md5=22caddb91a0f63efc73b351a079852f7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFleischmann%26aufirst%3DA.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DOverexpression%2520of%2520gastrin-releasing%2520peptide%2520receptors%2520in%2520tumor-associated%2520blood%2520vessels%2520of%2520human%2520ovarian%2520neoplasms%26jtitle%3DCell%2520Oncol.%26date%3D2007%26volume%3D29%26issue%3D5%26spage%3D421%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, S.</span></span> <span> </span><span class="NLM_article-title">Targeting prostate cancer with radiolabelled bombesins</span>. <i>Cancer Imaging</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1102/1470-7330.2006.0025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1102%2F1470-7330.2006.0025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=153-157&author=T.+Mainaauthor=B.+Nockauthor=S.+Mather&title=Targeting+prostate+cancer+with+radiolabelled+bombesins&doi=10.1102%2F1470-7330.2006.0025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1102%2F1470-7330.2006.0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1102%252F1470-7330.2006.0025%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMather%26aufirst%3DS.%26atitle%3DTargeting%2520prostate%2520cancer%2520with%2520radiolabelled%2520bombesins%26jtitle%3DCancer%2520Imaging%26date%3D2006%26volume%3D6%26spage%3D153%26epage%3D157%26doi%3D10.1102%2F1470-7330.2006.0025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span> <span> </span><span class="NLM_article-title">From bench to bed: new gastrin-releasing peptide receptor-directed radioligands and their use in prostate cancer</span>. <i>PET Clin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1016/j.cpet.2016.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2Fj.cpet.2016.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=28267454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADC%252BC1czjs1Sitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=205-217&issue=2&author=T.+Mainaauthor=B.+A.+Nock&title=From+bench+to+bed%3A+new+gastrin-releasing+peptide+receptor-directed+radioligands+and+their+use+in+prostate+cancer&doi=10.1016%2Fj.cpet.2016.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">From Bench to Bed: New Gastrin-Releasing Peptide Receptor-Directed Radioligands and Their Use in Prostate Cancer</span></div><div class="casAuthors">Maina Theodosia; Nock Berthold A</div><div class="citationInfo"><span class="NLM_cas:title">PET clinics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-217</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gastrin-releasing peptide receptors (GRPRs) are overexpressed in prostate and breast cancer, and are therefore attractive molecular targets for diagnosis and therapy with radiolabeled GRPR-directed peptide probes.  The amphibian tetradecapeptide bombesin or the mammalian gastrin-releasing peptide and neuromedin C have been modified with a variety of chelators.  As a result, labeling with radiometals attractive for SPECT or PET imaging and for radionuclide therapy has led to the development of peptide radioligands suitable for in vivo targeting of prostate cancer.  A shift of paradigm from internalizing GRPR-agonists to antagonists has occurred owing to the higher biosafety and superior pharmacokinetics of radioantagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8kZQs422J5rjnyZkbE8yXfW6udTcc2eYDjBNjv0FFxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czjs1Sitg%253D%253D&md5=da743260b2950b940d5df67c980e3128</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cpet.2016.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cpet.2016.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%2BA.%26atitle%3DFrom%2520bench%2520to%2520bed%253A%2520new%2520gastrin-releasing%2520peptide%2520receptor-directed%2520radioligands%2520and%2520their%2520use%2520in%2520prostate%2520cancer%26jtitle%3DPET%2520Clin.%26date%3D2017%26volume%3D12%26issue%3D2%26spage%3D205%26epage%3D217%26doi%3D10.1016%2Fj.cpet.2016.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos-Alvarez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1517/14728222.2016.1164694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1517%2F14728222.2016.1164694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=26981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlOks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=1055-1073&issue=9&author=P.+Morenoauthor=I.+Ramos-Alvarezauthor=T.+W.+Moodyauthor=R.+T.+Jensen&title=Bombesin+related+peptides%2Freceptors+and+their+promising+therapeutic+roles+in+cancer+imaging%2C+targeting+and+treatment&doi=10.1517%2F14728222.2016.1164694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment</span></div><div class="casAuthors">Moreno, Paola; Ramos-Alvarez, Irene; Moody, Terry W.; Jensen, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1055-1073</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Despite remarkable advances in tumor treatment, many patients still die from common tumors (breast, prostate, lung, CNS, colon, and pancreas), and thus, new approaches are needed.  Many of these tumors synthesize bombesin (Bn)-related peptides and over-express their receptors (BnRs), hence functioning as autocrine-growth-factors.  Recent studies support the conclusion that Bn-peptides/BnRs are well-positioned for numerous novel antitumor treatments, including interrupting autocrine-growth and the use of over-expressed receptors for imaging and targeting cytotoxic-compds., either by direct-coupling or combined with nanoparticle-technol.  The unique ability of common neoplasms to synthesize, secrete, and show a growth/proliferative/differentiating response due to BnR over-expression, is reviewed, both in general and with regard to the most frequently investigated neoplasms (breast, prostate, lung, and CNS).  Particular attention is paid to advances in the recent years.  Also considered are the possible therapeutic approaches to the growth/differentiation effect of Bn-peptides, as well as the therapeutic implication of the frequent BnR over-expression for tumor-imaging and/or targeted-delivery.  Given that Bn-related-peptides/BnRs are so frequently ectopically-expressed by common tumors, which are often malignant and become refractory to conventional treatments, therapeutic interventions using novel approaches to Bn-peptides and receptors are being explored.  Of particular interest is the potential of reproducing with BnRs in common tumors the recent success of utilizing overexpression of somatostatin-receptors by neuroendocrine-tumors to provide the most sensitive imaging methods and targeted delivery of cytotoxic-compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRQJtC-I7OeLVg90H21EOLACvtfcHk0lg1nnsPU_VSkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlOks7s%253D&md5=0861d12da0993c6bd32f2dba1dd2f955</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F14728222.2016.1164694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2016.1164694%26sid%3Dliteratum%253Aachs%26aulast%3DMoreno%26aufirst%3DP.%26aulast%3DRamos-Alvarez%26aufirst%3DI.%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DBombesin%2520related%2520peptides%252Freceptors%2520and%2520their%2520promising%2520therapeutic%2520roles%2520in%2520cancer%2520imaging%252C%2520targeting%2520and%2520treatment%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2016%26volume%3D20%26issue%3D9%26spage%3D1055%26epage%3D1073%26doi%3D10.1517%2F14728222.2016.1164694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delle Fave, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annibale, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Magistris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruzzone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puoti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torsoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erspamer, V.</span></span> <span> </span><span class="NLM_article-title">Bombesin effects on human GI functions</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">Suppl. 3</span>),  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/0196-9781(85)90360-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0196-9781%2885%2990360-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1985&pages=113-116&issue=Suppl.+3&author=G.+Delle+Faveauthor=B.+Annibaleauthor=L.+de+Magistrisauthor=C.+Severiauthor=R.+Bruzzoneauthor=M.+Puotiauthor=P.+Melchiorriauthor=A.+Torsoliauthor=V.+Erspamer&title=Bombesin+effects+on+human+GI+functions&doi=10.1016%2F0196-9781%2885%2990360-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0196-9781%2885%2990360-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0196-9781%252885%252990360-2%26sid%3Dliteratum%253Aachs%26aulast%3DDelle%2BFave%26aufirst%3DG.%26aulast%3DAnnibale%26aufirst%3DB.%26aulast%3Dde%2BMagistris%26aufirst%3DL.%26aulast%3DSeveri%26aufirst%3DC.%26aulast%3DBruzzone%26aufirst%3DR.%26aulast%3DPuoti%26aufirst%3DM.%26aulast%3DMelchiorri%26aufirst%3DP.%26aulast%3DTorsoli%26aufirst%3DA.%26aulast%3DErspamer%26aufirst%3DV.%26atitle%3DBombesin%2520effects%2520on%2520human%2520GI%2520functions%26jtitle%3DPeptides%26date%3D1985%26volume%3D6%26issue%3DSuppl.%25203%26spage%3D113%26epage%3D116%26doi%3D10.1016%2F0196-9781%2885%2990360-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruzzone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburrano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauceri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annibale, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Magistris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delle Fave, G.</span></span> <span> </span><span class="NLM_article-title">Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man</span>. <i>J. Clin. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1210/jcem-56-4-643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1210%2Fjcem-56-4-643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=6339534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADyaL3sXktFKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1983&pages=643-647&issue=4&author=R.+Bruzzoneauthor=G.+Tamburranoauthor=A.+Lalaauthor=M.+Mauceriauthor=B.+Annibaleauthor=C.+Severiauthor=L.+de+Magistrisauthor=F.+Leonettiauthor=G.+Delle+Fave&title=Effect+of+bombesin+on+plasma+insulin%2C+pancreatic+glucagon%2C+and+gut+glucagon+in+man&doi=10.1210%2Fjcem-56-4-643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man</span></div><div class="casAuthors">Bruzzone, R.; Tamburrano, G.; Lala, A.; Mauceri, M.; Annibale, B.; Severi, Carola; De Magistris, Laura; Leonetti, Frida; Delle Fave, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">643-7</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">The effect of bombesin [31362-50-2] on insulin [9004-10-8], pancreatic glucagon [9007-92-5], and gut glucagon [62340-29-8] was investigated in healthy volunteers and pancreatectomized patients.  Bombesin (5 ng/kg/min, i.v) produced a sharp rise in the plasma insulin concn.  The peak was reached at 5 min (26 μU/mL); followed by a prolonged decrease in blood glucose.  Pancreatic glucagon rapidly rose to a maximal value of 80.5 pmol/L.  In contrast with the prompt increase in insulin and glucagon plasma levels, the peak in gut glucagon concn. (55.8 pmol/L) was reached 30 min after bombesin infusion was discontinued.  In the 2 pancreatectomized patients, bombesin induced an increase in gut glucagon concns. only.  Apparently, bombesin acts directly on the A and B cells of the pancreas, influencing glucose homeostasis; however, more complex mechanisms seem to be involved in gut glucagon secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjsKsC2G2cp7Vg90H21EOLACvtfcHk0lg1nnsPU_VSkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXktFKqt7c%253D&md5=7144703b752a0b3b4d49173aeea43f21</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1210%2Fjcem-56-4-643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-56-4-643%26sid%3Dliteratum%253Aachs%26aulast%3DBruzzone%26aufirst%3DR.%26aulast%3DTamburrano%26aufirst%3DG.%26aulast%3DLala%26aufirst%3DA.%26aulast%3DMauceri%26aufirst%3DM.%26aulast%3DAnnibale%26aufirst%3DB.%26aulast%3DSeveri%26aufirst%3DC.%26aulast%3Dde%2BMagistris%26aufirst%3DL.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DDelle%2BFave%26aufirst%3DG.%26atitle%3DEffect%2520of%2520bombesin%2520on%2520plasma%2520insulin%252C%2520pancreatic%2520glucagon%252C%2520and%2520gut%2520glucagon%2520in%2520man%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1983%26volume%3D56%26issue%3D4%26spage%3D643%26epage%3D647%26doi%3D10.1210%2Fjcem-56-4-643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bitar, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. X.</span></span> <span> </span><span class="NLM_article-title">Expression of bombesin-receptor subtypes and their differential regulation of colonic smooth muscle contraction</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1672</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1016/0016-5085(93)91062-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0016-5085%2893%2991062-M" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1993&pages=1672-1680&issue=6&author=K.+N.+Bitarauthor=X.+X.+Zhu&title=Expression+of+bombesin-receptor+subtypes+and+their+differential+regulation+of+colonic+smooth+muscle+contraction&doi=10.1016%2F0016-5085%2893%2991062-M"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0016-5085%2893%2991062-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0016-5085%252893%252991062-M%26sid%3Dliteratum%253Aachs%26aulast%3DBitar%26aufirst%3DK.%2BN.%26aulast%3DZhu%26aufirst%3DX.%2BX.%26atitle%3DExpression%2520of%2520bombesin-receptor%2520subtypes%2520and%2520their%2520differential%2520regulation%2520of%2520colonic%2520smooth%2520muscle%2520contraction%26jtitle%3DGastroenterology%26date%3D1993%26volume%3D105%26issue%3D6%26spage%3D1672%26epage%3D1680%26doi%3D10.1016%2F0016-5085%2893%2991062-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scardino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiberini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bufi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Cobelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paganelli, G.</span></span> <span> </span><span class="NLM_article-title"><sup>177</sup>Lu-AMBA bombesin analogue in hormone refractory prostate cancer patients: a phase I escalation study with single-cycle administrations</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">S221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=S221&issue=Suppl.+2&author=L.+Bodeiauthor=M.+Ferrariauthor=A.+Nunnauthor=J.+Llullauthor=M.+Cremonesiauthor=L.+Martanoauthor=G.+Lauroraauthor=E.+Scardinoauthor=S.+Tiberiniauthor=G.+Bufiauthor=S.+Eatonauthor=O.+de+Cobelliauthor=G.+Paganelli&title=177Lu-AMBA+bombesin+analogue+in+hormone+refractory+prostate+cancer+patients%3A+a+phase+I+escalation+study+with+single-cycle+administrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodei%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DNunn%26aufirst%3DA.%26aulast%3DLlull%26aufirst%3DJ.%26aulast%3DCremonesi%26aufirst%3DM.%26aulast%3DMartano%26aufirst%3DL.%26aulast%3DLaurora%26aufirst%3DG.%26aulast%3DScardino%26aufirst%3DE.%26aulast%3DTiberini%26aufirst%3DS.%26aulast%3DBufi%26aufirst%3DG.%26aulast%3DEaton%26aufirst%3DS.%26aulast%3Dde%2BCobelli%26aufirst%3DO.%26aulast%3DPaganelli%26aufirst%3DG.%26atitle%3D177Lu-AMBA%2520bombesin%2520analogue%2520in%2520hormone%2520refractory%2520prostate%2520cancer%2520patients%253A%2520a%2520phase%2520I%2520escalation%2520study%2520with%2520single-cycle%2520administrations%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2007%26volume%3D34%26issue%3DSuppl.%25202%26spage%3DS221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiotellis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loudos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maintas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span> <span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1007/s00259-002-1040-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-002-1040-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=12552343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1CntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=247-258&issue=2&author=B.+Nockauthor=A.+Nikolopoulouauthor=E.+Chiotellisauthor=G.+Loudosauthor=D.+Maintasauthor=J.+C.+Reubiauthor=T.+Maina&title=%5B99mTc%5DDemobesin+1%2C+a+novel+potent+bombesin+analogue+for+GRP+receptor-targeted+tumour+imaging&doi=10.1007%2Fs00259-002-1040-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging</span></div><div class="casAuthors">Nock, Berthold; Nikolopoulou, Anastasia; Chiotellis, Efstratios; Loudos, George; Maintas, Dimitrios; Reubi, Jean Claude; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Demobesin 1 is a potent new GRP-R-selective bombesin (BN) analog contg. an open chain tetraamine chelator for stable technetium-99m binding.  Following a convenient labeling protocol, the radiopeptide, [99mTc]Demobesin 1, formed in nearly quant. yields and with high specific activities.  Both unlabeled and labeled peptide demonstrated high-affinity binding in membrane prepns. of the human androgen-independent prostate adenocarcinoma PC-3 cell line.  The IC50 values detd. for Demobesin 1 and [Tyr4]BN were 0.70±0.08 nM and 1.5±0.20 nM, resp., while the Kd defined for [99mTc/99gTc]Demobesin 1 was 0.67±0.10 nM. [99mTc]Demobesin 1 was rather stable in murine plasma, whereas it degraded rapidly in kidney and liver homogenates.  After injection in healthy Swiss albino mice, [99mTc]Demobesin 1 accumulated very efficiently in the target organs (pancreas, intestinal tract) via a GRP-R-mediated process, as shown by in vivo receptor blocking expts.  An equally high and GRP-R-mediated uptake was exhibited by [99mTc]Demobesin 1 after injection in PC-3 tumor-bearing athymic mice.  The initial high radioligand uptake of 16.2±3.1%ID/g in the PC-3 xenografts at 1 h p.i. remained at a similar level (15.61±1.19%ID/g) at 4 h p.i.  Even after 24 h p.i., when the radioactivity had cleared from all other tissues, a value of 5.24±0.67%ID/g was still obsd. in the tumor.  The high and prolonged localization of [99mTc]Demobesin 1 at the tumor site and its rapid background clearance are very promising qualities for GRP-R-targeted tumor imaging in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_PXKboVxArVg90H21EOLACvtfcHk0lgiefn0bnQuzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1CntA%253D%253D&md5=19ebcbebcf11cac029412ad304113f77</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-1040-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-1040-x%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DChiotellis%26aufirst%3DE.%26aulast%3DLoudos%26aufirst%3DG.%26aulast%3DMaintas%26aufirst%3DD.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3D%255B99mTc%255DDemobesin%25201%252C%2520a%2520novel%2520potent%2520bombesin%2520analogue%2520for%2520GRP%2520receptor-targeted%2520tumour%2520imaging%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26issue%3D2%26spage%3D247%26epage%3D258%26doi%3D10.1007%2Fs00259-002-1040-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantey, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frucht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1021/bi00455a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00455a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=616-622&issue=3&author=L.+H.+Wangauthor=D.+H.+Coyauthor=J.+E.+Taylorauthor=N.+Y.+Jiangauthor=S.+H.+Kimauthor=J.+P.+Moreauauthor=S.+C.+Huangauthor=S.+A.+Manteyauthor=H.+Fruchtauthor=R.+T.+Jensen&title=Desmethionine+alkylamide+bombesin+analogues%3A+a+new+class+of+bombesin+receptor+antagonists+with+potent+antisecretory+activity+in+pancreatic+acini+and+antimitotic+activity+in+Swiss+3T3+cells&doi=10.1021%2Fbi00455a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbi00455a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00455a004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DTaylor%26aufirst%3DJ.%2BE.%26aulast%3DJiang%26aufirst%3DN.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DMoreau%26aufirst%3DJ.%2BP.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DMantey%26aufirst%3DS.%2BA.%26aulast%3DFrucht%26aufirst%3DH.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DDesmethionine%2520alkylamide%2520bombesin%2520analogues%253A%2520a%2520new%2520class%2520of%2520bombesin%2520receptor%2520antagonists%2520with%2520potent%2520antisecretory%2520activity%2520in%2520pancreatic%2520acini%2520and%2520antimitotic%2520activity%2520in%2520Swiss%25203T3%2520cells%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26issue%3D3%26spage%3D616%26epage%3D622%26doi%3D10.1021%2Fbi00455a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frucht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haffar, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title"><i>des</i>-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>265</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">15695</span>– <span class="NLM_lpage">15703</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=15695-15703&issue=26&author=L.+H.+Wangauthor=D.+H.+Coyauthor=J.+E.+Taylorauthor=N.+Y.+Jiangauthor=J.+P.+Moreauauthor=S.+C.+Huangauthor=H.+Fruchtauthor=B.+M.+Haffarauthor=R.+T.+Jensen&title=des-Met+carboxyl-terminally+modified+analogues+of+bombesin+function+as+potent+bombesin+receptor+antagonists%2C+partial+agonists%2C+or+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DTaylor%26aufirst%3DJ.%2BE.%26aulast%3DJiang%26aufirst%3DN.%2BY.%26aulast%3DMoreau%26aufirst%3DJ.%2BP.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DFrucht%26aufirst%3DH.%26aulast%3DHaffar%26aufirst%3DB.%2BM.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3Ddes-Met%2520carboxyl-terminally%2520modified%2520analogues%2520of%2520bombesin%2520function%2520as%2520potent%2520bombesin%2520receptor%2520antagonists%252C%2520partial%2520agonists%252C%2520or%2520agonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26issue%3D26%26spage%3D15695%26epage%3D15703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordopatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span> <span> </span><span class="NLM_article-title">Potent bombesin-like peptides for GRP-receptor targeting of tumors with <sup>99m</sup>Tc: a preclinical study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1021/jm049437y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049437y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=100-110&issue=1&author=B.+A.+Nockauthor=A.+Nikolopoulouauthor=A.+Galanisauthor=P.+Cordopatisauthor=B.+Waserauthor=J.+C.+Reubiauthor=T.+Maina&title=Potent+bombesin-like+peptides+for+GRP-receptor+targeting+of+tumors+with+99mTc%3A+a+preclinical+study&doi=10.1021%2Fjm049437y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm049437y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049437y%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DGalanis%26aufirst%3DA.%26aulast%3DCordopatis%26aufirst%3DP.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DPotent%2520bombesin-like%2520peptides%2520for%2520GRP-receptor%2520targeting%2520of%2520tumors%2520with%252099mTc%253A%2520a%2520preclinical%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D1%26spage%3D100%26epage%3D110%26doi%3D10.1021%2Fjm049437y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mather, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobnack, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colebrook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halberrt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szysko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powles, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avril, N.</span></span> <span> </span><span class="NLM_article-title">GRP receptor imaging of prostate cancer using [<sup>99m</sup>Tc]Demobesin 4: a first-in-man study</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">895</span>, <span class="refDoi"> DOI: 10.1007/s11307-014-0754-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs11307-014-0754-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=24915934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADC%252BC2cfhtVCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=888-895&issue=6&author=S.+J.+Matherauthor=B.+A.+Nockauthor=T.+Mainaauthor=V.+Gibsonauthor=D.+Ellisonauthor=I.+Murrayauthor=R.+Sobnackauthor=S.+Colebrookauthor=S.+Wanauthor=G.+Halberrtauthor=T.+Szyskoauthor=T.+Powlesauthor=N.+Avril&title=GRP+receptor+imaging+of+prostate+cancer+using+%5B99mTc%5DDemobesin+4%3A+a+first-in-man+study&doi=10.1007%2Fs11307-014-0754-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">GRP receptor imaging of prostate cancer using [(99m)Tc]Demobesin 4: a first-in-man study</span></div><div class="casAuthors">Mather Stephen J; Nock Berthold A; Maina Theodosia; Gibson Vickie; Ellison David; Murray Iain; Sobnack Ravin; Colebrook Steve; Wan Susan; Halberrt Gavin; Szysko Teresa; Powles Thomas; Avril Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">888-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  We explored the imaging of bombesin receptors and evaluated the clinical use of [(99m)Tc]Demobesin 4 ([(99m)Tc]DB4) in prostate cancer patients.  PROCEDURES:  [(99m)Tc]DB4 was prepared according to Good Manufacturing Practice.  Patients with prostate cancer underwent serial planar and SPECT imaging up to 3 h after administration.  Blood and urine samples were taken to assess pharmacokinetics.  RESULTS:  [(99m)Tc]DB4 is safe and clears rapidly from the bloodstream via the kidneys resulting in low background activity.  The tracer binds strongly to the gastrin-releasing peptide receptor (GRPR) in vivo as indicated by the high uptake in the pancreas seen in all patients.  In patients who had undergone hormone therapy, [(99m)Tc]DB4 did not efficiently image metastatic prostate cancer.  In contrast, in newly diagnosed patients local disease was visualised.  CONCLUSIONS:  The GRPR is an unsuitable target for imaging refractory prostate cancer but may be useful in untreated disease. [(99m)Tc]DB4 is a promising radiopharmaceutical which merits further exploration in this specific group of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSccUKpYUtPKd-cVm4E2RlLfW6udTcc2eaK7eChOwjTpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfhtVCltg%253D%253D&md5=c473b529191f8d6c6d8251e29e891755</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11307-014-0754-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-014-0754-z%26sid%3Dliteratum%253Aachs%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DGibson%26aufirst%3DV.%26aulast%3DEllison%26aufirst%3DD.%26aulast%3DMurray%26aufirst%3DI.%26aulast%3DSobnack%26aufirst%3DR.%26aulast%3DColebrook%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DS.%26aulast%3DHalberrt%26aufirst%3DG.%26aulast%3DSzysko%26aufirst%3DT.%26aulast%3DPowles%26aufirst%3DT.%26aulast%3DAvril%26aufirst%3DN.%26atitle%3DGRP%2520receptor%2520imaging%2520of%2520prostate%2520cancer%2520using%2520%255B99mTc%255DDemobesin%25204%253A%2520a%2520first-in-man%2520study%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2014%26volume%3D16%26issue%3D6%26spage%3D888%26epage%3D895%26doi%3D10.1007%2Fs11307-014-0754-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charalambidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccand, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Bombesin receptor antagonists may be preferable to agonists for tumor targeting</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.2967/jnumed.107.045054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.107.045054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=18199616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVOltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=318-326&issue=2&author=R.+Cescatoauthor=T.+Mainaauthor=B.+Nockauthor=A.+Nikolopoulouauthor=D.+Charalambidisauthor=V.+Piccandauthor=J.+C.+Reubi&title=Bombesin+receptor+antagonists+may+be+preferable+to+agonists+for+tumor+targeting&doi=10.2967%2Fjnumed.107.045054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin receptor antagonists may be preferable to agonists for tumor targeting</span></div><div class="casAuthors">Cescato, Renzo; Maina, Theodosia; Nock, Berthold; Nikolopoulou, Anastasia; Charalambidis, David; Piccand, Veronique; Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-326</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Two bombesin analogs, Demobesin 4 and Demobesin 1, were characterized in vitro as gastrin-releasing peptide (GRP) receptor agonist and antagonist, resp., and were compared as 99mTc-labeled ligands for their in vitro and in vivo tumor-targeting properties.  N4-[Pro1,Tyr4,Nle14]Bombesin (Demobesin 4) and N4-[D-Phe6,Leu-NHEt13,des-Met14]bombesin(6-14) (Demobesin 1) were characterized in vitro for their binding properties with GRP receptor autoradiog. using GRP receptor-transfected HEK293 cells, PC3 cells, and human prostate cancer specimens.  Their ability to modulate calcium mobilization in PC3 and transfected HEK293 cells was analyzed as well as their ability to trigger internalization of the GRP receptor in transfected HEK293 cells, as detd. qual. by immunofluorescence microscopy and quant. by ELISA.  Further, their internalization properties as 99mTc-labeled radioligands were tested in vitro in both cell lines.  Finally, their biodistribution was analyzed in PC3 tumor-bearing mice.  A comparable binding affinity with the 50% inhibitory concn. (IC50) in the nanomolar range was measured for Demobesin 4 and Demobesin 1 in all tested tissues.  Demobesin 4 behaved as an agonist by strongly stimulating calcium mobilization and by triggering GRP receptor internalization.  Demobesin 1 was ineffective in stimulating calcium mobilization and in triggering GRP receptor internalization.  However, in these assays, it behaved as a competitive antagonist as it reversed completely the agonist-induced effects in both systems.  99mTc-Labeled Demobesin 1 was only weakly taken up by PC3 cells or GRP receptor-transfected HEK293 cells (10% and 5%, resp., of total added radioactivity) compared with 99mTc-labeled Demobesin 4 (45% of total added radioactivity in both cell lines).  Remarkably, the biodistribution study revealed a much more pronounced uptake at 1, 4, and 24 h after injection of 99mTc-labeled Demobesin 1 in vivo into PC3 tumors than 99mTc-labeled Demobesin 4.  In vivo competition expts. demonstrated a specific uptake in PC3 tumors and in physiol. GRP receptor-expressing tissues.  The tumor-to-kidney ratios were 0.7 for Demobesin 4 and 5.2 for Demobesin 1 at 4 h.  This comparative in vitro/in vivo study with Demobesin 1 and Demobesin 4 indicates that GRP receptor antagonists may be superior targeting agents to GRP receptor agonists, suggesting a change of paradigm in the field of bombesin radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXs6GzVpy9Z7Vg90H21EOLACvtfcHk0lgcU946hW5ptw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVOltb8%253D&md5=bfa0cc7efd90357b7061b39c9722b58a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.107.045054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.107.045054%26sid%3Dliteratum%253Aachs%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DCharalambidis%26aufirst%3DD.%26aulast%3DPiccand%26aufirst%3DV.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DBombesin%2520receptor%2520antagonists%2520may%2520be%2520preferable%2520to%2520agonists%2520for%2520tumor%2520targeting%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26issue%3D2%26spage%3D318%26epage%3D326%26doi%3D10.2967%2Fjnumed.107.045054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamma, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1021/jm5012066</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=682-691&issue=2&author=R.+Mansiauthor=K.+Abirajauthor=X.+Wangauthor=M.+L.+Tammaauthor=E.+Gourniauthor=R.+Cescatoauthor=S.+Berndtauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Evaluation+of+three+different+families+of+bombesin+receptor+radioantagonists+for+targeted+imaging+and+therapy+of+gastrin+releasing+peptide+receptor+%28GRP-R%29+positive+tumors&doi=10.1021%2Fjm5012066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm5012066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012066%26sid%3Dliteratum%253Aachs%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTamma%26aufirst%3DM.%2BL.%26aulast%3DGourni%26aufirst%3DE.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DBerndt%26aufirst%3DS.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DEvaluation%2520of%2520three%2520different%2520families%2520of%2520bombesin%2520receptor%2520radioantagonists%2520for%2520targeted%2520imaging%2520and%2520therapy%2520of%2520gastrin%2520releasing%2520peptide%2520receptor%2520%2528GRP-R%2529%2520positive%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D2%26spage%3D682%26epage%3D691%26doi%3D10.1021%2Fjm5012066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charalambidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krenning, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, R. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [<sup>68</sup>Ga]SB3 and PET/CT</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">964</span>– <span class="NLM_lpage">973</span>, <span class="refDoi"> DOI: 10.1007/s00259-015-3232-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-015-3232-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=26631238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvF2nurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=964-973&issue=5&author=T.+Mainaauthor=H.+Bergsmaauthor=H.+R.+Kulkarniauthor=D.+Muellerauthor=D.+Charalambidisauthor=E.+P.+Krenningauthor=B.+A.+Nockauthor=M.+de+Jongauthor=R.+P.+Baum&title=Preclinical+and+first+clinical+experience+with+the+gastrin-releasing+peptide+receptor-antagonist+%5B68Ga%5DSB3+and+PET%2FCT&doi=10.1007%2Fs00259-015-3232-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT</span></div><div class="casAuthors">Maina, Theodosia; Bergsma, Hendrik; Kulkarni, Harshad R.; Mueller, Dirk; Charalambidis, David; Krenning, Eric P.; Nock, Berthold A.; de Jong, Marion; Baum, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">964-973</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Gastrin-releasing peptide receptors (GRPR) represent attractive targets for tumor diagnosis and therapy because of their overexpression in major human cancers.  Internalizing GRPR agonists were initially proposed for prolonged lesion retention, but a shift of paradigm to GRPR antagonists has recently been made.  Surprisingly, radioantagonists, such as [99mTc]DB1 (99mTc-N4'-DPhe6,Leu-NHEt13BBN(6-13)), displayed better pharmacokinetics than radioagonists, in addn. to their higher inherent biosafety.  We introduce here [68Ga]SB3, a [99mTc]DB1 mimic-carrying, instead of the 99mTc-binding tetraamine, the chelator DOTA for labeling with the PET radiometal 68Ga.  Competition binding assays of SB3 and [natGa]SB3 were conducted against [125I-Tyr4]BBN in PC-3 cell membranes.  Blood samples collected 5 min postinjection (pi) of the [67Ga]SB3 surrogate in mice were analyzed using high-performance liq. chromatog. (HPLC) for degrdn. products.  Likewise, biodistribution was performed after injection of [67Ga]SB3 (37 kBq, 100 μL, 10 pmol peptide) in severe combined immunodeficiency (SCID) mice bearing PC-3 xenografts.  Eventually, [68Ga]SB3 (283 ± 91 MBq, 23 ± 7 nmol) was injected into 17 patients with breast (8) and prostate (9) cancer.  All patients had disseminated disease and had received previous therapies.  PET/CT fusion images were acquired 60-115 min pi.  SB3 and [natGa]SB3 bound to the human GRPR with high affinity (IC50: 4.6 ± 0.5 nM and 1.5 ± 0.3 nM, resp.).  [67Ga]SB3 displayed good in vivo stability (>85 % intact at 5 min pi).  [67Ga]SB3 showed high, GRPR-specific and prolonged retention in PC-3 xenografts (33.1 ± 3.9%ID/g at 1 h pi - 27.0 ± 0.9%ID/g at 24 h pi), but much faster clearance from the GRPR-rich pancreas (≈160%ID/g at 1 h pi to <17%ID/g at 24 h pi) in mice.  In patients, [68Ga]SB3 elicited no adverse effects and clearly visualized cancer lesions.  Thus, 4 out of 8 (50 %) breast cancer and 5 out of 9 (55 %) prostate cancer patients showed pathol. uptake on PET/CT with [68Ga]SB3.  [67Ga]SB3 showed excellent pharmacokinetics in PC-3 tumor-bearing mice, while [68Ga]SB3 PET/CT visualized lesions in about 50 % of patients with advanced and metastasized prostate and breast cancer.  We expect imaging with [68Ga]SB3 to be superior in patients with primary breast or prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJWrBrBlHv_7Vg90H21EOLACvtfcHk0lguQlKOZoTDWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvF2nurzF&md5=ad4cff527edd17d41dc10cec4092ed1b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00259-015-3232-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-015-3232-1%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DBergsma%26aufirst%3DH.%26aulast%3DKulkarni%26aufirst%3DH.%2BR.%26aulast%3DMueller%26aufirst%3DD.%26aulast%3DCharalambidis%26aufirst%3DD.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBaum%26aufirst%3DR.%2BP.%26atitle%3DPreclinical%2520and%2520first%2520clinical%2520experience%2520with%2520the%2520gastrin-releasing%2520peptide%2520receptor-antagonist%2520%255B68Ga%255DSB3%2520and%2520PET%252FCT%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2016%26volume%3D43%26issue%3D5%26spage%3D964%26epage%3D973%26doi%3D10.1007%2Fs00259-015-3232-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaloudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lymperis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giarika, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klette, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krenning, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, R. P.</span></span> <span> </span><span class="NLM_article-title">Theranostic perspectives in prostate cancer with the gastrin-releasing peptide receptor antagonist NeoBOMB1: preclinical and first clinical results</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.2967/jnumed.116.178889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.116.178889" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=75-80&issue=1&author=B.+A.+Nockauthor=A.+Kaloudiauthor=E.+Lymperisauthor=A.+Giarikaauthor=H.+R.+Kulkarniauthor=I.+Kletteauthor=A.+Singhauthor=E.+P.+Krenningauthor=M.+de+Jongauthor=T.+Mainaauthor=R.+P.+Baum&title=Theranostic+perspectives+in+prostate+cancer+with+the+gastrin-releasing+peptide+receptor+antagonist+NeoBOMB1%3A+preclinical+and+first+clinical+results&doi=10.2967%2Fjnumed.116.178889"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.116.178889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.116.178889%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DKaloudi%26aufirst%3DA.%26aulast%3DLymperis%26aufirst%3DE.%26aulast%3DGiarika%26aufirst%3DA.%26aulast%3DKulkarni%26aufirst%3DH.%2BR.%26aulast%3DKlette%26aufirst%3DI.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DBaum%26aufirst%3DR.%2BP.%26atitle%3DTheranostic%2520perspectives%2520in%2520prostate%2520cancer%2520with%2520the%2520gastrin-releasing%2520peptide%2520receptor%2520antagonist%2520NeoBOMB1%253A%2520preclinical%2520and%2520first%2520clinical%2520results%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2017%26volume%3D58%26issue%3D1%26spage%3D75%26epage%3D80%26doi%3D10.2967%2Fjnumed.116.178889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatalic, K. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konijnenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonnekens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Blois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeben, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ridder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gent, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Weerden, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span> <span> </span><span class="NLM_article-title">In vivo stabilization of gastrin-releasing peptide receptor antagonist enhances PET imaging and radionuclide therapy of prostate cancer in preclinical studies</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.7150/thno.13580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.7150%2Fthno.13580" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=104-117&issue=1&author=K.+L.+S.+Chatalicauthor=M.+Konijnenbergauthor=J.+Nonnekensauthor=E.+de+Bloisauthor=S.+Hoebenauthor=C.+de+Ridderauthor=L.+Brunelauthor=J.+A.+Fehrentzauthor=J.+Martinezauthor=D.+C.+van+Gentauthor=B.+A.+Nockauthor=T.+Mainaauthor=W.+M.+van+Weerdenauthor=M.+de+Jong&title=In+vivo+stabilization+of+gastrin-releasing+peptide+receptor+antagonist+enhances+PET+imaging+and+radionuclide+therapy+of+prostate+cancer+in+preclinical+studies&doi=10.7150%2Fthno.13580"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.7150%2Fthno.13580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.13580%26sid%3Dliteratum%253Aachs%26aulast%3DChatalic%26aufirst%3DK.%2BL.%2BS.%26aulast%3DKonijnenberg%26aufirst%3DM.%26aulast%3DNonnekens%26aufirst%3DJ.%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DHoeben%26aufirst%3DS.%26aulast%3Dde%2BRidder%26aufirst%3DC.%26aulast%3DBrunel%26aufirst%3DL.%26aulast%3DFehrentz%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3Dvan%2BGent%26aufirst%3DD.%2BC.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3Dvan%2BWeerden%26aufirst%3DW.%2BM.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DIn%2520vivo%2520stabilization%2520of%2520gastrin-releasing%2520peptide%2520receptor%2520antagonist%2520enhances%2520PET%2520imaging%2520and%2520radionuclide%2520therapy%2520of%2520prostate%2520cancer%2520in%2520preclinical%2520studies%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26issue%3D1%26spage%3D104%26epage%3D117%26doi%3D10.7150%2Fthno.13580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kähkönen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jambor, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemppainen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gronroos, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuisma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luoto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipila, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolvanen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alanen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallajoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roivainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schibli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johayem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borkowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minn, H.</span></span> <span> </span><span class="NLM_article-title">In vivo imaging of prostate cancer using [<sup>68</sup>Ga]-labeled bombesin analog BAY86-7548</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5434</span>– <span class="NLM_lpage">5443</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1158%2F1078-0432.CCR-12-3490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=23935037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADC%252BC3sfosFOlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=5434-5443&issue=19&author=E.+K%C3%A4hk%C3%B6nenauthor=I.+Jamborauthor=J.+Kemppainenauthor=K.+Lehtioauthor=T.+J.+Gronroosauthor=A.+Kuismaauthor=P.+Luotoauthor=H.+J.+Sipilaauthor=T.+Tolvanenauthor=K.+Alanenauthor=J.+Silenauthor=M.+Kallajokiauthor=A.+Roivainenauthor=N.+Schaferauthor=R.+Schibliauthor=M.+Dragicauthor=A.+Johayemauthor=R.+Valenciaauthor=S.+Borkowskiauthor=H.+Minn&title=In+vivo+imaging+of+prostate+cancer+using+%5B68Ga%5D-labeled+bombesin+analog+BAY86-7548&doi=10.1158%2F1078-0432.CCR-12-3490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548</span></div><div class="casAuthors">Kahkonen Esa; Jambor Ivan; Kemppainen Jukka; Lehtio Kaisa; Gronroos Tove J; Kuisma Anna; Luoto Pauliina; Sipila Henri J; Tolvanen Tuula; Alanen Kalle; Silen Jonna; Kallajoki Markku; Roivainen Anne; Schafer Niklaus; Schibli Roger; Dragic Martina; Johayem Anass; Valencia Ray; Borkowski Sandra; Minn Heikki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5434-43</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">PURPOSE:  A novel [(68)Ga]-labeled DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 peptide (BAY86-7548) having high affinity to bombesin receptor subtype II to detect primary and metastatic prostate carcinoma using positron emission tomography/computed tomography (PET/CT) was synthesized and evaluated for prostate cancer.  EXPERIMENTAL DESIGN:  In this first human study with BAY86-7548, 14 men scheduled for radical prostatectomy (n = 11) or with biochemical recurrence after surgery or hormonal therapy (n = 3) were enrolled.  The patients received an intravenous injection of BAY86-7548 followed by over 60-minute dynamic imaging of prostate gland (n = 10) and/or subsequent whole-body imaging (n = 14).  The visual assessment of PET/CT images included evaluation of intraprostatic (12 subsextants) and pelvic nodal uptake of BAY86-7548 in 11 surgical patients and detection of potential metastatic foci in all patients.  In patients with biochemical recurrence, results were compared with those of either [(11)C]-acetate (n = 2) or [(18)F]-fluoromethylcholine (n = 1) PET/CT.  RESULTS:  We found a sensitivity, specificity, and accuracy of 88%, 81% and 83%, respectively, for detection of primary PCa and sensitivity of 70% for metastatic lymph nodes using histology as gold standard.  BAY86-7548 correctly detected local recurrence in prostate bed and showed nodal relapse in accordance with [(11)C]-acetate PET/CT in 2 patients with biochemical relapse.  In the third hormone refractory patient, BAY86-7548 failed to show multiple bone metastases evident on [(18)F]-fluoromethylcholine PET/CT.  CONCLUSION:  BAY86-7548 PET/CT is a promising molecular imaging technique for detecting intraprostatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_j6Lp9PxEt6e0F5ixvZgXfW6udTcc2eZtPscRLzkeBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfosFOlsQ%253D%253D&md5=726d236135632416999951b75b76e9a0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3490%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25A4hk%25C3%25B6nen%26aufirst%3DE.%26aulast%3DJambor%26aufirst%3DI.%26aulast%3DKemppainen%26aufirst%3DJ.%26aulast%3DLehtio%26aufirst%3DK.%26aulast%3DGronroos%26aufirst%3DT.%2BJ.%26aulast%3DKuisma%26aufirst%3DA.%26aulast%3DLuoto%26aufirst%3DP.%26aulast%3DSipila%26aufirst%3DH.%2BJ.%26aulast%3DTolvanen%26aufirst%3DT.%26aulast%3DAlanen%26aufirst%3DK.%26aulast%3DSilen%26aufirst%3DJ.%26aulast%3DKallajoki%26aufirst%3DM.%26aulast%3DRoivainen%26aufirst%3DA.%26aulast%3DSchafer%26aufirst%3DN.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DDragic%26aufirst%3DM.%26aulast%3DJohayem%26aufirst%3DA.%26aulast%3DValencia%26aufirst%3DR.%26aulast%3DBorkowski%26aufirst%3DS.%26aulast%3DMinn%26aufirst%3DH.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520prostate%2520cancer%2520using%2520%255B68Ga%255D-labeled%2520bombesin%2520analog%2520BAY86-7548%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26issue%3D19%26spage%3D5434%26epage%3D5443%26doi%3D10.1158%2F1078-0432.CCR-12-3490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wieser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosu, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultze-Seemann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont-Walter, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, W. A.</span></span> <span> </span><span class="NLM_article-title">Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist–from mice to men</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.7150/thno.7324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.7150%2Fthno.7324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=412-419&issue=4&author=G.+Wieserauthor=R.+Mansiauthor=A.+L.+Grosuauthor=W.+Schultze-Seemannauthor=R.+A.+Dumont-Walterauthor=P.+T.+Meyerauthor=H.+R.+Maeckeauthor=J.+C.+Reubiauthor=W.+A.+Weber&title=Positron+emission+tomography+%28PET%29+imaging+of+prostate+cancer+with+a+gastrin+releasing+peptide+receptor+antagonist%E2%80%93from+mice+to+men&doi=10.7150%2Fthno.7324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.7150%2Fthno.7324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.7324%26sid%3Dliteratum%253Aachs%26aulast%3DWieser%26aufirst%3DG.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DGrosu%26aufirst%3DA.%2BL.%26aulast%3DSchultze-Seemann%26aufirst%3DW.%26aulast%3DDumont-Walter%26aufirst%3DR.%2BA.%26aulast%3DMeyer%26aufirst%3DP.%2BT.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26atitle%3DPositron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520of%2520prostate%2520cancer%2520with%2520a%2520gastrin%2520releasing%2520peptide%2520receptor%2520antagonist%25E2%2580%2593from%2520mice%2520to%2520men%26jtitle%3DTheranostics%26date%3D2014%26volume%3D4%26issue%3D4%26spage%3D412%26epage%3D419%26doi%3D10.7150%2Fthno.7324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span> <span> </span><span class="NLM_article-title">Progress in the development of potent bombesin receptor antagonists</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(91)90483-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0165-6147%2891%2990483-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=13-19&issue=1&author=R.+T.+Jensenauthor=D.+H.+Coy&title=Progress+in+the+development+of+potent+bombesin+receptor+antagonists&doi=10.1016%2F0165-6147%2891%2990483-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990483-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990483-9%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DR.%2BT.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520potent%2520bombesin%2520receptor%2520antagonists%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26issue%3D1%26spage%3D13%26epage%3D19%26doi%3D10.1016%2F0165-6147%2891%2990483-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dilworth, J. R.</span>; <span class="NLM_string-name">Pascu, S. I.</span></span> <span> </span><span class="NLM_article-title">The Radiopharmaceutical Chemistry of Technetium and Rhenium</span>. In  <i>The Chemistry of Molecular Imaging</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, N. L. W.-T.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">164</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2F9781118854754.ch6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=137-164&author=J.+R.+Dilworth&author=S.+I.+Pascuauthor=N.+L.+W.-T.+Wong&title=The+Chemistry+of+Molecular+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2F9781118854754.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118854754.ch6%26sid%3Dliteratum%253Aachs%26aulast%3DDilworth%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Radiopharmaceutical%2520Chemistry%2520of%2520Technetium%2520and%2520Rhenium%26btitle%3DThe%2520Chemistry%2520of%2520Molecular%2520Imaging%26aulast%3DWong%26aufirst%3DN.%2BL.%2BW.-T.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2014%26spage%3D137%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span> <span> </span><span class="NLM_article-title">Tetraamine-coupled peptides and resulting <sup>99m</sup>Tc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">2655</span>– <span class="NLM_lpage">2667</span>, <span class="refDoi"> DOI: 10.2174/1568026611212230003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2174%2F1568026611212230003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=23339761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=2655-2667&issue=23&author=B.+Nockauthor=T.+Maina&title=Tetraamine-coupled+peptides+and+resulting+99mTc-radioligands%3A+an+effective+route+for+receptor-targeted+diagnostic+imaging+of+human+tumors&doi=10.2174%2F1568026611212230003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Tetraamine-coupled peptides and resulting 99mTc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors</span></div><div class="casAuthors">Nock, Berthold A.; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2655-2667</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The successful application of OctreoScan ([111In-DTPA]octreotide) in the diagnosis of sst2-expressing neuroendocrine tumors (NETs), on one hand, and the manifestation of peptide receptor targets in a wide range of human cancers, on the other, have synergistically induced a booming emergence of numerous radiolabeled peptide (radiopeptide) probes for tumor diagnosis and therapy in man.  Definition of mol. targets and their relation to neoplastic disease has preceded peptide-based radiopharmaceutical design and development.  New criteria have been set to safeguard efficient localization of radionuclides on tumor-assocd. high affinity - low capacity peptide receptor systems.  New tech. and biol. terms, such as specific activity or receptor affinity and internalization, have invaded the Radiopharmacy domain and have irrevocably altered our concept of radiopharmaceutical design.  Nonetheless, 99mTc remains the gold std. of diagnostic nuclear medicine as a result of ideal nuclear characteristics, cost-effectiveness and wide availability in high purity and high specific activity by means of com. 99Mo/99mTc-generators.  The evolution of conventional 99mTc-perfusion agents into modern state-of-the-art mol. radiopharmaceuticals has been a challenge addressed by several researchers.  The present review summarizes recent advances in the development of 99mTc-labeled peptides for in vivo targeting of neoplastic disease, and, in particular, those functionalized with acyclic tetraamines.  Conclusions on their applicability in non-invasive diagnosis and staging of cancer patients are drawn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5hbozbNVAzLVg90H21EOLACvtfcHk0liIqEDNM2RW7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlGqs70%253D&md5=f7464c81a9bfcc9b0d0b273431df9d72</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F1568026611212230003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611212230003%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DTetraamine-coupled%2520peptides%2520and%2520resulting%252099mTc-radioligands%253A%2520an%2520effective%2520route%2520for%2520receptor-targeted%2520diagnostic%2520imaging%2520of%2520human%2520tumors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26issue%3D23%26spage%3D2655%26epage%3D2667%26doi%3D10.2174%2F1568026611212230003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vigna, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantyh, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraud, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantyh, P. W.</span></span> <span> </span><span class="NLM_article-title">Localization of specific binding sites for bombesin in the canine gastrointestinal tract</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.1016/0016-5085(87)90257-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0016-5085%2887%2990257-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1987&pages=1287-1295&issue=6&author=S.+R.+Vignaauthor=C.+R.+Mantyhauthor=A.+S.+Giraudauthor=A.+H.+Sollauthor=J.+H.+Walshauthor=P.+W.+Mantyh&title=Localization+of+specific+binding+sites+for+bombesin+in+the+canine+gastrointestinal+tract&doi=10.1016%2F0016-5085%2887%2990257-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0016-5085%2887%2990257-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0016-5085%252887%252990257-5%26sid%3Dliteratum%253Aachs%26aulast%3DVigna%26aufirst%3DS.%2BR.%26aulast%3DMantyh%26aufirst%3DC.%2BR.%26aulast%3DGiraud%26aufirst%3DA.%2BS.%26aulast%3DSoll%26aufirst%3DA.%2BH.%26aulast%3DWalsh%26aufirst%3DJ.%2BH.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26atitle%3DLocalization%2520of%2520specific%2520binding%2520sites%2520for%2520bombesin%2520in%2520the%2520canine%2520gastrointestinal%2520tract%26jtitle%3DGastroenterology%26date%3D1987%26volume%3D93%26issue%3D6%26spage%3D1287%26epage%3D1295%26doi%3D10.1016%2F0016-5085%2887%2990257-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Old and new peptide receptor targets in cancer: future directions</span>. <i>Recent Results Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1007/978-3-642-27994-2_34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2F978-3-642-27994-2_34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=22918784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVehtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2013&pages=567-576&author=J.+C.+Reubi&title=Old+and+new+peptide+receptor+targets+in+cancer%3A+future+directions&doi=10.1007%2F978-3-642-27994-2_34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Old and New Peptide Receptor Targets in Cancer: Future Directions</span></div><div class="casAuthors">Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Recent Results in Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">Theranostics, Gallium-68, and Other Radionuclides</span>),
    <span class="NLM_cas:pages">567-576</span>CODEN:
                <span class="NLM_cas:coden">RRCRBU</span>;
        ISSN:<span class="NLM_cas:issn">0080-0015</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  A precise definition of the tumor tissue targets to be selected for in vivo peptide receptor targeting, namely to know which peptide receptor is expressed in which type of cancer, is an important prerequisite for successful clin. application of this technol.  In this short review, I give three selected examples of new and promising peptide receptor targets.  In the somatostatin receptor field, based on in vitro receptor autoradiog. expts. showing that much more sst2 binding sites are detected in tumors using a177 Lu-labeled sst2 antagonist than a177 Lu-labeled agonist, it can be proposed that, in addn. to neuroendocrine tumors, nonneuroendocrine tumors with lower sst2 levels such as breast carcinomas, renal cell carcinomas, and non-Hodgkin lymphomas may become potential candidates for sst2 antagonist targeting.  In the gastrin-releasing peptide receptor field, recent in vitro data show that not only tumor cells may overexpress gastrin-releasing peptide receptors but also neoangiogenic tumoral vessels, making tumors expressing high levels of gastrin-releasing peptide receptors in tumor vessels, such as ovarian or urinary tract cancers, attractive new candidates for gastrin-releasing peptide receptor targeting.  In the incretin receptor field, it was found in vitro that, apart from glucagon-like peptide 1 receptors overexpressed in benign insulinomas, incretin receptors, esp. the glucose-dependent insulinotropic polypeptide receptors, can be overexpressed in medullary thyroid cancers, an unexpected finding making also these tumors potential novel candidates for incretin receptor targeting.  Due to the abundance of peptide receptors in various cancers, it may be possible in the future to define for each tumor type a corresponding overexpressed peptide receptor suitable for targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Nx3l_MlZS7Vg90H21EOLACvtfcHk0liIqEDNM2RW7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVehtbo%253D&md5=61aa71c7dd4b59b0f44b0e2dcf909c61</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-27994-2_34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-27994-2_34%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DOld%2520and%2520new%2520peptide%2520receptor%2520targets%2520in%2520cancer%253A%2520future%2520directions%26jtitle%3DRecent%2520Results%2520Cancer%2520Res.%26date%3D2013%26volume%3D194%26spage%3D567%26epage%3D576%26doi%3D10.1007%2F978-3-642-27994-2_34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baum, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, H. R.</span></span> <span> </span><span class="NLM_article-title">THERANOSTICS: from molecular imaging using Ga-68 labeled tracers and PET/CT to personalized radionuclide therapy - the Bad Berka experience</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.7150/thno.3645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.7150%2Fthno.3645" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=437-447&issue=5&author=R.+P.+Baumauthor=H.+R.+Kulkarni&title=THERANOSTICS%3A+from+molecular+imaging+using+Ga-68+labeled+tracers+and+PET%2FCT+to+personalized+radionuclide+therapy+-+the+Bad+Berka+experience&doi=10.7150%2Fthno.3645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.7150%2Fthno.3645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.3645%26sid%3Dliteratum%253Aachs%26aulast%3DBaum%26aufirst%3DR.%2BP.%26aulast%3DKulkarni%26aufirst%3DH.%2BR.%26atitle%3DTHERANOSTICS%253A%2520from%2520molecular%2520imaging%2520using%2520Ga-68%2520labeled%2520tracers%2520and%2520PET%252FCT%2520to%2520personalized%2520radionuclide%2520therapy%2520-%2520the%2520Bad%2520Berka%2520experience%26jtitle%3DTheranostics%26date%3D2012%26volume%3D2%26issue%3D5%26spage%3D437%26epage%3D447%26doi%3D10.7150%2Fthno.3645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleischmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laderach, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friess, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span> <span> </span><span class="NLM_article-title">Bombesin receptors in distinct tissue compartments of human pancreatic diseases</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1807</span>– <span class="NLM_lpage">1817</span>, <span class="refDoi"> DOI: 10.1038/labinvest.3780192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1038%2Flabinvest.3780192" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2000&pages=1807-1817&issue=12&author=A.+Fleischmannauthor=U.+Laderachauthor=H.+Friessauthor=M.+W.+Buechlerauthor=J.+C.+Reubi&title=Bombesin+receptors+in+distinct+tissue+compartments+of+human+pancreatic+diseases&doi=10.1038%2Flabinvest.3780192"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.3780192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.3780192%26sid%3Dliteratum%253Aachs%26aulast%3DFleischmann%26aufirst%3DA.%26aulast%3DLaderach%26aufirst%3DU.%26aulast%3DFriess%26aufirst%3DH.%26aulast%3DBuechler%26aufirst%3DM.%2BW.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DBombesin%2520receptors%2520in%2520distinct%2520tissue%2520compartments%2520of%2520human%2520pancreatic%2520diseases%26jtitle%3DLab.%2520Invest.%26date%3D2000%26volume%3D80%26issue%3D12%26spage%3D1807%26epage%3D1817%26doi%3D10.1038%2Flabinvest.3780192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lantry, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappelletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddalena, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalfe, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattuada, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedle, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A. D.</span></span> <span> </span><span class="NLM_article-title"><sup>177</sup>Lu-AMBA: synthesis and characterization of a selective <sup>177</sup>Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1144-1152&issue=7&author=L.+E.+Lantryauthor=E.+Cappellettiauthor=M.+E.+Maddalenaauthor=J.+S.+Foxauthor=W.+Fengauthor=J.+Chenauthor=R.+Thomasauthor=S.+M.+Eatonauthor=N.+J.+Bogdanauthor=T.+Arunachalamauthor=J.+C.+Reubiauthor=N.+Rajuauthor=E.+C.+Metcalfeauthor=L.+Lattuadaauthor=K.+E.+Linderauthor=R.+E.+Swensonauthor=M.+F.+Tweedleauthor=A.+D.+Nunn&title=177Lu-AMBA%3A+synthesis+and+characterization+of+a+selective+177Lu-labeled+GRP-R+agonist+for+systemic+radiotherapy+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLantry%26aufirst%3DL.%2BE.%26aulast%3DCappelletti%26aufirst%3DE.%26aulast%3DMaddalena%26aufirst%3DM.%2BE.%26aulast%3DFox%26aufirst%3DJ.%2BS.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DEaton%26aufirst%3DS.%2BM.%26aulast%3DBogdan%26aufirst%3DN.%2BJ.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DMetcalfe%26aufirst%3DE.%2BC.%26aulast%3DLattuada%26aufirst%3DL.%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DSwenson%26aufirst%3DR.%2BE.%26aulast%3DTweedle%26aufirst%3DM.%2BF.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26atitle%3D177Lu-AMBA%253A%2520synthesis%2520and%2520characterization%2520of%2520a%2520selective%2520177Lu-labeled%2520GRP-R%2520agonist%2520for%2520systemic%2520radiotherapy%2520of%2520prostate%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26issue%3D7%26spage%3D1144%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Castiglione, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gozzini, L.</span></span> <span> </span><span class="NLM_article-title">Bombesin receptor antagonists</span>. <i>Crit. Rev. Oncol. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/1040-8428(96)00220-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F1040-8428%2896%2900220-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=8889369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADyaK2s%252FksVaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1996&pages=117-151&issue=2&author=R.+de+Castiglioneauthor=L.+Gozzini&title=Bombesin+receptor+antagonists&doi=10.1016%2F1040-8428%2896%2900220-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin receptor antagonists</span></div><div class="casAuthors">de Castiglione R; Gozzini L</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-51</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLOfsJIimRp0mhnSqMnvzDfW6udTcc2eZF-R9KOuoqL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FksVaqug%253D%253D&md5=1963743fcadc113b98822d5a10c57d85</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F1040-8428%2896%2900220-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1040-8428%252896%252900220-X%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCastiglione%26aufirst%3DR.%26aulast%3DGozzini%26aufirst%3DL.%26atitle%3DBombesin%2520receptor%2520antagonists%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D1996%26volume%3D24%26issue%3D2%26spage%3D117%26epage%3D151%26doi%3D10.1016%2F1040-8428%2896%2900220-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moody, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantey, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuselier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">23580</span>– <span class="NLM_lpage">23589</span>, <span class="refDoi"> DOI: 10.1074/jbc.M401938200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1074%2Fjbc.M401938200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=23580-23589&issue=22&author=T.+W.+Moodyauthor=S.+A.+Manteyauthor=T.+K.+Pradhanauthor=M.+Schumannauthor=T.+Nakagawaauthor=A.+Martinezauthor=J.+Fuselierauthor=D.+H.+Coyauthor=R.+T.+Jensen&title=Development+of+high+affinity+camptothecin-bombesin+conjugates+that+have+targeted+cytotoxicity+for+bombesin+receptor-containing+tumor+cells&doi=10.1074%2Fjbc.M401938200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M401938200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M401938200%26sid%3Dliteratum%253Aachs%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DMantey%26aufirst%3DS.%2BA.%26aulast%3DPradhan%26aufirst%3DT.%2BK.%26aulast%3DSchumann%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DFuselier%26aufirst%3DJ.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DDevelopment%2520of%2520high%2520affinity%2520camptothecin-bombesin%2520conjugates%2520that%2520have%2520targeted%2520cytotoxicity%2520for%2520bombesin%2520receptor-containing%2520tumor%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D22%26spage%3D23580%26epage%3D23589%26doi%3D10.1074%2Fjbc.M401938200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stangelberger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szepeshazi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, G.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=15671527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVehtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=49-57&issue=1&author=A.+Stangelbergerauthor=A.+V.+Schallyauthor=J.+L.+Vargaauthor=M.+Zarandiauthor=K.+Szepeshaziauthor=P.+Armatisauthor=G.+Halmos&title=Inhibitory+effect+of+antagonists+of+bombesin+and+growth+hormone-releasing+hormone+on+orthotopic+and+intraosseous+growth+and+invasiveness+of+PC-3+human+prostate+cancer+in+nude+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice</span></div><div class="casAuthors">Stangelberger, Anton; Schally, Andrew V.; Varga, Jozsef L.; Zarandi, Marta; Szepeshazi, Karoly; Armatis, Patricia; Halmos, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-57</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To det. whether antagonists of growth hormone-releasing hormone (GHRH) and bombesin/gastrin-releasing peptide (BN/GRP) can inhibit the orthotopic and metastatic growth of PC-3 human androgen-independent prostate cancers.  The effects of administration of GHRH antagonist MZ-J-7-118, BN/GRP antagonist RC-3940-II, and their combination on the growth and metastatic spread of PC-3 tumors implanted orthotopically into nude mice were evaluated.  The efficacy of this treatment on PC-3 tumors implanted intratibially and s.c. was also detd.  Treatment with MZ-J-7-118, RC-3940-II, or their combination significantly inhibited the growth of PC-3 tumors implanted orthotopically, intraosseously, and s.c.  The combination of the two antagonists had the greatest effect, inhibiting orthotopic tumor growth by 77%, intratibially implanted tumors by 86%, and s.c. tumors by 86%.  The therapy with BN/GRP and GHRH antagonists, esp. in combination, also reduced the local tumor spread and distant metastases in animals bearing orthotopic tumors.  Combination therapy was likewise the most effective in reducing the incidence and severity of tibial osteolytic lesions and pathol. fractures in intraosseously implanted tumors.  High-affinity binding sites for BN/GRP and GHRH were found in s.c. and orthotopic PC-3 tumor samples.  MZ-J-7-118, RC-3940-II, and the combination of both compds. inhibited in vitro growth of PC-3 cells.  Our findings show the efficacy of BN/GRP antagonists and GHRH antagonists for the treatment of advanced prostate cancer in preclin. metastatic models.  As BN/GRP antagonists are already in clin. trials and GHRH antagonists are effective in androgen-independent prostate cancer models, these analogs could be considered for the management of advanced prostate carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor8D9MdDfWC7Vg90H21EOLACvtfcHk0lhOH8DyZOL8xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVehtbY%253D&md5=819759d7579729e83c7f044006916a20</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStangelberger%26aufirst%3DA.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26aulast%3DVarga%26aufirst%3DJ.%2BL.%26aulast%3DZarandi%26aufirst%3DM.%26aulast%3DSzepeshazi%26aufirst%3DK.%26aulast%3DArmatis%26aufirst%3DP.%26aulast%3DHalmos%26aufirst%3DG.%26atitle%3DInhibitory%2520effect%2520of%2520antagonists%2520of%2520bombesin%2520and%2520growth%2520hormone-releasing%2520hormone%2520on%2520orthotopic%2520and%2520intraosseous%2520growth%2520and%2520invasiveness%2520of%2520PC-3%2520human%2520prostate%2520cancer%2520in%2520nude%2520mice%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26issue%3D1%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamharzi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szepeshazi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, R. Z.</span></span> <span> </span><span class="NLM_article-title">Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(97)10123-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2FS0959-8049%2897%2910123-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=710-717&issue=5&author=M.+Miyazakiauthor=N.+Lamharziauthor=A.+V.+Schallyauthor=G.+Halmosauthor=K.+Szepeshaziauthor=K.+Grootauthor=R.+Z.+Cai&title=Inhibition+of+growth+of+MDA-MB-231+human+breast+cancer+xenografts+in+nude+mice+by+bombesin%2Fgastrin-releasing+peptide+%28GRP%29+antagonists+RC-3940-II+and+RC-3095&doi=10.1016%2FS0959-8049%2897%2910123-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2897%2910123-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252897%252910123-X%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DLamharzi%26aufirst%3DN.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26aulast%3DHalmos%26aufirst%3DG.%26aulast%3DSzepeshazi%26aufirst%3DK.%26aulast%3DGroot%26aufirst%3DK.%26aulast%3DCai%26aufirst%3DR.%2BZ.%26atitle%3DInhibition%2520of%2520growth%2520of%2520MDA-MB-231%2520human%2520breast%2520cancer%2520xenografts%2520in%2520nude%2520mice%2520by%2520bombesin%252Fgastrin-releasing%2520peptide%2520%2528GRP%2529%2520antagonists%2520RC-3940-II%2520and%2520RC-3095%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1998%26volume%3D34%26issue%3D5%26spage%3D710%26epage%3D717%26doi%3D10.1016%2FS0959-8049%2897%2910123-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamma, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akyel, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2115</span>– <span class="NLM_lpage">2124</span>, <span class="refDoi"> DOI: 10.1002/chem.200902011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fchem.200902011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=20066690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2115-2124&issue=7&author=K.+Abirajauthor=R.+Mansiauthor=M.+L.+Tammaauthor=F.+Forrerauthor=R.+Cescatoauthor=J.+C.+Reubiauthor=K.+G.+Akyelauthor=H.+R.+Maecke&title=Tetraamine-derived+bifunctional+chelators+for+technetium-99m+labelling%3A+synthesis%2C+bioconjugation+and+evaluation+as+targeted+SPECT+imaging+probes+for+GRP-receptor-positive+tumours&doi=10.1002%2Fchem.200902011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Tetraamine-Derived Bifunctional Chelators for Technetium-99m Labelling: Synthesis, Bioconjugation and Evaluation as Targeted SPECT Imaging Probes for GRP-Receptor-Positive Tumours</span></div><div class="casAuthors">Abiraj, Keelara; Mansi, Rosalba; Tamma, Maria-Luisa; Forrer, Flavio; Cescato, Renzo; Reubi, Jean Claude; Akyel, Kayhan G.; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2115-2124</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Owing to its optimal nuclear properties, ready availability, low cost and favorable dosimetry, 99mTc continues to be the ideal radioisotope for medical-imaging applications.  Bifunctional chelators based on a tetraamine framework exhibit facile complexation with Tc(V)O2 to form monocationic species with high in vivo stability and significant hydrophilicity, which leads to favorable pharmacokinetics.  The synthesis of a series of 1,4,8,11-tetraazaundecane derivs. (01-06) contg. different functional groups at the 6-position for the conjugation of biomols. and subsequent labeling with 99mTc is described herein.  The chelator 01 was used as a starting material for the facile synthesis of chelators functionalised with OH (02), N3 (04) and O-succinyl ester (05) groups.  A straightforward and easy synthesis of carboxyl-functionalised tetraamine-based chelator 06 was achieved by using inexpensive and com. available starting materials.  Conjugation of 06 to a potent bombesin-antagonist peptide and subsequent labeling with 99mTc afforded the radiotracer 99mTc-N4-BB-ANT, with radiolabelling yields of >97 % at a specific activity of 37 GBq μmol-1.  An IC50 value of (3.7±1.3) nM was obtained, which confirmed the high affinity of the conjugate to the gastrin-releasing-peptide receptor (GRPr).  Immunofluorescence and calcium mobilisation assays confirmed the strong antagonist properties of the conjugate.  In vivo pharmacokinetic studies of 99mTc-N4-BB-ANT showed high and specific uptake in PC3 xenografts and in other GRPr-pos. organs.  The tumor uptake was (22.5±2.6) % injected activity per g (% IA g-1) at 1 h post injection (p.i.). and increased to (29.9±4.0) % IA g-1 at 4 h p.i.  The SPECT/computed tomog. (CT) images showed high tumor uptake, clear background and negligible radioactivity in the abdomen.  The promising preclin. results of 99mTc-N4-BB-ANT warrant its potential candidature for clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEM2EgIx-abVg90H21EOLACvtfcHk0lhOH8DyZOL8xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKrtbs%253D&md5=6579350a00c7e81c0eaf3725b59d1e3b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fchem.200902011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200902011%26sid%3Dliteratum%253Aachs%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DTamma%26aufirst%3DM.%2BL.%26aulast%3DForrer%26aufirst%3DF.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DAkyel%26aufirst%3DK.%2BG.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DTetraamine-derived%2520bifunctional%2520chelators%2520for%2520technetium-99m%2520labelling%253A%2520synthesis%252C%2520bioconjugation%2520and%2520evaluation%2520as%2520targeted%2520SPECT%2520imaging%2520probes%2520for%2520GRP-receptor-positive%2520tumours%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26issue%3D7%26spage%3D2115%26epage%3D2124%26doi%3D10.1002%2Fchem.200902011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krenning, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span> <span> </span><span class="NLM_article-title">“To serve and protect”: enzyme inhibitors as radiopeptide escorts promote tumor targeting</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.2967/jnumed.113.129411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.113.129411" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=121-127&issue=1&author=B.+A.+Nockauthor=T.+Mainaauthor=E.+P.+Krenningauthor=M.+de+Jong&title=%E2%80%9CTo+serve+and+protect%E2%80%9D%3A+enzyme+inhibitors+as+radiopeptide+escorts+promote+tumor+targeting&doi=10.2967%2Fjnumed.113.129411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.129411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.129411%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3D%25E2%2580%259CTo%2520serve%2520and%2520protect%25E2%2580%259D%253A%2520enzyme%2520inhibitors%2520as%2520radiopeptide%2520escorts%2520promote%2520tumor%2520targeting%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26issue%3D1%26spage%3D121%26epage%3D127%26doi%3D10.2967%2Fjnumed.113.129411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oçak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helbok, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peitl, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosabowski, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeman, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decristoforo, C.</span></span> <span> </span><span class="NLM_article-title">Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1426</span>– <span class="NLM_lpage">1435</span>, <span class="refDoi"> DOI: 10.1007/s00259-011-1818-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-011-1818-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=21528387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2mtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=1426-1435&issue=8&author=M.+O%C3%A7akauthor=A.+Helbokauthor=C.+Ranggerauthor=P.+K.+Peitlauthor=B.+A.+Nockauthor=G.+Morelliauthor=A.+Eekauthor=J.+K.+Sosabowskiauthor=W.+A.+Breemanauthor=J.+C.+Reubiauthor=C.+Decristoforo&title=Comparison+of+biological+stability+and+metabolism+of+CCK2+receptor+targeting+peptides%2C+a+collaborative+project+under+COST+BM0607&doi=10.1007%2Fs00259-011-1818-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607</span></div><div class="casAuthors">Ocak, Meltem; Helbok, Anna; Rangger, Christine; Peitl, Petra Kolenc; Nock, Berthold A.; Morelli, Giancarlo; Eek, Annemarie; Sosabowski, Jane K.; Breeman, Wout A. P.; Reubi, Jean Claude; Decristoforo, Clemens</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1426-1435</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Stability of radiolabeled cholecystokinin 2 (CCK2) receptor targeting peptides has been a major limitation in the use of such radiopharmaceuticals esp. for targeted radionuclide therapy applications, e.g. for treatment of medullary thyroid carcinoma (MTC).  The purpose of this study was to compare the in vitro stability of a series of peptides binding to the CCK2 receptor [selected as part of the COST Action on Targeted Radionuclide Therapy (BM0607)] and to identify major cleavage sites.  Methods: Twelve different 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-minigastrin/CCK conjugates were provided within an European COST Action (BM0607) by different labs. and radiolabeled with 177Lu.  Their in vitro stabilities were tested in fresh human serum.  Radiochem. yields (RCY) and intact radioligands for half-life calcns. were detd. by radio-HPLC.  Matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) anal. of metabolites was performed to identify cleavage products using conjugates labeled with excess stable natLu, incubated in serum at 37°C.  Urine metabolite anal. after injection in normal mice was performed by radio-HPLC anal.  Results: Variable stability in human serum was found for the different peptides with calcd. half-lives between 4.5 ± 0.1 h and 198 ± 0.1 h (n = 2).  In urine of normal mice only metabolised peptide fragments were detected even at short times after injection for all peptides.  MALDI-TOF MS revealed a major cleavage site of all minigastrin derivs. between Asp and Phe-NH2 at the C-terminal end.  Conclusion: Development of CCK2 receptor ligands esp. for therapeutic purposes in patients with MTC or small cell lung cancer (SCLC) is still ongoing in different labs.  This comparative study provided valuable insight into the importance of biol. stability esp. in the context of other results of this comparative trial within the COST Action BM0607.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpom7RrjISX8bVg90H21EOLACvtfcHk0liRHDWVZTxskw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2mtLk%253D&md5=01062dcc0b2bfb5cebe770d1763433d8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs00259-011-1818-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-011-1818-9%26sid%3Dliteratum%253Aachs%26aulast%3DO%25C3%25A7ak%26aufirst%3DM.%26aulast%3DHelbok%26aufirst%3DA.%26aulast%3DRangger%26aufirst%3DC.%26aulast%3DPeitl%26aufirst%3DP.%2BK.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMorelli%26aufirst%3DG.%26aulast%3DEek%26aufirst%3DA.%26aulast%3DSosabowski%26aufirst%3DJ.%2BK.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DDecristoforo%26aufirst%3DC.%26atitle%3DComparison%2520of%2520biological%2520stability%2520and%2520metabolism%2520of%2520CCK2%2520receptor%2520targeting%2520peptides%252C%2520a%2520collaborative%2520project%2520under%2520COST%2520BM0607%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2011%26volume%3D38%26issue%3D8%26spage%3D1426%26epage%3D1435%26doi%3D10.1007%2Fs00259-011-1818-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linder, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalfe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantry, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, R. E.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1171</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1021/bc9000189</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9000189" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1171-1178&issue=6&author=K.+E.+Linderauthor=E.+Metcalfeauthor=T.+Arunachalamauthor=J.+Chenauthor=S.+M.+Eatonauthor=W.+Fengauthor=H.+Fanauthor=N.+Rajuauthor=A.+Cagnoliniauthor=L.+E.+Lantryauthor=A.+D.+Nunnauthor=R.+E.+Swenson&title=In+vitro+and+in+vivo+metabolism+of+Lu-AMBA%2C+a+GRP-receptor+binding+compound%2C+and+the+synthesis+and+characterization+of+its+metabolites&doi=10.1021%2Fbc9000189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and in Vivo Metabolism of Lu-AMBA, a GRP-Receptor Binding Compound, and the Synthesis and Characterization of Its Metabolites</span></div><div class="casAuthors">Linder, Karen E.; Metcalfe, Edmund; Arunachalam, Thangavel; Chen, Jianqing; Eaton, Stephen M.; Feng, Weiwei; Fan, Hong; Raju, Natarajan; Cagnolini, Aldo; Lantry, Laura E.; Nunn, Adrian D.; Swenson, Rolf E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1171-1178</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metab. of 177Lu-AMBA (AMBA = DO3A-CH2CO-G-(4-aminobenzoyl)-QWAVGHLM-NH2), a radiotherapeutic compd. in clin. development that binds to GRP and NMB receptors, was studied in vitro (mouse, rat and human plasma, mouse kidney homogenate) and in vivo (by anal. of mouse and rat plasma and urine following IV injection of 177Lu-AMBA).  The primary metabolites were Lu-DO3A-CH2CO-G-Abz4-R, where R = -Q-OH (A), -QW-OH (B), and -QWAVGH-OH (C).  Minor amts. of (D) where R = -QWAVGHLM-OH and (E) -QWAVGHL-OH were also obsd.  Clearance of 177Lu-AMBA and of radioactivity from mouse and rat blood was rapid in vivo.  In mouse and rat urine, only metabolites Lu-A and Lu-B were found-no parent drug was excreted.  Unmetalated ligands and natLu and 177Lu complexes for Lu-AMBA metabolites A-E were synthesized, characterized by HPLC and MS, and used to perform in vitro competition and direct binding studies on GRP receptor-pos. PC-3 (human prostate) cancer cells.  Biodistribution studies with 177Lu-labeled metabolites A-E were performed in PC-3 tumor-bearing mice and the results compared with intact 177Lu-AMBA. IC50 values for unmetalated metabolite ligands A-E were >400 nM in PC-3 cells in competition binding studies against 177Lu-AMBA.  No direct binding to PC-3 cells was obsd. with 177Lu-labeled A-C, confirming IC50 results. 177Lu-labeled metabolites A-E showed no uptake in GRP-receptor pos. tumor or pancreas in PC-3 tumor bearing mice.  All metabolites were rapidly excreted via the renal route (∼78-87%) within 1 h.  These results demonstrate that the tumor uptake obsd. with 177Lu-AMBA is due to parent drug and not due to any of its identified metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqAOuUWHaErVg90H21EOLACvtfcHk0liRHDWVZTxskw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFGlsLY%253D&md5=da849967f62a36434ddaeae9a2f972eb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbc9000189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9000189%26sid%3Dliteratum%253Aachs%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DMetcalfe%26aufirst%3DE.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DS.%2BM.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DCagnolini%26aufirst%3DA.%26aulast%3DLantry%26aufirst%3DL.%2BE.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26aulast%3DSwenson%26aufirst%3DR.%2BE.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520metabolism%2520of%2520Lu-AMBA%252C%2520a%2520GRP-receptor%2520binding%2520compound%252C%2520and%2520the%2520synthesis%2520and%2520characterization%2520of%2520its%2520metabolites%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26issue%3D6%26spage%3D1171%26epage%3D1178%26doi%3D10.1021%2Fbc9000189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roques, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauge, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournie-Zaluski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, A.</span></span> <span> </span><span class="NLM_article-title">Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=8475170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADyaK3sXktVems7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=87-146&issue=1&author=B.+P.+Roquesauthor=F.+Nobleauthor=V.+Daugeauthor=M.+C.+Fournie-Zaluskiauthor=A.+Beaumont&title=Neutral+endopeptidase+24.11%3A+structure%2C+inhibition%2C+and+experimental+and+clinical+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology</span></div><div class="casAuthors">Roques, Bernard P.; Noble, Florence; Dauge, Valerie; Fournie-Zaluski, Marie Claude; Beaumont, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-146</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    </div><div class="casAbstract">A review with ∼600 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ShbW5r3kwrVg90H21EOLACvtfcHk0liRHDWVZTxskw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVems7g%253D&md5=880a50a3eb17ae3745cc6010949a8df3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoques%26aufirst%3DB.%2BP.%26aulast%3DNoble%26aufirst%3DF.%26aulast%3DDauge%26aufirst%3DV.%26aulast%3DFournie-Zaluski%26aufirst%3DM.%2BC.%26aulast%3DBeaumont%26aufirst%3DA.%26atitle%3DNeutral%2520endopeptidase%252024.11%253A%2520structure%252C%2520inhibition%252C%2520and%2520experimental%2520and%2520clinical%2520pharmacology%26jtitle%3DPharmacol.%2520Rev.%26date%3D1993%26volume%3D45%26issue%3D1%26spage%3D87%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Märki, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivier, J. E.</span></span> <span> </span><span class="NLM_article-title">Bombesin analogs: effects on thermoregulation and glucose metabolism</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/0196-9781(81)90027-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0196-9781%2881%2990027-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1981&pages=169-177&issue=Suppl.+2&author=W.+M%C3%A4rkiauthor=M.+Brownauthor=J.+E.+Rivier&title=Bombesin+analogs%3A+effects+on+thermoregulation+and+glucose+metabolism&doi=10.1016%2F0196-9781%2881%2990027-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0196-9781%2881%2990027-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0196-9781%252881%252990027-9%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4rki%26aufirst%3DW.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DRivier%26aufirst%3DJ.%2BE.%26atitle%3DBombesin%2520analogs%253A%2520effects%2520on%2520thermoregulation%2520and%2520glucose%2520metabolism%26jtitle%3DPeptides%26date%3D1981%26volume%3D2%26issue%3DSuppl.%25202%26spage%3D169%26epage%3D177%26doi%3D10.1016%2F0196-9781%2881%2990027-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shipp, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarr, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Switzer, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersh, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunday, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinherz, E. L.</span></span> <span> </span><span class="NLM_article-title">CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10662</span>– <span class="NLM_lpage">10666</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.23.10662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1073%2Fpnas.88.23.10662" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=10662-10666&issue=23&author=M.+A.+Shippauthor=G.+E.+Tarrauthor=C.+Y.+Chenauthor=S.+N.+Switzerauthor=L.+B.+Hershauthor=H.+Steinauthor=M.+E.+Sundayauthor=E.+L.+Reinherz&title=CD10%2Fneutral+endopeptidase+24.11+hydrolyzes+bombesin-like+peptides+and+regulates+the+growth+of+small+cell+carcinomas+of+the+lung&doi=10.1073%2Fpnas.88.23.10662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.23.10662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.23.10662%26sid%3Dliteratum%253Aachs%26aulast%3DShipp%26aufirst%3DM.%2BA.%26aulast%3DTarr%26aufirst%3DG.%2BE.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DSwitzer%26aufirst%3DS.%2BN.%26aulast%3DHersh%26aufirst%3DL.%2BB.%26aulast%3DStein%26aufirst%3DH.%26aulast%3DSunday%26aufirst%3DM.%2BE.%26aulast%3DReinherz%26aufirst%3DE.%2BL.%26atitle%3DCD10%252Fneutral%2520endopeptidase%252024.11%2520hydrolyzes%2520bombesin-like%2520peptides%2520and%2520regulates%2520the%2520growth%2520of%2520small%2520cell%2520carcinomas%2520of%2520the%2520lung%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26issue%3D23%26spage%3D10662%26epage%3D10666%26doi%3D10.1073%2Fpnas.88.23.10662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaloudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lymperis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krenning, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span> <span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labeled gastrins of varying peptide chain length: distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2016.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2Fj.nucmedbio.2016.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=27260775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVSmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=347-354&issue=6&author=A.+Kaloudiauthor=B.+A.+Nockauthor=E.+Lymperisauthor=E.+P.+Krenningauthor=M.+de+Jongauthor=T.+Maina&title=99mTc-labeled+gastrins+of+varying+peptide+chain+length%3A+distinct+impact+of+NEP%2FACE-inhibition+on+stability+and+tumor+uptake+in+mice&doi=10.1016%2Fj.nucmedbio.2016.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice</span></div><div class="casAuthors">Kaloudi, Aikaterini; Nock, Berthold A.; Lymperis, Emmanouil; Krenning, Eric P.; de Jong, Marion; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-354</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In situ inhibition of neutral endopeptidase (NEP) has been recently shown to impressively increase the bioavailability and tumor uptake of biodegradable gastrin radioligands.  Furthermore, angiotensin converting enzyme (ACE) has been previously shown to cleave gastrin analogs in vitro.  In the present study, we have assessed the effects induced by single or dual NEP/ACE-inhibition on the pharmacokinetic profile of three 99mTc-labeled gastrins of varying peptide chain length: [99mTc]SG6 ([99mTc-N4-Gln1]gastrin(1-17)), [99mTc]DG2 ([99mTc-N4-Gly4,DGlu5]gastrin(4-17)) and [99mTc]DG4 ([99mTc-N4-DGlu10]gastrin(10-17)).  Mouse blood samples were collected 5 min after injection of each of [99mTc]SG6/DG2/DG4 together with: (a) vehicle, (b) the NEP-inhibitor phosphoramidon (PA), (c) the ACE-inhibitor lisinopril (Lis), or (d) PA plus Lis and were analyzed by RP-HPLC for radiometabolite detection.  Biodistribution was studied in SCID mice bearing A431-CCK2R(+/-) xenografts at 4 h postinjection (pi). [99mTc]SG6 or [99mTc]DG4 was coinjected with either vehicle or the above described NEP/ACE-inhibitor regimens; for [99mTc]DG2 control and PA animal groups were only included.  Treatment of mice with PA induced significant stabilization of 99mTc-radiotracers in peripheral blood, while treatment with Lis or Lis + PA affected the stability of des(Glu)5 [99mTc]DG4 only.  In line with these findings, PA coinjection led to notable amplification of tumor uptake of radiopeptides compared to controls (P < 0.01).  Only [99mTc]DG4 profited by single Lis (2.06 ± 0.39%ID/g vs 0.99 ± 0.13%ID/g in controls) or combined Lis + PA coinjection (8.91 ± 1.61%ID/g vs 4.89 ± 1.33%ID/g in PA-group).  Furthermore, kidney uptake remained favorably low and unaffected by PA and/or Lis coinjection only in the case of [99mTc]DG4 (< 1.9%ID/g) resulting in the most optimal tumor-to-kidney ratios.  In situ NEP/ACE-inhibition diversely affected the in vivo profile of 99mTc-radioligands based on different-length gastrins.  Truncated [99mTc]DG4 exhibited overall the most attractive profile during combined NEP/ACE-inhibition in mouse models, providing new opportunities for CCK2R-expressing tumor imaging in man with SPECT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv__ZwhKqUzLVg90H21EOLACvtfcHk0licoyUdG3pxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVSmtbY%253D&md5=4d20b7eafbaa44cf42afb9721161f6de</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2016.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2016.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DKaloudi%26aufirst%3DA.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DLymperis%26aufirst%3DE.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3D99mTc-labeled%2520gastrins%2520of%2520varying%2520peptide%2520chain%2520length%253A%2520distinct%2520impact%2520of%2520NEP%252FACE-inhibition%2520on%2520stability%2520and%2520tumor%2520uptake%2520in%2520mice%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2016%26volume%3D43%26issue%3D6%26spage%3D347%26epage%3D354%26doi%3D10.1016%2Fj.nucmedbio.2016.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherry, S. R.</span></span> <span> </span><span class="NLM_article-title">Multimodality imaging: beyond PET/CT and SPECT/CT</span>. <i>Semin. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1053/j.semnuclmed.2009.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1053%2Fj.semnuclmed.2009.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=19646559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADC%252BD1MrivVKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=348-353&issue=5&author=S.+R.+Cherry&title=Multimodality+imaging%3A+beyond+PET%2FCT+and+SPECT%2FCT&doi=10.1053%2Fj.semnuclmed.2009.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodality imaging: beyond PET/CT and SPECT/CT</span></div><div class="casAuthors">Cherry Simon R</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Multimodality imaging with positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT has become commonplace in clinical practice and in preclinical and basic biomedical research.  Do other combinations of imaging modalities have a similar potential to impact medical science and clinical medicine? Presently, the combination of PET or SPECT with magnetic resonance imaging (MRI) is an area of active research, while other, perhaps less obvious combinations, including CT/MRI and PET/optical also are being studied.  In addition to the integration of the instrumentation, there are parallel developments in synthesizing imaging agents that can be viewed by multiple imaging modalities.  Is the fusion of PET and SPECT with CT the ultimate answer in multimodality imaging, or is it just the first example of a more general trend toward harnessing the complementary nature of the different modalities on integrated imaging platforms?</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxaXfvG57o1besJRIHUP1ofW6udTcc2eY0stBYVDeH-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrivVKqsA%253D%253D&md5=99bb34e6fe6bd598105df68df487ea67</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2009.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2009.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DS.%2BR.%26atitle%3DMultimodality%2520imaging%253A%2520beyond%2520PET%252FCT%2520and%2520SPECT%252FCT%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D39%26issue%3D5%26spage%3D348%26epage%3D353%26doi%3D10.1053%2Fj.semnuclmed.2009.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, F. F.,  Jr</span></span> <span> </span><span class="NLM_article-title">Diversification of <sup>99</sup>Mo/<sup>99m</sup>Tc separation: non-fission reactor production of <sup>99</sup>Mo as a strategy for enhancing <sup>99m</sup>Tc availability</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.2967/jnumed.114.149609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.2967%2Fjnumed.114.149609" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=159-161&issue=1&author=M.+R.+Pillaiauthor=A.+Dashauthor=F.+F.+Knapp&title=Diversification+of+99Mo%2F99mTc+separation%3A+non-fission+reactor+production+of+99Mo+as+a+strategy+for+enhancing+99mTc+availability&doi=10.2967%2Fjnumed.114.149609"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.149609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.149609%26sid%3Dliteratum%253Aachs%26aulast%3DPillai%26aufirst%3DM.%2BR.%26aulast%3DDash%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DF.%2BF.%26atitle%3DDiversification%2520of%252099Mo%252F99mTc%2520separation%253A%2520non-fission%2520reactor%2520production%2520of%252099Mo%2520as%2520a%2520strategy%2520for%2520enhancing%252099mTc%2520availability%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26issue%3D1%26spage%3D159%26epage%3D161%26doi%3D10.2967%2Fjnumed.114.149609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, P. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of stable rhenium(V) dioxo complexes with acyclic tetraamine ligands, [LReO<sub>2</sub>]<sup>+</sup></span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">4127</span>– <span class="NLM_lpage">4130</span>, <span class="refDoi"> DOI: 10.1021/ic00296a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic00296a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1988&pages=4127-4130&issue=23&author=D.+Parkerauthor=P.+S.+Roy&title=Synthesis+and+characterization+of+stable+rhenium%28V%29+dioxo+complexes+with+acyclic+tetraamine+ligands%2C+%5BLReO2%5D%2B&doi=10.1021%2Fic00296a010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fic00296a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00296a010%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DD.%26aulast%3DRoy%26aufirst%3DP.%2BS.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520stable%2520rhenium%2528V%2529%2520dioxo%2520complexes%2520with%2520acyclic%2520tetraamine%2520ligands%252C%2520%255BLReO2%255D%252B%26jtitle%3DInorg.%2520Chem.%26date%3D1988%26volume%3D27%26issue%3D23%26spage%3D4127%26epage%3D4130%26doi%3D10.1021%2Fic00296a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mantey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frucht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coy, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=762-774&issue=5&author=S.+Manteyauthor=H.+Fruchtauthor=D.+H.+Coyauthor=R.+T.+Jensen&title=Characterization+of+bombesin+receptors+using+a+novel%2C+potent%2C+radiolabeled+antagonist+that+distinguishes+bombesin+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMantey%26aufirst%3DS.%26aulast%3DFrucht%26aufirst%3DH.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DCharacterization%2520of%2520bombesin%2520receptors%2520using%2520a%2520novel%252C%2520potent%252C%2520radiolabeled%2520antagonist%2520that%2520distinguishes%2520bombesin%2520receptor%2520subtypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26issue%3D5%26spage%3D762%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armatis, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span> <span> </span><span class="NLM_article-title">Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound <sup>125</sup>I-(Tyr<sup>4</sup>) bombesin by tumor cells</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1002/pros.2990250105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1002%2Fpros.2990250105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=8022709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFKntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=29-38&issue=1&author=H.+Reileauthor=P.+E.+Armatisauthor=A.+V.+Schally&title=Characterization+of+high-affinity+receptors+for+bombesin%2Fgastrin+releasing+peptide+on+the+human+prostate+cancer+cell+lines+PC-3+and+DU-145%3A+internalization+of+receptor+bound+125I-%28Tyr4%29+bombesin+by+tumor+cells&doi=10.1002%2Fpros.2990250105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-[Tyr4]bombesin by tumor cells</span></div><div class="casAuthors">Reile, Herta; Armatis, Patricia E.; Schally, Andrew V.</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (New York, NY, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-38</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    </div><div class="casAbstract">Specific receptors for bombesin/gastrin releasing peptide (GRP) on the androgen-independent human prostate cancer cell lines PC-3 and DU-145 were characterized.  No specific binding of 125I-[Tyr4]bombesin to the androgen-dependent human prostate cancer cell line LNCaP was detectable.  The binding of 125I-[Tyr4]bombesin to PC-3 and DU-145 cells was time- and temp.-dependent, saturable, and reversible.  Scatchard anal. revealed a single class of binding sites with high affinity (Kd 9.8×10-11M for PC-3, and 9.1×10-11M for DU-145 cells at 25°) and with a binding capacity of 44,000 binding sites/cell and 19,000 binding sites/cell, resp.  Bound 125I-[Tyr4]bombesin was rapidly internalized by PC-3 cells.  The nonhydrolyzable GTP analog GTP-γ-S caused a dose-dependent inhibition of 125I-[Tyr4]bombesin binding to PC-3 and DU-145 cells, indicating that a G-protein couples the bombesin receptor to intracellular effector systems.  Bombesin and GRP(14-27) inhibited the binding of 125I-[Tyr4]-bombesin to both cell lines in a dose-dependent manner with inhibition consts. (Ki) of 0.5 nM and 0.4 nM, resp.  Both cell lines express the bombesin/GRP-preferring bombesin receptor subtype, since, in displacement studies, neuromedin B was >200-fold less potent than bombesin and GRP(14-27) in inhibiting the binding of 125I-[Tyr4]bombesin.  Two synthetic bombesin/GRP antagonists, RC 3095 and RC 3110, powerfully inhibited the specific binding of 125I-[Tyr4]bombesin with Ki 0.92 nM and 0.26 nM on PC-3 cells, and 3.3 nM and 0.89 nM on DU-145 cells, resp.  Apparently, the PC-3 and DU-145 human prostate cancer cell lines possess specific high-affinity receptors for bombesin/GRP, and are suitable models for the evaluation of the antineoplastic activity of new bombesin/GRP antagonists in the treatment of androgen-independent prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFBUt99JVPWLVg90H21EOLACvtfcHk0li4vM6RLMKPyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFKntro%253D&md5=a5d894000e1c9873fb8558798f89425f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fpros.2990250105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.2990250105%26sid%3Dliteratum%253Aachs%26aulast%3DReile%26aufirst%3DH.%26aulast%3DArmatis%26aufirst%3DP.%2BE.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DCharacterization%2520of%2520high-affinity%2520receptors%2520for%2520bombesin%252Fgastrin%2520releasing%2520peptide%2520on%2520the%2520human%2520prostate%2520cancer%2520cell%2520lines%2520PC-3%2520and%2520DU-145%253A%2520internalization%2520of%2520receptor%2520bound%2520125I-%2528Tyr4%2529%2520bombesin%2520by%2520tumor%2520cells%26jtitle%3DProstate%26date%3D1994%26volume%3D25%26issue%3D1%26spage%3D29%26epage%3D38%26doi%3D10.1002%2Fpros.2990250105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graham, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Eb, A. J.</span></span> <span> </span><span class="NLM_article-title">A new technique for the assay of infectivity of human adenovirus 5 DNA</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1016/0042-6822(73)90341-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1016%2F0042-6822%2873%2990341-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=4705382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A280%3ADyaE3s7otVyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1973&pages=456-467&issue=2&author=F.+L.+Grahamauthor=A.+J.+van+der+Eb&title=A+new+technique+for+the+assay+of+infectivity+of+human+adenovirus+5+DNA&doi=10.1016%2F0042-6822%2873%2990341-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A new technique for the assay of infectivity of human adenovirus 5 DNA</span></div><div class="casAuthors">Graham F L; van der Eb A J</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">456-67</span>
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjgl3m-H_dRM25P7XSLhESfW6udTcc2eZSeAIVmkuljrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s7otVyhuw%253D%253D&md5=b6b045d16d2f8fd2d73de105d571fbaa</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0042-6822%2873%2990341-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0042-6822%252873%252990341-3%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DF.%2BL.%26aulast%3Dvan%2Bder%2BEb%26aufirst%3DA.%2BJ.%26atitle%3DA%2520new%2520technique%2520for%2520the%2520assay%2520of%2520infectivity%2520of%2520human%2520adenovirus%25205%2520DNA%26jtitle%3DVirology%26date%3D1973%26volume%3D52%26issue%3D2%26spage%3D456%26epage%3D467%26doi%3D10.1016%2F0042-6822%2873%2990341-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotiriou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loudos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maintas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordopatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiotellis, E.</span></span> <span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Demotate, a new <sup>99m</sup>Tc-based [Tyr<sup>3</sup>]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.1007/s00259-002-0782-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=10.1007%2Fs00259-002-0782-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=12029547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVWnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=742-753&issue=6&author=T.+Mainaauthor=B.+Nockauthor=A.+Nikolopoulouauthor=P.+Sotiriouauthor=G.+Loudosauthor=D.+Maintasauthor=P.+Cordopatisauthor=E.+Chiotellis&title=%5B99mTc%5DDemotate%2C+a+new+99mTc-based+%5BTyr3%5Doctreotate+analogue+for+the+detection+of+somatostatin+receptor-positive+tumours%3A+synthesis+and+preclinical+results&doi=10.1007%2Fs00259-002-0782-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">[99mTc]demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results</span></div><div class="casAuthors">Maina, Theodosia; Nock, Berthold; Nikolopoulou, Anastasia; Sotiriou, Petros; Loudos, George; Maintas, Dimitrios; Cordopatis, Paul; Chiotellis, Efstratios</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">742-753</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Demotate is a new tetraamine-functionalised [Tyr3]octreotate deriv. that binds technetium-99m with a high efficiency under mild conditions.  The resulting radioligand, [99mTc]Demotate, forms in a high purity and is stable for at least 6 h after labeling.  The affinity of the unlabeled peptide for somatostatin receptors is high (IC50=0.13 nM) and comparable to that of [Tyr3]octreotate or [Tyr3]octreotide, as demonstrated by competition binding expts. in rat brain cortex or AR42J cell membrane prepns.  An equally very high affinity (Kd=0.07 nM) was exhibited by [99mTc/99gTc]Demotate during satn. binding expts. using rat brain cortex membrane homogenates.  The radioligand resisted hydrolytic degrdn. in mouse plasma and was excreted intact in mouse urine.  In vivo, [99mTc]Demotate cleared very rapidly from non-target tissues into the bladder via the kidneys, while radioactivity uptake in target organs was very high.  In mice bearing the exptl. AR42J tumor, [99mTc]Demotate demonstrated a very high tumor uptake at 1 h p.i. (25%ID/g) that remained high (20%ID/g) at 4 h p.i.  This uptake could be effectively blocked by co-injection of a high dose of [Tyr3]octreotate together with the radioligand.  High-quality planar and single-photon emission tomog. images were acquired 1 h after injection of [99mTc]Demotate in tumor-bearing mice, illustrating the excellent properties of this agent for somatostatin receptor tumor imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIcan4zmFhrVg90H21EOLACvtfcHk0li4vM6RLMKPyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVWnu7w%253D&md5=560a8036d7fda50be148fca8b586b592</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-0782-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-0782-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DSotiriou%26aufirst%3DP.%26aulast%3DLoudos%26aufirst%3DG.%26aulast%3DMaintas%26aufirst%3DD.%26aulast%3DCordopatis%26aufirst%3DP.%26aulast%3DChiotellis%26aufirst%3DE.%26atitle%3D%255B99mTc%255DDemotate%252C%2520a%2520new%252099mTc-based%2520%255BTyr3%255Doctreotate%2520analogue%2520for%2520the%2520detection%2520of%2520somatostatin%2520receptor-positive%2520tumours%253A%2520synthesis%2520and%2520preclinical%2520results%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2002%26volume%3D29%26issue%3D6%26spage%3D742%26epage%3D753%26doi%3D10.1007%2Fs00259-002-0782-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i37"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00177">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_70518"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00177">10.1021/acs.jmedchem.8b00177</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Radiochromatograms of [<sup>99m</sup>Tc]<b>4</b> incubates in fresh mouse plasma at 37 °C over time (Figure S1), radiochromatograms of [<sup>99m</sup>Tc]<b>4</b> incubates in fresh kidney homogenates at 37 °C and in urine (Figure S2), and tumor-to-nontarget tissue ratios for [<sup>99m</sup>Tc]<b>1</b>–[<sup>99m</sup>Tc]<b>6</b> at 1, 4, and 24 h pi (Figure S3) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_001.pdf">jm8b00177_si_001.pdf (426.32 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00177/suppl_file/jm8b00177_si_002.csv">jm8b00177_si_002.csv (2.24 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00177&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00177" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00177" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679944e7eb353d24","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
